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 Mammalian fertility is governed by a neural circuit that ultimately controls the activity 
of gonadotropin-releasing hormone (GnRH) neurons. Activation of GnRH neurons results in 
the pituitary release of luteinising hormone (LH) and follicle-stimulating hormone. Prior to 
ovulation, there is a surge in the release of LH, due to the increased activity of afferent 
kisspeptin neurons in the rostral periventricular area of the third ventricle (RP3V). These 
kisspeptin neurons are under the control of circadian inputs from the suprachiasmatic nucleus 
(SCN) and ovarian steroid hormone feedback. One key circadian input to kisspeptin neurons is 
the vasopressin (AVP) neurons from the SCN. Recent evidence has shown that AVP increases 
RP3V kisspeptin neuron activity, in relation to the level of ovarian steroids. As such, it is 
hypothesised that SCN AVP neurons are a key input onto RP3V kisspeptin neurons and their 
activation underpins the downstream activation of kisspeptin neurons and the resulting 
preovulatory LH surge.  
 Using genetically-mediated anterograde viral tract tracing, the projection from SCN 
AVP neurons was traced in the Avp-cre mouse model. Avp-cre projections to the RP3V were 
found in the RP3V and were in close appositions to kisspeptin neurons present. There was a 
significant correlation between the amount of viral-expression in Avp-cre neurons in the SCN 
to the density of projections seen in the RP3V; there was no correlation between other AVP-
expressing regions and the RP3V. This indicates that the Avp-cre projection to the RP3V is 
specifically from the SCN, rather than from other areas if the brain.  
 To determine whether the Avp-cre projections to RP3V kisspeptin neurons were 
communicating by GABAergic fast-synaptic transmission, a viral vector expressing a 
channelrhodopsin (ChR2) variant was injected into the SCN of female Avp-cre:Kiss1-hrGFP 
mice. Using short pulses of blue light, the ChR2-expressing projections were optogenetically 
stimulated while whole-cell electrophysiological recordings were made from identified 
kisspeptin neurons in the RP3V. Despite the Avp-cre appositions to RP3V kisspeptin neurons, 
very few received inhibitory postsynaptic currents from ChR2-expressing Avp-cre projections 
 
iii 
in response to optogenetic stimulation. There were no differences to this input across the 
oestrous cycle. 
 To determine the contribution of AVPergic to RP3V kisspeptin neurons, high-frequency 
light stimulation (HFLS) of Avp-cre projections was carried out whilst on-cell loose-patch 
recordings were made from identified RP3V kisspeptin neurons. There was a significant 
increase in kisspeptin firing rate following HLFS solely in proestrus, which was not seen in 
other oestrous cycle stages. This response was able to be blocked by the V1R antagonist 
Manning Compound, indicating it was mediated by AVP release. Surprisingly, a second 
response was found, solely in oestrus. Rather than a delayed, AVP-mediated excitation of 
kisspeptin neurons, an immediate inhibition in kisspeptin firing was noted. This response was 
not seen in other oestrous cycle stages. To determine the potential mechanism of this inhibition, 
the GABAAR antagonist, gabazine, was applied throughout HFLS. This inhibited the HFLS-
induced decrease during oestrus, suggesting it was mediated by GABA release. Both the 
excitatory and inhibitory responses seen across the oestrous cycle correlate to time points where 
the LH surge should and should not be initiated respectively. This points towards a mechanism 
by which SCN AVP neurons can either trigger or inhibit the onset of the LH surge.  
 This work was followed by an examination of the SCN-to-RP3V circuit in a mouse 
model of polycystic ovary syndrome (PCOS), which does not naturally mount an LH surge. In 
the prenatally androgen-treated (PNA) mouse model, the Avp-cre projection to the RP3V was 
reduced; as was the proportion of close appositions made with kisspeptin neurons. Despite this, 
kisspeptin neurons from the PNA mouse were able to respond to AVP application. 
 Overall, this work has confirmed a projection from SCN AVP neurons to RP3V 
kisspeptin neurons, that comprises an indirect pathway leading to GnRH neuron activation. 
Activation of this circuit shows oestrous cycle-dependent changes that are consistent with 
increases in neural activity at the time of the LH surge. Finally, as this circuitry is critical for 
the timing of the LH surge, its reduction in a clinically relevant mouse model, may be an 
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 Hormones involved in the control of fertility are released under tight circadian control. 
The circadian system controlling hormone release is within the brain’s master clock, an area of 
the brain known as the suprachiasmatic nucleus (SCN), located at the base of the hypothalamus. 
Vasopressin (AVP) neurons projecting from the SCN are suspected to exert a circadian tone 
onto kisspeptin neurons in the rostral periventricular region of the third ventricle (RP3V). These 
kisspeptin neurons, in turn project to gonadotropin-releasing hormone (GnRH) neurons that 
ultimately control mammalian fertility. This literature review will look at the role of this 
circuitry in the control of fertility, and how pathological conditions of endocrine-related 
infertility such as polycystic ovary syndrome (PCOS) may alter its function. 
 
1.1 The hypothalamic-pituitary-gonadal axis 
 Mammalian fertility is exquisitely controlled by the sequential release of hormones as 
part of the hypothalamic-pituitary-gonadal (HPG) axis. Essentially, GnRH is released from 
GnRH neurons in the hypothalamus into the vasculature of the median eminence. GnRH then 
travels in the portal vasculature to the anterior pituitary gland where it stimulates gonadotropin 
cells to release the gonadotropin hormones, luteinising hormone (LH) and follicle-stimulating 
hormone (FSH). These two hormones enter the peripheral bloodstream and act at either the 
ovaries or testes (in females and males respectively) to promote gametogenesis and sex steroid 
synthesis. The secreted sex steroids can then feedback to the hypothalamus and anterior 
pituitary gland to regulate gonadotropin release (Figure 1.1). 
1.1.1 GnRH neurons 






Figure 1.1: The hypothalamic-pituitary-gonadal axis.  
At the head of the HPG axis, GnRH neurons in the hypothalamus extend long projections to the median 
eminence where GnRH peptide is released (1). This travels in the blood to the anterior pituitary gland 
where it stimulates gonadotropin cells to release LH and FSH (2). These then act at the ovary or testis to 
cause the release of sex steroids: oestradiol (E2), progesterone (P4) and testosterone (T) (3). The sex 
steroids then act back at the hypothalamus and anterior pituitary gland to regulate the HPG axis. 
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neurons, which cluster in discrete populations, GnRH neurons show a scattered distribution 
throughout the forebrain. This is due to their migratory pattern during embryonic development, 
where they migrate from the nasal placode to the base of the brain (Cariboni et al., 2007). As 
such, GnRH neurons can be found along a continuum from the olfactory bulb through to the 
rostral preoptic area (rPOA), before diverging into two paths along either side of the third 
ventricle into the anterior and mediobasal hypothalamus (MBH) (Herbison, 2015). The key 
locus of the densest GnRH neuron population differs between species: sheep and rodents have 
the highest number of GnRH neurons in the rPOA (King & Anthony, 1984; Silverman et al., 
1987), while primates show the highest density in the MBH (Silverman et al., 1982; King & 
Anthony, 1984). 
Typical GnRH neurons have a bipolar configuration with a cell body and two opposing 
dendrites (King & Anthony, 1984; Campbell et al., 2009). Fifty to seventy per cent of the GnRH 
neurons extend these processes deep into the external zone of the median eminence (Silverman 
et al., 1987; Merchenthaler et al., 1989). Unlike typical neuroendocrine neurons, this projection 
is not strictly axonal. GnRH neuron projections near the median eminence can receive synaptic 
input and propagate action potentials (Herde et al., 2013). Thus, GnRH neuron 
hypophysiotropic projections are both dendritic and axonal in nature, resulting in their 
classification as ‘dendrons’ (Herde et al., 2013). At their distal extent, GnRH dendrons ramify 
into axon terminals that make contact onto median eminence blood vessels where the GnRH 
peptide is released (Herbison, 2015). 
 
1.1.2 Anterior pituitary gland and gonads 
 GnRH peptide travels in the portal bloodstream to the anterior pituitary gland, where it 
stimulates gonadotropes by binding the GnRH receptor (GnRHR). The GnRHR is a Gs-
protein-coupled receptor that drives the secretion of the gonadotropins, LH and FSH, into 
capillaries within the anterior pituitary gland and, thus, the peripheral bloodstream (Pelletier et 
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al., 1971; Luborsky-Moore et al., 1975). For normal fertility, the release of GnRH and 
downstream LH must be pulsatile (Belchetz et al., 1978; Clarke et al., 1986). Despite the 
importance of gonadotropes in the regulation of fertility, it is interesting to note that these only 
comprise up to 10% of the total anterior pituitary cell number (Yeung et al., 2006). The release 
of gonadotropins has been shown to faithfully mirror the secretion of GnRH (Clarke & 
Cummins, 1982; Moenter et al., 1992). It is thought that the frequency and amplitude of GnRH 
release can preferentially drive the release of either FSH or LH, with high-frequency GnRH 
release correlating to the preferential release of LH, and low GnRH secretion preferentially 
causing the release of FSH (Wildt et al., 1981; Savoy-Moore & Swartz, 1987). 
 Following release, LH and FSH act at their receptors (LHR and FSHR respectively), 
both of which are Gs-protein-coupled receptors, promoting gametogenesis and 
steroidogenesis. In the male, LH binds LHRs on interstitial testicular Leydig cells promoting 
the production of the androgens testosterone, androstenedione and dehydroepiandrosterone. 
Meanwhile, FSHR activation in testicular Sertoli cells stimulates the secretion of substances 
that promote spermatogenesis and maintain the health of the developing spermatids 
(Ramaswamy & Weinbauer, 2015). 
Unlike the male, the female has a set amount of immature gametes which require 
gonadotropin signalling to develop to maturity (Hunzicker-Dunn & Mayo, 2014). FSH initially 
acts to drive the growth of the follicular cells surrounding the oocyte, while LH drives the later 
expansion of the antral compartment surrounding the oocyte. Stimulation of the ovarian theca 
cell by LH drives the activation of enzymes that catalyse the conversion of cholesterol into 
steroids, particularly androstenedione. Androstenedione is then shuttled to the ovarian 
granulosa cell where it is converted to testosterone (Young & McNeilly, 2010). FSHR 
activation on the granulosa cell stimulates the production of aromatase enzymes that convert 
androgens to oestrogens, particularly 17-oestradiol (henceforth referred to as oestradiol) 
(Garzo & Dorrington, 1984). Just prior to ovulation, granulosa cells begin to express greater 
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levels of LHR (Kumar & Sait, 2011; Yung et al., 2014). This coincides with a higher serum LH 
concentration, which drives the release of the oocyte from the follicle, known as ovulation. The 
increase of LHR results in an endocrine change to the follicle. As ovulation is about to occur, 
the follicle becomes less receptive to oestradiol, decreases oestradiol output, and begins to 
secrete progesterone (Johnson, 2007b). The hormonal changes in the follicle allow the 
remaining granulosa cells, post-ovulation, to remodel into a postovulatory structure known as 
the corpus luteum. The corpus luteum is the main source of progestogens, predominantly 
progesterone, which are secreted to support the uterine endometrium for implantation should 
fertilisation occur, and then early pregnancy (Johnson, 2007a). 
 
1.1.3 Gonadal hormone feedback 
 The production of androgen, oestrogen and progestogen steroids from the gonads is 
critical for fertility and the support of peripheral reproductive tissues. These steroids regulate 
the level of GnRH, LH and FSH release from the brain and pituitary respectively to ensure 
homeostasis of hormone secretion. The roles of these in males and females and their control of 
the HPG axis will now be discussed. 
 
1.1.3.1 Gonadal hormone action in the male 
Testosterone is necessary for the development of secondary sexual characteristics, 
sexual behaviour and spermatogenesis. Importantly, however, it also acts as part of a negative 
feedback loop where its release from the testis results in inhibition of GnRH and gonadotropin 
release (Veldhuis et al., 1993). For negative feedback to occur, the androgen receptor (AR) 
must be activated by either testosterone or its reduction product 5-dihydrotestosterone (DHT). 
Despite being the predominant free androgen in the blood, testosterone has a weaker affinity 
for AR than does DHT (Grino et al., 1990). Negative feedback mediated by the AR is thought 
7 
 
to rely solely on testosterone rather than its metabolites, as treatment with chemical inhibitors 
of enzymes necessary for the conversion of testosterone to oestrogens or DHT do not 
significantly alter the plasma levels of gonadotropins (Sharma et al., 1999). Thus, oestrogen 
and DHT are unlikely to play a role in regulating GnRH release in the male. Activation of the 
AR by testosterone is sufficient to decrease the release of GnRH peptide into the median 
eminence (Caraty & Locatelli, 1988) and repress the Gnrh1 gene transcript (Brayman et al., 
2012). Conversely, the loss of AR in the brain significantly alters gonadotropin release, 
suggesting a role for AR-mediated negative feedback, particularly at the hypothalamus (Raskin 
et al., 2009). In the anterior pituitary, ARs expressed by gonadotropes decrease the cellular 
response to GnRH, further inhibiting the release of LH and FSH (Tobin et al., 1997). In 
gonadectomised (GDX) males there is also a measurable rise in circulating gonadotropins, 
which can be attenuated by testosterone replacement (Schanbacher, 1980; d’Occhio et al., 1983; 
Caraty & Locatelli, 1988). This shows that androgens, particularly those from the testes, are 
critical for negative feedback of the male HPG axis. The tonic feedback pattern seen in the male 
does not change over time; in contrast, however, feedback to the HPG axis in females is 
variable. For the remainder of this thesis, the focus will be on that of hormone changes and 
action in the female. 
 
1.1.3.2 Gonadal hormone action in the female 
 Feedback action in the female is variable depending on the stage of the ovarian cycle. 
Unlike the male, most testosterone synthesised in the gonad (i.e. the ovary) is rapidly oxidised 
to oestradiol, due to the action of aromatase enzymes. Oestradiol is necessary for the 
development and maintenance of secondary sexual features, sexual behaviour and maintenance 
of the oocyte. The levels of oestradiol fluctuate along the course of the ovarian cycle, or oestrous 





























































































































































































































































































































































































































dioestrus), the granulosa cell layer surrounding the oocyte thickens. This increase in the number 
of aromatase-producing cells drives greater oestradiol synthesis causing the concentration to 
peak prior to ovulation (during the rodent proestrus). Following ovulation, there is a rapid 
decline in oestradiol synthesis, as the degenerating granulosa cells become the corpus luteum 
and steroidogenesis switches mainly to the production of progesterone (the rodent oestrus). 
Throughout the luteal phase, increased progesterone is important to support the endometrium 
and, if fertilisation occurs, maintains early pregnancy; it also acts to suppress the release of 
GnRH, LH and FSH (Skinner et al., 1998). It is important to note here that most spontaneously 
ovulating rodents lack a true luteal phase, as the rodent metoestrus does not commonly last 
more than several hours (Smith et al., 1975).  
 Oestradiol acts at two key nuclear receptors: oestrogen receptor alpha (ER) and 
oestrogen receptor beta (ER) (Dahlman-Wright et al., 2006); and at two relatively 
understudied non-nuclear receptors: the membrane-bound oestrogen receptor, and an 
oestrogen-activated GPCR (Prossnitz et al., 2007; Micevych & Kelly, 2012). ER is more 
critical for fertility than ER. Seminal work by Lubahn et al. (1993) produced a global knockout 
(KO) of ER in a mouse line. Female mice display normal external sexual features but have 
severely hypoplastic uteri with small, cystic ovaries. Conversely, the ER-KO mouse shows 
overtly normal reproductive anatomy and can sufficiently support pregnancy without 
complication (Krege et al., 1998; Walker & Korach, 2004). These models have proved useful 
in determining the role that the individual oestrogen receptors may play in fertility. Further to 
this, the role of oestradiol is complicated by the fact that it does not solely feedback negatively 
to inhibit the HPG axis. As will now be discussed, the female HPG axis displays two patterns 
of activity in response to oestradiol feedback. 
 
1.1.3.3 Oestradiol negative feedback 
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 Classically, endocrine homeostasis is considered to be a cycle of hormone release 
followed by negative feedback into the hypothalamus and pituitary. In the female, this is the 
case over the majority of the ovarian cycle. Oestradiol synthesised by the granulosa cells 
negatively feeds back to the hypothalamus to inhibit the release of GnRH (Herbison, 2015). 
This negative feedback also occurs at the anterior pituitary gland, inhibiting the release of LH 
and FSH (Shaw et al., 2010). Given that ER-KO mice show overtly normal fertility (Cheong 
et al., 2014), it is likely that oestradiol-mediated feedback or GnRH neuron activity is 
unaffected in the ER-KO mouse (Krege et al., 1998). A mutant rat model with truncated ER 
appears to have attenuated oestradiol feedback but still has recognisable patterns of hormone 
changes (Rumi et al., 2017). This indicates that ER is not likely involved with oestradiol 
negative feedback in the HPG axis. In contrast, ER-KO mice have significantly higher serum 
LH levels (Couse & Korach, 1999; Couse et al., 2003) similar to that of ovariectomised (OVX) 
mice lacking ovarian tissue necessary for the production of oestradiol (Fink, 1988; Couse & 
Korach, 1999; Glidewell-Kenney et al., 2007). As such, the high levels of LH in the ER-KO 
mouse are indicative of a loss of oestradiol-mediated negative feedback, due to the knockout of 
ER. Thus, ER is likely to be the key receptor involved with oestradiol negative feedback. 
This negative feedback is unlikely to be direct at the level of the GnRH neurons as it has been 
shown that GnRH neurons only express ER and not ER (Herbison & Theodosis, 1992; 
Shughrue et al., 1997). Interestingly, some evidence suggests that the genomic effects of the 
ERs may be unnecessary, and rather a non-classical action of the ER may be sufficient for 
negative feedback potentially through a membrane bound ER (Glidewell-Kenney et al., 2007). 
 
1.1.3.4 Oestradiol positive feedback 
Unlike males, females show a second pattern of GnRH secretion due to a positive 
hormonal feedback during the mid-late follicular phase when oestradiol concentrations have 
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increased. Oestradiol positive feedback occurs in parallel with the increased thickening of the 
ovarian granulosa cell layer prior to ovulation. The aforementioned negative feedback that 
maintains LH at a basal concentration is essentially overridden by a positive feedback whereby 
the serum LH concentration rapidly increases, known as the LH surge. Portal bleeding studies 
in sheep have revealed that prior to ovulation, GnRH release gradually begins to increase, 
indicating the replacement of negative feedback by a stronger positive feedback (Caraty & 
Locatelli, 1988; Evans et al., 1995). Although rodent models are too small to reliably take portal 
blood to measure GnRH peptide release, they have revealed that at similar time points to the 
hypothesised increase in GnRH release, there is an increase in the activity of GnRH neurons 
(Christian et al., 2005) and an increase in GnRH neuron c-FOS expression, as a proxy for 
increased activity (Lee et al., 1990; Hoffman et al., 1993). 
 For positive feedback to occur, it is thought that oestradiol must be at a sufficiently high 
concentration for several hours to trigger the actions of negative feedback (Karsch et al., 1973; 
Legan et al., 1975; Legan & Karsch, 1975). Studies have shown that implants of oestradiol are 
sufficient to drive daily positive feedback and increase GnRH and LH release (Kalra & 
McCann, 1975; Bronson & vom Saal, 1979; Bronson, 1981; Christian et al., 2005). 
Interestingly, if the oestradiol implants are given and subsequently removed, the LH surge will 
still occur, indicating that oestradiol exposure makes a prolonged genomic change sufficient to 
drive several hours of positive feedback necessary for ovulation (Evans et al., 1997). This is 
dependent on the genetic oestrogen response element as part of the classical actions of 
oestradiol, rather than at membrane bound receptors (Glidewell-Kenney et al., 2007). Like 
oestradiol negative feedback, the positive feedback pattern is thought to be mediated by ER 
rather than ER. As ER-KO mice maintain an LH surge and are still fertile (Wintermantel et 
al., 2006), the necessary positive feedback prior to ovulation likely remains intact (Krege et al., 
1998). ER-KO mice, however, are infertile and do not show changes to GnRH neuron activity 
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or hormonal increases at the expected onset of positive feedback (Wintermantel et al., 2006; 
Glidewell-Kenney et al., 2007). 
 
1.1.3.5 Progesterone feedback 
 During the oestrus stage of the oestrous cycle, there is a marked change in the hormonal 
profile of the mouse, presenting with higher secretion of progesterone than oestradiol. 
Progesterone typically inhibits GnRH secretion and thus LH release (Goodman & Karsch, 
1980; Skinner et al., 1998), however, GnRH neurons do not express the progesterone receptor 
(PR) (Skinner et al., 2001). As such, an upstream neuronal population must mediate the effects 
of progesterone on the suppression of GnRH release. Mice lacking PR expression are unable to 
suppress LH release in response to progesterone and display significant reproductive 
abnormalities (Lydon et al., 1995; Chappel et al., 1997). 
 While it seems clear that progesterone action suppresses the GnRH neuronal network, 
there is evidence to suggest that PR signalling is also necessary to drive positive feedback. 
When rodents are primed with oestradiol following OVX, progesterone can mediate an increase 
in LH release when delivered in a pulsatile manner (Kim & Ramirez, 1982). When PR is 
specifically knocked out of the hypothalamus, however, this ability is lost (Stephens et al., 
2015; Gal et al., 2016). It has been hypothesised that increases in progesterone, prior to 
ovulation, may be mediated by progesterone synthesised within the brain itself (known as 
‘neuroprogesterone’) (Micevych & Sinchak, 2011). Neuroprogesterone produced in astrocytes, 
in response to astrocytic and neuronal ER activation (Micevych et al., 2003; Micevych et al., 
2007), could be acting to stimulate afferent neuron activity, thus exciting the GnRH neurons. 
This would coincide with the timing for oestradiol-mediated positive feedback, implicating 




1.2 Luteinising hormone release patterns  
While both FSH and LH are important for fertility, LH release more faithfully mirrors 
the secretion of GnRH. Thus, LH concentration is typically used as a read out for how the 
hypothalamus integrates oestradiol feedback. Over the course of the oestrous cycle, LH 
secretion patterns change in response to gonadal steroid hormone feedback. These different 
patterns of release will be the focus of the subsequent sections.  
 
1.2.1 Pulsatile LH release 
 For the majority of the oestrous cycle, LH is released in discrete, roughly hourly, pulses 
(Czieselsky et al., 2016). This mimics the secretion of GnRH, which in all mammalian species 
studied to date is also pulsatile (Dierschke et al., 1970; Nankin & Troen, 1971; Butler et al., 
1972; Gay & Sheth, 1972; Levine et al., 1982). Pulsatile GnRH release is necessary for 
appropriate LH secretion, as a constant infusion of GnRH downregulates the release of LH 
(Belchetz et al., 1978; Clarke et al., 1986). LH pulses have typically been studied in GDX 
animals in order to remove gonadal hormone negative feedback. 
How these pulses are generated has been contentious, however, several hypotheses have 
been presented. Historically it was suggested that the GnRH neurons themselves form an 
intrinsic pulse generator, where they are connected to allow synchronous output, where the 
population can intercommunicate by the release of neurotransmitters in order to coordinate a 
pulsatile release. In saying this, however, there is very little electrophysiological (or otherwise) 
evidence supporting a reciprocal communication pathway within the GnRH neuron population 
(Campbell et al., 2011). The idea of an intrinsic GnRH pulse generator came predominantly 
from in vitro brain slice work or using an immortalised GnRH cell line. These studies showed 
that GnRH neurons exhibit periods of spontaneous bursting activity (Terasawa et al., 1999a; 
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Terasawa et al., 1999b; Funabashi et al., 2001; Nunemaker et al., 2001), although this has not 
been recapitulated in vivo (Constantin et al., 2013). 
It is more likely that a population of neurons upstream of the GnRH neurons control the 
pulse generation. Deafferentation of GnRH neurons has proved particularly interesting when 
studying the external pulse generator. Rat MBH neurons show some contact with GnRH 
neurons, which, when removed, diminishes the pulse frequency (Halász & Gorski, 1967; Blake 
& Sawyer, 1974). This is similar to results seen with deafferentation from suprachiasmatic areas 
(Hoffman & Gibbs, 1982), though neither show complete abolishment of GnRH/LH pulses. 
Lesions of the rat and monkey arcuate nucleus (ARN) inhibit the occurrence of LH pulses (Plant 
et al., 1978; Soper & Weick, 1980), indicating the necessity of ARN neurons in pulse 
generation. Recordings of neurons in the ARN revealed pulsatile bursts as well as transient 
calcium increases occurring just prior to the onset of an LH pulse (Karsch et al., 1973; Ördög 
& Knobil, 1995; Clarkson et al., 2017). As such, the pulse generator is thought to reside in the 
ARN (Clarkson et al., 2017).  
 
1.2.2 The LH surge 
Unlike the pulses of LH, the preovulatory LH surge occurs once per oestrous cycle and 
can last hours such as in the rodent, up to a day in livestock such as sheep or cattle, or several 
up to several days in humans (Murr et al., 1973; Rawlings & Cook, 1993; McElhinny et al., 
1999; Ginther et al., 2013; Czieselsky et al., 2016). As mentioned, oestradiol reaches a 
threshold to trigger positive feedback and increases the activity, and the output, of GnRH 
neurons, however, it appears that only GnRH neurons located in the rPOA and around the 
organum vasculosum of the lamina terminalis (OVLT) express c-FOS (as a proxy for an 
increase in their activity) during the development of the surge (Lee et al., 1990; Wintermantel 
et al., 2006). The increasing levels of GnRH cause a massive rise in serum LH concentration, 
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which is then able to stimulate the induction of ovulation by driving the preovulatory follicle 
to release the oocyte (Kumar & Sait, 2011). 
How the onset of the LH surge occurs is a more difficult question. As discussed, rising 
oestradiol concentrations are critical in the development of positive feedback (Petersen et al., 
1989), particularly through its activity at ER. GnRH neurons do not express ER, so an 
oestrogen responsive brain region expressing ER, capable of exciting GnRH neurons would 
be a likely candidate driving the hormonal surge. Lesion studies have indicated that preoptic 
brain areas are key candidates for the development of the LH surge. A lesion of the area 
encompassing the anteroventral periventricular nucleus (AVPV) and periventricular nucleus 
(PeN), which together form a region coined the rostral periventricular region of the third 
ventricle (RP3V) (Herbison, 2008), results in an inhibition of oestradiol-mediated positive 
feedback and the loss of the LH surge, but not oestradiol-mediated negative feedback (Wiegand 
et al., 1980; Wiegand & Terasawa, 1982). 
The RP3V lies adjacent to the third ventricle and contains a heterogeneous population 
of neuronal phenotypes including the well-known kisspeptin neurons, whose specific role is 
discussed below (Herbison, 2008). Projections from the RP3V are known to project towards 
GnRH neurons (Polston & Simerly, 2006). Thus, RP3V neurons make perfect candidates for 
the generation of the LH surge, particularly as c-FOS is present in this area at the onset of the 
LH surge, indicating their activation (Clarkson et al., 2008). The classification of the neuronal 
phenotype responsible for GnRH activation includes the ability to classically respond to 
oestrogen through ER, as well as forming anatomical and functional projection to GnRH 
neurons (Clarkson & Herbison, 2009). While the studies looking at the RP3V and its role in the 
LH surge have mainly been rodent-focussed, this may not be the case for other species (Plant, 
2012, 2015). 
 
1.3 The GnRH neuronal network 
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Although GnRH neurons are considered the head of the HPG axis, it is more correct to 
consider them as the final output of the brain network regulating fertility. As mentioned, the 
key driver of homeostatic feedback mediating fertility are the sex steroids, that is, androgens, 
oestrogens and progestogens. Given that GnRH neurons do not express the AR, ER⍺ nor PR 
(Herbison & Theodosis, 1992; Huang & Harlan, 1993; Skinner et al., 2001), it is likely the 
afferent neuronal connections, that drive key changes in GnRH neuron activity, are associated 
with feedback. The ARN and RP3V regions have been noted as likely sites mediating sex 
steroid integration for negative and positive feedback resulting in changes in GnRH activity. 
The following section will introduce the likely neuronal phenotypes involved. 
 Multiple neurotransmitters and neuropeptides are known to alter the activity of GnRH 
neurons (Herbison, 2015). To classify these inputs, it is important to consider whether these 
inputs have a meaningful, functional impact on GnRH neuron activity, as well as whether the 
neurons that produce the peptides make anatomical inputs to GnRH neurons. Finally, it is 
necessary to know whether the neuronal afferents are either androgen or oestrogen receptive, 
to coordinate either negative or positive feedback. Combining these criteria, as well as looking 




Originally known as metastin, kisspeptin was defined by its inhibition of tumour 
metastasis (Lee et al., 1996). Isoforms of kisspeptin come in 54- (52- in rodents) 14-, 13- and 
10-amino acid sequences, each sharing a conserved C-terminus (Kotani et al., 2001; Bilban et 
al., 2004). Each isoform of kisspeptin is biologically active, although kisspeptin-10 (commonly 
referred to as simply kisspeptin) has the strongest action in terms of the GnRH neuronal network 
(Abbara et al., 2013). The role of kisspeptin in fertility  was uncovered when members of two 
consanguineous families showed inherited defects in the orphan G-protein-coupled receptor 
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GPR54, (later shown to be the kisspeptin receptor, Kiss1R), and exhibited hypogonadotropic 
hypogonadism, a disease characterised by failure to go through puberty, and infertility (de Roux 
et al., 2003; Seminara et al., 2003). The development of the GPR54-KO mouse line 
corroborated this finding, indicating the evolutionary conservation of Kiss1R as an essential 
regulator of fertility (Funes et al., 2003; Seminara et al., 2003). Kisspeptin itself must also be 
functional for adequate fertility. Patients with mutations in the kisspeptin gene, Kiss1, show 
similar patterns of infertility and hypogonadotropic hypogonadism to the Kiss1R mutations 
(Topaloglu et al., 2012), as do both the GPR54-KO and Kiss1-KO mice (Seminara et al., 2003; 
d'Anglemont de Tassigny et al., 2007; Clarkson et al., 2008).  
The question, then, is how does kisspeptin and associated downstream signalling 
contribute to the development of fertility? Kisspeptin injection in vivo is sufficient to drive the 
release of LH (Gottsch et al., 2004; Thompson et al., 2004; Han et al., 2005; Messager et al., 
2005). Well-designed work by Kirilov et al. (2013) using a mouse model with Kiss1R restored 
specifically in GnRH neurons, showed that the action of kisspeptin at GnRH neurons is critical 
for fertility, rather than elsewhere in the HPG axis. Kiss1R is a Gq-protein-coupled receptor 
and, as such, drives neuronal depolarisation. In the brain, Kiss1R is most densely expressed 
through the rostral preoptic area, hippocampus (particularly the dentate gyrus) and cerebellum, 
along with sparse expression in other hypothalamic and midbrain regions (Herbison et al., 
2010). Kisspeptin is the most potent stimulator of GnRH neurons and their electrical activity 
known to date (Han et al., 2005), causing long-lasting depolarisation of GnRH neurons even at 
the nanomolar concentration expected in vivo (Gottsch et al., 2004; Thompson et al., 2004; Han 
et al., 2005).This results in the closure of inwardly-rectifying potassium channels (Liu et al., 
2008; Zhang et al., 2008), as well as opening the transient receptor potential cationic channel 
4, potentiating the depolarising influx of cations (Liu et al., 2008; Zhang et al., 2008). 
It is clear that kisspeptin and its signalling through Kiss1R is critical for fertility. As 
mentioned in the previous section, there are two distinct populations of neurons controlling 
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either the pulsatile or the surge release of GnRH. Maybe not surprisingly, both the ARN and 
RP3V contain dense populations of kisspeptin neurons (Clarkson & Herbison, 2009; Yip et al., 
2015; Yeo et al., 2016), each of which will now be discussed in turn. 
 
1.3.1.1 KNDy neurons 
Within the ARN resides a dense population of kisspeptin neurons, that project to GnRH 
neurons, within the ARN, to other hypothalamic regions including the PVN and DMH, and the 
supramamillary nucleus (Yip et al., 2015). As well as being predominantly glutamatergic, 
arcuate kisspeptin neurons co-express two other functional peptides: neurokinin B (NKB) and 
dynorphin (Goodman et al., 2007; Navarro et al., 2009; Hrabovszky et al., 2010; Ramaswamy 
et al., 2010) resulting in their naming as KNDy (kisspeptin-neurokinin B-dynorphin) neurons 
(Lehman et al., 2010a). These arcuate kisspeptin neurons express the neurokinin 3 receptor and 
kappa-opioid receptor indicating that they are responsive to locally secreted NKB and 
dynorphin respectively (Navarro et al., 2009). Electrophysiological recordings of kisspeptin 
neurons show that NKB stimulates action potentials in KNDy neurons (Navarro et al., 2011; 
de Croft et al., 2013; Ruka et al., 2013); while dynorphin acts to suppress KNDy neuron activity 
(de Croft et al., 2013; Ruka et al., 2013).  
Similar to GnRH and LH secretion, kisspeptin neuron activity is also pulsatile (Choe et 
al., 2013; Clarkson et al., 2017), which is thought to be coordinated by the sequential release 
of NKB and dynorphin. Thus, the proposed mechanism for pulse generation begins with NKB 
release stimulating surrounding kisspeptin neurons to release kisspeptin at the median eminence 
GnRH terminals. The increased activity of KNDy neurons then causes the release of dynorphin 
to rapidly inhibit either itself or surrounding KNDy neurons, ceasing the release of kisspeptin, 
resulting in a burst of kisspeptin release, causing a pulse-like activation of the GnRH neuron 
(Navarro et al., 2009; Lehman et al., 2010a). Together, the KNDy neurons form an 
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interconnected network suspected to be responsible for their pulsatile activity pattern (Burke et 
al., 2006; Qiu et al., 2016). 
 
1.3.1.2 RP3V kisspeptin neurons 
The population of kisspeptin neurons in the RP3V is significantly different from those 
in the ARN. While the KNDy neurons form a synchronous network to coordinate activity, 
RP3V kisspeptin neurons do not. Rather, RP3V kisspeptin neurons rely on changes in ion 
channels and electrical activity dependent on activation of ER to coordinate their activity 
(Smith et al., 2005a; Clarkson et al., 2009; Frazão et al., 2013; Piet et al., 2013; Wang et al., 
2016). Like the ARN kisspeptin neurons, however, they do project to GnRH neurons, but in a 
more wide-spread pattern. The RP3V kisspeptin neurons are more likely to project to GnRH 
neuron somata and proximal dendrites, while the ARN kisspeptin neurons solely target GnRH 
neuron projections towards the median eminence (Clarkson & Herbison, 2006; Yip et al., 
2015). Further, the RP3V kisspeptin neurons also project to the dorsomedial and ventromedial 
hypothalamus, and bed nucleus of the stria terminalis (Polston & Simerly, 2006; Yip et al., 
2015). 
The RP3V kisspeptin population is sexually dimorphic. Females have a dramatic ten-
fold higher number of kisspeptin neurons throughout the RP3V compared to males (Smith et 
al., 2005a; Smith et al., 2005b; Clarkson & Herbison, 2006; Kauffman et al., 2007). This is 
perhaps not surprising, as males do not display an LH surge which is mediated by the RP3V 
kisspeptin neurons. The activation of RP3V kisspeptin neurons, as demarcated by c-FOS 
expression, is coincident with the expression of c-FOS in GnRH neurons at the time of the LH 
surge, indicating their vital role in surge development (Kinoshita et al., 2005; Smith et al., 2006; 
Clarkson et al., 2008). When this population of kisspeptin neurons are activated 





1.3.2 Oestrogenic feedback to kisspeptin neurons 
The feedback of oestrogen to kisspeptin neurons can easily be studied through OVX, 
where the endogenous oestrogen from the ovary is removed. OVX leads to ARN Kiss1 gene 
expression being massively upregulated (Smith et al., 2005a; Smith et al., 2006). The same 
holds true for GDX male rodents lacking endogenous testosterone production (Smith et al., 
2005b). Steroid negative feedback inhibits the spontaneous activity of ARN kisspeptin neurons 
and increases postsynaptic inhibitory currents (Frazão et al., 2013). In OVX animals, 
replacement of oestradiol is sufficient to restore the levels of kisspeptin to that of intact animals 
(Smith et al., 2005a), indicating a restoration of negative feedback. Further, some studies have 
suggested that some negative feedback may be independent of ER⍺ (Mayer et al., 2010; Wang 
et al., 2019). 
 In contrast to the ARN population of kisspeptin neurons, OVX and the removal of 
oestradiol decreases RP3V expression of kisspeptin (Smith et al., 2006), and decreases RP3V 
action potential firing (de Croft et al., 2012). This indicates that RP3V kisspeptin neurons are 
involved in positive feedback (Figure 1.3). During proestrus, when rodent oestradiol levels are 
high, RP3V kisspeptin neurons exhibit a higher hyperpolarisation-activated cation current (IH) 
(Piet et al., 2013; Zhang et al., 2013; Wang et al., 2016). potentially allowing greater rebound 
action potential firing and dampening of inhibitory postsynaptic currents. This rebound firing 
is dependent on transient low-threshold calcium currents, which have also been shown to be 
upregulated when circulating oestradiol is high (Zhang et al., 2013).  
 Oestradiol acts as an important mediator of feedback to kisspeptin neurons in female 
fertility. This project focusses on kisspeptin neurons in the RP3V that regulate positive 
feedback. Although the oestrogen feedback to the RP3V kisspeptin neuron population is 






Figure 1.3: Kisspeptin neurons control the hypothalamic-pituitary-gonadal axis. 
In the female, oestradiol (E2) negatively feeds back to the arcuate nucleus (ARN) kisspeptin neurons (1) 
to maintain a low, pulsatile secretion of gonadotropin-releasing hormone (GnRH) and luteinising hormone 
(LH) from the anterior pituitary (2). During proestrus, when circulating E2 levels rise, positive feedback 
occurs, stimulating the kisspeptin neurons in the rostral periventricular region of the third ventricle (RP3V) 
(3). This results in an increase in GnRH neuron activity, and the resulting surge output of LH (4). 
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1.4 Circadian regulation of fertility 
 In rodents, the LH surge is almost perfectly timed to occur prior to the active phase of 
proestrus (Murr et al., 1973; McElhinny et al., 1999). This allows ovulation to be timed to just 
before activity and sexual behaviour (McElhinny et al., 1997).  
In humans, a timed LH surge is debated. A study by Hoff et al. (1983) suggests that the human 
LH surge is not time-specific, and may occur any time throughout the day before ovulation. 
Their data, however, suggest that the LH surge is coincident with an exponential increase in 
serum oestradiol concentration (Hoff et al., 1983). In a more robust study, however, it was 
shown that the majority of LH surges occur at 0300 ± 1.5 h (Testart et al., 1982), providing 
some evidence that in humans, similar to rodents, ovulation occurs prior to the awake period. 
The majority of work looking at this phenomenon corroborates the data for the early morning 
LH surge in women, suggesting it may occur anywhere between 0000 h and 0900 h (Edwards, 
1981; Seibel et al., 1982; Cahill et al., 1998). While the link between oestradiol increase and 
the LH surge is clear, it is interesting to note that the LH surge is almost perfectly time-locked 
to the morning peak of cortisol occurring around 0800 h, and the initiation of an increase in 
serum progesterone (Kerdelhué et al., 2002). 
 
1.4.1 Oestrogenic regulation of a timed LH surge 
A link between the timed LH surge and fertility becomes clear with artificial 
manipulation of hormone levels in OVX animals. After bilateral OVX in the rat, subcutaneous 
capsules of oestradiol can be implanted, or oestradiol injected, to artificially raise the serum 
oestradiol concentration. This is thought to prime the RP3V kisspeptin neurons to just prior to 
the awake phase of the animal, where their activation causes the downstream LH levels to surge 
(Legan et al., 1975; Bronson & vom Saal, 1979; Christian et al., 2005). This phenomenon of 
an artificially induced LH surge repeats every 24 hours in the presence of the high concentration 
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of oestradiol and persists until oestrogen concentrations drop below a critical threshold (Legan 
et al., 1975; Legan & Karsch, 1975; Christian et al., 2005). This gives rise to the idea that 
something is timing the LH surge to repeat at a specific time point. Interestingly, this 24-hour 
repeating phenomenon can be blocked by the administration of barbiturates to the animal 
(Legan et al., 1975). Similarly, even in rodents without artificially increased oestradiol, 
barbiturate administration a few hours before the expected LH surge in proestrus delays the LH 
surge by almost exactly 24 hours (Everett & Sawyer, 1950). Thus, the inhibition of the neuronal 
component of the HPG axis by barbiturates, even in the presence of high oestradiol, will delay 
the surge. Further, this provides evidence for a daily signal of neural origin that can time the 
surge. 
 The first understanding of how the brain controls the circadian clock came from studies 
where regions of the brain were lesioned, and the resulting activity of the animal was monitored. 
Lesions of the rat suprachiasmatic region, including the suprachiasmatic nucleus inhibited the 
development of an LH surge (Wiegand et al., 1980; Wiegand & Terasawa, 1982), implicating 
the role of the SCN. 
 
1.5 The suprachiasmatic nucleus 
 The SCN is the locus of the brain’s biological clock. The SCN generates an endogenous 
circadian rhythm and receives input from neurons responsive to environmental changes, such 
as light, and synchronises its activity with the environment. A circadian rhythm is an oscillatory 
rhythm which occurs about a 24-hour time period, synchronised to the Earth’s day. Endogenous 
rhythms occur throughout the body and include behavioural rhythms such as locomotor 
behaviour, or physiological rhythms such as body temperature changes, hormone release and 
oestrous cycles (Hastings et al., 2018). The SCN coordinates these endogenous rhythms in 
response to environmental cues known as zeitgebers. Zeitgebers allow the SCN to synchronise 
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to external signals by a process known as entrainment. Without any zeitgebers or entrainment, 
an organism will rely solely on the changes in gene and protein expression occurring in its cells 
to maintain its rhythms. The most obvious zeitgeber is the change from dark to light as night 
becomes day. Animals most active in the day, such as humans, are considered to be diurnal 
species, while animals most active in the night, such as many rodents, are considered as 
nocturnal species. The introduction, or removal, of a zeitgeber from an organism’s 
environment, can reset the circadian rhythm.  
 Circadian rhythms originating from the SCN have been extensively studied. When the 
SCN is lesioned, circadian rhythms are essentially lost (Moore & Eichler, 1972; Stephan & 
Zucker, 1972; Wiegand et al., 1980; Brown & Nunez, 1986), and the organism is put into a 
state of arrhythmicity, where it does not respond to any zeitgeber. This reveals changes in 
locomotor activity, the sleep-wake cycle, and even oestrous cycles (Stetson & Watson-
Whitmyre, 1976; Wiegand et al., 1980). In order for these processes to occur, the intact SCN 
must have an oscillatory activity pattern. This pattern is controlled by a change in genetic and 
protein expression, known as a transcriptional-translational feedback loop (Welsh et al., 1995; 
Mohawk & Takahashi, 2011).  
 
1.5.1 Transcriptional-translational feedback loops 
Endogenous circadian rhythm is dependent upon changing gene expression and the 
resulting differences in protein expression. Genetic oscillation is not solely a feature of SCN 
neurons but occurs throughout cells in the body. Each cell contains a genetic regulatory element 
known as the enhancer box (EBox) upstream to the clock genes, which is sensitive to proteins 
vital to circadian rhythms. Circadian locomotor output cycles kaput (CLOCK) and brain and 
muscle Arnt-like protein-1 (BMAL-1) proteins in the neuronal cytoplasm dimerise, enter the 
nucleus and activate EBox for each gene. This stimulates the transcription of the REV-ERBα 
complex and the Period (PER) and Cryptochrome (CRY) proteins (Gekakis et al., 1998). 
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Throughout the day, REV-ERBα acts at the REV-ERBα response element (RRE) to inhibit the 
production of BMAL-1; while post-transcriptionally modified PER and CRY, along act to 
inhibit their own production by inhibiting BMAL-1 and CLOCK binding of their respective 
EBox (Eide et al., 2005; Partch et al., 2014). Furthermore, BMAL-1 and CLOCK are 
independently able to regulate the activity of genes within the SCN (Mohawk & Takahashi, 
2011). This forms a cycle of proteins being up- and downregulated throughout the course of the 
day (Figure 1.4a). This transcriptional-translational feedback loop lasts for a period of about 24 
hours (Welsh et al., 1995) providing evidence for an internal circadian oscillatory system, both 
in vivo as well as in tissue explants (Welsh et al., 1995; Foley et al., 2011).  
 
1.5.1.1 Electrical activity of the SCN 
 The relative change in protein expression over the 24-hour cycle results in a change in 
the electrical activity of SCN neurons. Thus, they act as intrinsic pacemaker cells (Colwell, 
2011). SCN neurons can maintain their rhythm in vivo (Inouye & Kawamura, 1979), ex vivo 
(Green & Gillette, 1982), and in tissue culture preparations (Welsh et al., 1995). During the 
day, SCN neurons have high rates of spontaneous action potential firing, which drops off 
towards the night (Figure 1.4) (Green & Gillette, 1982; Schaap et al., 2003); this is also true 
regardless of whether the animal is diurnal or nocturnal (Colwell, 2011). 
 During the day, the majority of SCN neurons are relatively depolarised with a resting 
membrane potential (RMP) near action potential threshold (~ -45 mV) (Colwell, 2011). The 
high depolarising drive to SCN neurons even results in a subset displaying an RMP of ≥ -30 
mV, functionally inhibiting their ability to fire action potentials (Belle et al., 2009). This 
depolarisation during the day is attributable to persistent sodium currents driving sodium influx 
in SCN neurons (Jackson et al., 2004; Kononenko et al., 2004; Flourakis et al., 2015). In order 







Figure 1.4: Circadian activity of individual SCN neurons. 
a) Arrangement of circadian gene expression. The REV-ERB⍺ response element (RRE) drives the 
production of BMAL-1. BMAL-1 and CLOCK dimerise to activate the EBox. EBox activation results in 
the production of PER, CRY and REV-ERB⍺. PER and CRY dimerise to breakdown of CLOCK and 
BMAL-1, while REV-ERB⍺ binds the RRE to restart the cycle. b) Throughout the course of the day, 
circadian changes in membrane channels in SCN neurons cause alterations in the overall activity of 
individual SCN neurons. A persistent sodium current (green) drives a high overall resting membrane 
potential (RMP) in SCN neurons. This is buffered by daily increases in the Na+-K+ ATPase (red). The 
extrusion of Na+ triggers further Na+ influx by the HCN channel (orange), also highly expressed during 
the day. There is also a low amplitude daily increase in L-/T-type calcium channels (yellow), further 
raising RMP. At night, these channels reduce expression. In turn, these are replaced by K2P channels 
(purple) and BK channels (blue) which increase the intracellular K+ concentration. This results in a 
lowering of RMP. This change in RMP throughout the course of the day results in the circadian changes 
in overall SCN neuron activity. 
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the day (Wang & Huang, 2006) to extrude excess Na+. Following the depolarisation of SCN 
neurons, there is a hyperpolarisation of the membrane voltage, sufficient to activate 
hyperpolarisation-activated cyclic-nucleotide-gated ion (HCN) channels. The activation of 
HCN channels drives an IH. The IH causes a rapid influx of Na+ causing a rebound depolarisation 
of SCN neurons to maintain the depolarised membrane potential (Akasu et al., 1993; de Jeu & 
Pennartz, 1997). The activity of HCN channels also shows a diurnal rhythm, potentially 
contributing to the diurnal excitation of the SCN (Atkinson et al., 2011). The final ionic 
contribution to the increased SCN activity is due to L- and T-type calcium channels. Although 
not providing a great contribution to SCN neuron depolarisation, the influx of calcium through 
L-/T-type calcium channels exhibits a low amplitude circadian oscillation to slightly increase 
the RMP of SCN neurons during the day (Pennartz et al., 2002; Jackson et al., 2004).  
During the night, SCN neurons are essentially silenced by downregulation of HCN and 
calcium channels resulting in a repolarisation of the RMP (Pennartz et al., 2002; Atkinson et 
al., 2011). This is coupled with an increase in K+ channels resulting in an approximate 10 mV 
decrease in RMP, compared to during the day (Kuhlman & McMahon, 2004). This nightly 
repolarisation is predominantly driven by an increase in K+ efflux by K+ leak currents through 
the two-pore potassium (K2P) channel. Towards the night, as depolarisation currents decrease 
resulting in a net repolarisation of SCN neurons, K2P channels become more active, thus, 
further reducing RMP (Kuhlman & McMahon, 2004; Colwell, 2011; Flourakis et al., 2015). 
K+ conductance is further enhanced at night by a peak in expression of Ca++-activated K+ (BK) 
channels (Pitts et al., 2006). BK channels respond to any Ca++ influx by increasing the K+ efflux 
to lower RMP. As such, these circadian changes in SCN neuron conductance underpin the 
relative changes in excitability, and thus, how the SCN is able to coordinate its output to other 
brain areas (Figure 1.4b). 
 
1.5.2 SCN anatomy 
28 
 
The SCN comprises a small nucleus (the rat SCN having a volume of ~ 0.07 mm3 (van den Pol, 
1980)) that lies bilaterally at the base of the third ventricle, atop the optic chiasm, in the anterior 
hypothalamus (Figure 1.5a). It is a dense nucleus consisting of a heterogeneous group of 
neuronal phenotypes; in saying this, however, the majority, if not all of these neurons, are 
GABAergic (Moore & Speh, 1993; Castel & Morris, 2000; Abrahamson & Moore, 2001). 
Despite its small size, the SCN is commonly divided into two sections, the dorsal shell and 
ventral core regions (Morin & Allen, 2006; Morin, 2013). The division of these regions is 
traditionally based around the expression of two key neuropeptides: AVP expressed in the shell, 
and vasoactive intestinal polypeptide (VIP) expressed in the core (Figure 1.5b) (van den Pol, 
1980). The SCN, however, does not only produce these two neuropeptides, but also contains a 
scattering of neurons that produce peptides either co-expressed with AVP/VIP, or discretely. 
These include gastrin-releasing peptide (GRP), substance P, cholecystokinin, somatostatin, 
neurotensin, prokineticin 2 (PK2), enkephalin, calretinin and calbindin (Cheng et al., 2002; 
Morin & Allen, 2006). Further, the SCN produces neuromedin S (NMS) and is the only nucleus 
in the brain to do so, colocalising with ~ 95% of all AVP and VIP positive cells (Lee et al., 
2015). 
 
1.5.2.1 Intra-SCN microcircuits 
 As there is a clear division in the SCN anatomy, it is important to consider how 
the two discrete regions coordinate their activity. Early work using electron microscopy 
revealed that SCN neurons extend local axonal projections which terminate within the opposing 
division(van den Pol, 1991), likely acting as a neuronal connection between the core and shell 
(Leak et al., 1999; Yan et al., 2007). Cell-filling data suggests that these axons are a mechanism 
by which SCN core neurons are communicating with SCN shell neurons (Drouyer et al., 2010). 







Figure 1.5: The suprachiasmatic nucleus is the locus of the brain’s biological clock. 
a) Greyscale Nissl-stained coronal brain slice taken at ~ bregma + 0.05 mm. Dense staining at the ventral 
aspect outlined shows the location of the suprachiasmatic nucleus. Image from Allen Brain Atlas. b) 
Diagrammatic representation of the arrangement of the SCN, with the third ventricle between the two 
sides, atop the optic chiasm. Red indicates the SCN shell typically demarcated by the presence of 
vasopressin (AVP) neurons; orange and purple indicate the SCN core, demarcated by the presence of 
vasoactive intestinal polypeptide (VIP) neurons and gastrin-releasing peptide (GRP). Other neuronal 
phenotypes are noted in their particular regions. GABA and neuromedin S (NMS), shown on the right, are 
spread throughout the SCN colocalising with multiple peptides. PK2 = prokineticin 2, CCK = 
cholecystokinin, SST = somatostatin, CALB = calbindin, SP = substance P, CALR = calretinin, NT = 
neurotensin, ENK = enkephalin.  
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core (Pennartz et al., 1998). Whether this is a site for SCN core axonal connections remains 
unknown. These dendrites may release AVP directly (Castel et al., 1996), similar to the 
dendrites of AVP neurons in the paraventricular and supraoptic nuclei (PVN, SON) (Ludwig 
& Leng, 2006). Another feature of intra-SCN connectivity is the presence of gap junctions. 
Adjacent SCN neurons are electrically coupled by gap junctions (Jiang et al., 1997), however, 
this appears to be restricted to neurons within either the core or the shell, rather than between 
the two (Colwell, 2000).  
As discussed prior, neurons within the SCN are capable of maintaining individual 
circadian rhythms, however, analysis of the entire SCN reveals a wave-like pattern of activity 
throughout the nucleus (Mohawk & Takahashi, 2011). AVP and VIP neurons show subtly 
different oscillation patterns but remain somewhat coordinated (Schwartz et al., 1983), 
potentially allowing for differences in their output. When the SCN neurons are dissociated in 
culture, individual circadian rhythms persist but the synchrony between neurons is lost (Welsh 
et al., 1995; Herzog et al., 2004). This indicates that cell-to-cell coupling is necessary for the 
robustness and precision of circadian signals within the SCN (Mohawk & Takahashi, 2011). 
Synchrony within the SCN is likely coordinated by intra-SCN release of NMS. When NMS 
neurons are inhibited in the SCN, there is complete desynchronisation of the SCN (Lee et al., 
2015). This implicates NMS as a key coordinating molecule of neuronal synchrony in the SCN. 
The gap junctions within the SCN are likely to electrically couple nearby SCN neurons 
as connexin-36-KO mice with functionally ablated gap junctions display dampened circadian 
behaviour (Long et al., 2005). Studies looking at the communication between the core and shell 
support the idea that VIP is the most likely neuropeptide coupling the two regions (Aton et al., 
2005). VIP application to SCN explants resets the rhythm of SCN neurons (Watanabe et al., 
2000), while SCN neurons from VIP receptor-KO and VIP deficient mice are arrhythmic 
(Harmar et al., 2002; Brown et al., 2007). VIP is likely coordinating the activity of the core and 
shell, however, their subtly distinct rhythms may be a discrete mechanism of controlling 
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different outputs to separate efferent targets. The two rhythms could, therefore, provide distinct 
control over multiple brain regions. 
 
1.5.3 Inputs to the SCN 
 The activity of SCN neurons is regulated by several inputs, the best characterised being 
inputs from the retina, the geniculate pathway, and the midbrain raphe nuclei. These brain 
regions are predominantly those that associate their activity with changes in the environment, 
particularly with photic cues from the retina. 
 
1.5.3.1 The retinohypothalamic tract 
 The key environmental zeitgeber is light. Animals detect light by changes in neuronal 
activity occurring in the retina. These photic inputs activate non-visual melanopsin-positive 
ganglion cells (Berson et al., 2002; Hattar et al., 2002), whose axons bundle into a large, 
subcortical pathway, called the retinohypothalamic tract (RHT), and project to within the 
hypothalamus (Moore & Lenn, 1972). The key termination of the RHT is the SCN, with 
bilateral innervation from each retina that is predominantly contralateral (Sadun et al., 1984). 
The RHT further projects to innervate habenular, collicular and geniculate nuclei (Hattar et al., 
2006). Here the focus will be on RHT projections to the SCN. 
 RHT innervation of the SCN is highly variable across species (Morin et al., 2006). The 
hamster, for example, has a dense RHT innervation of the entire SCN (Pickard & Silverman, 
1981), while other rodents tend to show an almost exclusive innervation to the SCN core (Morin 
& Allen, 2006; Lokshin et al., 2015; Fernandez et al., 2016).  
 Despite there being no consensus on the exact anatomical innervation of the SCN by 
the RHT, it is known that the neurotransmitters released from the RHT are capable of entraining 
SCN rhythms. The primary neurotransmitter released from the RHT is thought to be glutamate 
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(Hannibal, 2002). Glutamate and ionotropic glutamate receptor agonists are capable of exciting 
SCN neurons with glutamate receptors being found extensively throughout the SCN (Stamp et 
al., 1997). The activation of glutamate receptors in the SCN mimics the effect seen in the onset 
of the light phase (Mintz & Albers, 1997; Mintz et al., 1999). Although these effects are 
attributed to glutamate receptors, in vivo these results may be due to the release of a similar 
amino acid, aspartate. This is because typical glutamate markers such as the vesicular glutamate 
transporters are not abundant in the SCN (Fujiyama et al., 2003), thus, aspartate may be having 
a greater effect on SCN neurons than glutamate (Shibata et al., 1986), and that electrical 
stimulation of the RHT can cause both glutamate and aspartate to be released (Liou et al., 1986).  
 Pituitary adenylate cyclase-activating polypeptide (PACAP) is co-expressed in the RHT 
(Hannibal et al., 1997). PACAP alters the activity of SCN neurons similar to that caused by 
glutamate/aspartate, although not to such an extent (Hannibal et al., 1997; Harrington et al., 
1999). Interestingly, when both PACAP and glutamate are applied together, the resulting phase 
shift is greater than that caused by the individual neurotransmitters (Chen et al., 1999). 
Interestingly, the main PACAP receptor, VPAC1R is also activated by VIP, thus, this result 
may be a modulatory response caused by intra-SCN signalling.  
 
1.5.3.2 Other neuronal inputs to the SCN 
 While the RHT is the main input to the SCN, there are several other key neural inputs 
which drive changes in SCN neuron activity (Morin & Allen, 2006). Here, the two key inputs, 
the intergeniculate leaflet (IGL) and median raphe nucleus (MRN) will be discussed.  
The IGL receives input from the RHT, that then, in turn, is passed on to the SCN via 
the geniculohypothalamic tract, forming an indirect pathway from the retina (Morin et al., 
1992). The IGL neurons predominantly produce neuropeptide Y (NPY) (Card & Moore, 1982). 
The release of NPY within the SCN drives phase advances similar to glutamate/aspartate and 
PACAP (Biello et al., 1997), likely through the Y5 receptor (Lall & Biello, 2003). While the 
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retinal input to the IGL is coming from the RHT, the IGL is likely integrating the oculomotor 
and vestibular activity. This is then directed to the SCN to provide subtle cues to circadian 
rhythms based on the environmental stimuli (Morin & Blanchard, 2005; Morin & Allen, 2006). 
Other than the SCN, the IGL projects to other brain regions involved with the maintenance of 
circadian rhythms, one of which is the MRN (Morin & Blanchard, 2005). 
 In the midbrain, IGL input to the MRN activates serotonergic neurons (Hay-Schmidt et 
al., 2003). The release of serotonin (5-HT) from these inputs to the SCN, unlike those 
mentioned previously, acts to inhibit the SCN neurons resulting in a phase delay (Meyer-
Bernstein et al., 1997). The SCN contains at least six different 5-HT receptor types (Morin et 
al., 2006); that which mediates this effect, however, remains unclear. 5-HT levels in the SCN 
increase in response to non-photic (i.e. unrelated to light) stimuli, particularly during the night 
to inhibit SCN activity (Dudley et al., 1998). Although the effect of 5-HT in the SCN is subtle, 
it is thought to drive motivational cues for changes in behaviour coincident with changes in 
time, for example (Meyer-Bernstein et al., 1997; Glass et al., 2000). 
 
1.5.3.3 Hormonal inputs 
 Along with regulating hormonal output, the SCN is under the control of hormonal inputs 
(Tsang et al., 2014). In terms of circadian regulation, the secretion of the hormone melatonin, 
driven by SCN activation, acts to inhibit the output of SCN neurons (Liu et al., 1997). 
Melatonin is released from the pineal gland and acts as an entrainment signal in response to the 
onset of the dark phase, directly signalling to the SCN through melatonin-1 receptors (Gillette 
& McArther, 1996). The role of melatonin in resetting circadian period is particularly important 
in maintaining circadian rhythms, as it is still released in a circadian manner during free-running 
conditions (Armstrong et al., 1986), and in humans lacking the ability to respond to photic cues 
(Arendt & Broadway, 1987). 
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 Stress hormones also communicate with the SCN. Projections from the SCN to stress-
sensitive neurons in the PVN regulate daily fluctuations in glucocorticoid release (Vrang et al., 
1995). The resulting glucocorticoids released from the adrenal gland, however, are unable to 
feedback into the SCN, due to SCN neurons lacking glucocorticoid receptors (Pezük et al., 
2012). As such, glucocorticoids act at peripheral tissues to change their responsiveness to 
circadian input, as well as indirectly targeting the SCN via other brain circuits, causing the 
release of hormones, or by subtly changing glucose concentration to change SCN activity 
(Dickmeis, 2009; Tsang et al., 2014). 
The SCN exhibits a somewhat sexually dimorphic pattern of gonadal steroid hormone 
receptor expression. SCN AR expression is higher in males than females (Wu et al., 1995; 
Fernández-Guasti et al., 2000; Iwahana et al., 2008), and appears to be localised within the 
SCN core (Karatsoreos et al., 2007). The ability to relay androgenic signals to the biological 
clock, however, is not solely at the SCN, with indirect projection regions, such as the IGL and 
MRN also expressing high levels of AR in the male (Karatsoreos et al., 2007). Activation of 
the AR in these regions results in less precise entrainment to photic cues (Karatsoreos & Silver, 
2007); the physiological relevance of which, however, is yet to be revealed. PRs have been 
consistently identified in the primate SCN (Goldsmith et al., 1997; Kruijver & Swaab, 2002), 
although no work has been carried out in the rodent. ERs are expressed consistently higher in 
the SCN of females than males (Vida et al., 2008). ER has no, or very little, expression in the 
SCN (Shughrue et al., 1996; Goldsmith et al., 1997; Shughrue et al., 1997; Vida et al., 2008). 
ER, however, has a 5-fold higher expression than ER (Kruijver & Swaab, 2002; Vida et al., 
2008). In contrast to the AR, ERs are more densely expressed in the SCN shell than the SCN 
core (Vida et al., 2008). As mentioned, ER has little impact on female fertility, thus is unlikely 
to mediate any oestrogenic feedback of the GnRH neuronal network at the level of the SCN. 
Interestingly, de la Iglesia et al. (1999) report many ER-expressing afferent neurons which 
may relay oestrogenic cues to the SCN. It has been suggested that due to the gonadal steroid 
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receptors in the SCN, gonadal steroids may be influencing certain circadian rhythms 
(particularly body temperature and sexual behaviour), but it has yet to be shown whether these 
are direct at the SCN, or acting at afferent populations (Kruijver & Swaab, 2002). 
 
1.5.4 Outputs from the SCN 
 Research investigating the outputs from the SCN has been significantly hampered by 
the small size of the nucleus itself. Injection of dyes into the SCN has never been 100% 
replicable, revealing some targets and not others (Leak & Moore, 2001; Morin & Allen, 2006); 
while cell filling data only allows individual neurons in brain slices to be targeted at any one 
time (Yan et al., 2007). Further, little work has looked at the actual functional contributions of 
neurons from the SCN as part of wider neural networks. As such, the majority of work in this 
field is purely anatomical with the inference being that SCN neurons are relaying circadian cues 
to the nuclei to which they project (Morin & Allen, 2006). 
 
1.5.4.1 Axonal outputs from the SCN 
Anatomical approaches to studying the efferent SCN connections have predominantly 
involved the injection of anterograde tracers into the SCN and tracing the axonal outputs; or 
injection of retrograde tracers into regions thought to be innervated by the SCN and tracing the 
neurons back to the SCN. More recent immunohistochemical methods, where peptides present 
in the SCN are labelled and their projections identified, are problematic, as many of these 
peptides are not exclusively found in the SCN making it difficult to determine their origin 
(Abrahamson & Moore, 2001).  
The majority of SCN projections can be grouped into three categories: rostral 
projections, dorsal projections, and ventrocaudal projections (Watts et al., 1987). The rostral 
projections send axons from the SCN to the forebrain, particularly the bed nucleus of the stria 
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terminalis, ventrolateral septum and the anterior portion of the paraventricular thalamus (PVT) 
(Watts & Swanson, 1987; Morin et al., 1994; Abrahamson & Moore, 2001; Schwartz et al., 
2011). The dorsal SCN projections spread throughout the surrounding hypothalamus, and in 
general target nearby hypothalamic regions such as the medial preoptic area, PVN, OVLT, PeN 
and dorsomedial hypothalamus (Watts & Swanson, 1987; Watts et al., 1987; Kalsbeek et al., 
1993; Morin et al., 1994; Schwartz et al., 2011). The ventrocaudal projection tracks downwards 
from the SCN and along the optic tracts to innervate more caudal brain regions such as the 
posterior PVT and periaqueductal grey (Watts et al., 1987; Morin et al., 1994), as well as those 
associated with the optic tracts, such as the SON (Kalsbeek et al., 1993; Abrahamson & Moore, 
2001). Although some conflict remains between studies about the innervation of some areas by 
the SCN, this is likely due to differences in technique or particular injection sites between 
research groups. Table 1.1 provides a more complete list of the areas reported to be innervated 
by the SCN as well as outlining differences reported between groups and between species. 
The peptidergic characteristics of the axonal projections from the SCN remain largely 
unknown, due to the difficulty in tracing long immunohistochemically labelled fibres 
throughout the brain. Typically, it is thought that the majority of targets are innervated by both 
SCN core and SCN shell neurons to some extent (Morin & Allen, 2006). There do appear to be 
some distinct differences, however; the parvocellular division of the PVN is likely to only be 
targeted by SCN AVP neurons (Abrahamson & Moore, 2001; Leak & Moore, 2001), while the 
SON appears to be only targeted by SCN VIP neurons (Kalsbeek et al., 1993; Abrahamson & 
Moore, 2001). Work by Kalsbeek et al. (1993) took a contrasting approach to determine the 
phenotypic differences in targets; the SCN was lesioned and the absence of peptide-expressing 
fibres was quantified. Thus, lesioning the SCN provided an indication of whether peptide-







 (Rattus norvegicus or 
Arvicanthus niloticus) 
Hamster 
 (Mesocricetus auratus) 
References 
Arcuate nucleus   Yes e 







a, d, g, h 
Diagonal band of Broca  Yes  h 
Dorsomedial hypothalamus Yes† Yes* Yes†* a, d, e, f, g, h, i 
Intergeniculate leaflet  
No 
(Likely only from the Peri-SCN 
region b) 
Yes a, b, c, d, e, h 




Median preoptic area Yes 
Yes* 
(More ventral a) 
Yes* a, d, e, f, g, h 
Olivary pretectal area   Yes e 
Organum vasculosum of the 
lamina terminalis 
Yes* Yes No a; Yes* f f, g, h 
Parataenial nucleus Yes* Yes†  b, d, f, g, h 
Paraventricular nucleus Yes* 
Yes 
(Dense in the dorsal parvocellular 
division h, sparse in the 
magnocellular division h) 
Yes* 
(Dense in the dorsal parvocellular 
division a, d, e, sparse in the  
magnocellular division a, e) 
a, b, d, e, f, h 
Paraventricular thalamus Yes† Yes*† 
Yes† 
(Rostral a but may also 
be caudal e) 
a, d, e, f, g, h 
Periaqueductal grey matter  
Yes 




Periventricular nucleus Yes*  Yes e, f 
Precommisural nucleus  Yes Yes a, d 
Premammillary area  Yes Yes a, d, g 








Ventral preoptic area   Yes i 
Ventrolateral septum Yes Yes Yes a, b, d, e, f, h, i 
Ventromedial hypothalamus Yes 
Yes† 
(Sparse b, denser medially g) 
Yes a, b, d, e, f 
 
Table 1.1: Efferent projections from the SCN studied in four model species. 
Gaps in the table indicate that the projection has not been reported/examined. Reference methodologies - a: 
Watts et al. (1987): Rats of both sexes, injected with Phaseolus vulgaris leucoagglutinin (Pha-L) into the SCN 
for anterograde tracing. b: Watts and Swanson (1987): Rats of both sexes, retrograde tracing of true blue or 
SITS injected into regions of interest. c: Card and Moore (1984): Rats of both sexes, retrograde tracing of 
FluroGold or rhodamine-labelled latex beads injected into regions of interest. d: Kalsbeek et al. (1993): Male 
hamsters, injected with Pha-L into the SCN for anterograde tracing. e: Morin et al. (1994): Male hamsters, 
injected with Pha-L into the SCN for anterograde tracing. f: Abrahamson and Moore (2001): Male mice, 
immunohistochemical staining for SCN peptides looking in regions of interest. g: Leak and Moore (2001): Rats 
of both sexes, retrograde tracing of cholera toxin-β, FluoroGold, swine herpes virus/pseudorabies virus or 
biotinylated dextran amine injected into regions of interest. h: Schwartz et al. (2011): Female rats, injected with 
biotinylated dextran amine into the SCN for anterograde tracing. i: Kriegsfeld et al. (2004): Male hamsters, 
injected with biotinylated dextran amine into the SCN for anterograde tracing. *area reported to be innervated 
by AVP-expressing neurons; †area reported to be innervated by VIP-expressing neurons. 
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1.5.4.2 Diffusible outputs from the SCN 
As mentioned, the anatomical identity of the SCN outputs is much better understood 
than their functional relevance. Lesions of the SCN have been a key mechanism in determining 
not only the presence of a biological clock but how the SCN controls its outputs. Removal of 
the SCN completely removes an organism’s ability to entrain to cues, effectively abolishing 
typical circadian sleep-wake cycles and circadian locomotor behaviour as well as disrupting 
circadian endocrine rhythms and oestrous cycles (Wiegand et al., 1980; Wiegand & Terasawa, 
1982; Brown & Nunez, 1986; Watts et al., 1989). Silver et al. (1996) took this approach a step 
further, whereby after the SCN was lesioned, a graft of foetal SCN tissue encapsulated in a 
semi-permeable membrane was implanted into the site of the lesion. Interestingly, the foetal 
SCN tissue was able to restore locomotor rhythms, but not oestrous cycles (Meyer-Bernstein et 
al., 1999). The semi-permeable capsule surrounding the foetal SCN tissue inhibited the growth 
of new axons from the SCN, however, it still allowed small molecules to pass in and out of the 
graft. As such, it was hypothesised that SCN neurons released a diffusible signal to control 
some circadian rhythms, but not others. The identity of such a diffusible signal, however, 
remains unknown. AVP-deficient rats still maintain circadian rhythms, thus ruling out AVP as 
a candidate (Boer et al., 1999). Other potential signals include transforming growth factor-⍺ 
(TGF⍺) and PK2. TGF⍺ displays a circadian expression pattern similar to the circadian 
locomotor behaviour, which was restored in the foetal SCN grafts (van der Zee et al., 2005). 
TGF⍺ has also been shown to inhibit locomotion in free running conditions, however (Kramer 
et al., 2001). PK2 shows the opposite pattern of expression, with very low levels at night when 
locomotor behaviour is highest (Cheng et al., 2002). Unsurprisingly, PK2 has been shown to 
inhibit running wheel activity (Cheng et al., 2002). Interestingly, Prok2-KO mice are 
arrhythmic and struggle to entrain to external cues (Li et al., 2006).  
To summarise, while circadian rhythms in behaviour are likely controlled by a diffusible 
signal the axonal outputs from the SCN likely contribute to the control of reproductive status, 
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if not other endocrine processes as well (Kriegsfeld & Silver, 2006). The role of VIP and AVP 
as part of these axonal outputs will now be discussed. 
 
1.5.5 The role of VIP 
VIP is a 28 amino acid peptide predominantly acting in the digestive system to stimulate 
smooth muscle relaxation (Umetsu et al., 2011). In the brain, however, VIP is present in 
neurons in discrete nuclei, though in particularly dense quantities in the SCN (Besson et al., 
1986). VIP acts through two receptors, VPAC1R and VPAC2R, both of which are also able to 
bind PACAP (Usdin et al., 1994). mRNA for Vip oscillates within the SCN in a circadian 
manner (Dardente et al., 2004), indicating that it may act to coordinate circadian outputs from 
the SCN.  
As mentioned, the VIP neurons might be acting as an intermediate between the RHT 
and the rest of the brain to coordinate this entrainment signal. The SCN contains the densest 
population of VPAC2R (Usdin et al., 1994) colocalising to ~ 30% of VIP neurons in the SCN, 
and ~ 50% of AVP neurons (Kalamatianos et al., 2004b; Kalló et al., 2004). As such, VIP is 
able to influence the neurons within the SCN. VIP signalling is essential to circadian 
rhythmicity as all VIP- and VPAC2R-KO animal models are unable to maintain circadian 
locomotor rhythms (Harmar et al., 2002; Colwell et al., 2003). Interestingly, VPAC2R-KO 
models show a more severe disruption than the VIP-KO animals, potentially underlying a loss 
of contribution from PACAP signalling (Vosko et al., 2007). Aside from the loss of locomotor 
rhythms in KO animal models, SCN neurons in culture from VPAC2R-KO mice do not 
generate oscillations in electrical rhythm (Cutler et al., 2003; Aton et al., 2005), or have 
appropriate rhythms in their transcriptional-translational feedback loops (Harmar et al., 2002). 




SCN VIP neurons extend long projections to neurons mainly involved in 
neuroendocrine control of homeostasis (Abrahamson & Moore, 2001; Kalsbeek & Buijs, 2002). 
VIP-immunoreactive (-ir) fibres make close appositions with PVN corticotropin-releasing 
hormone and thyrotropin-releasing hormone neurons, as well as GnRH neurons in the preoptic 
area (Kalsbeek & Buijs, 2002). The hormones released from these neuroendocrine neurons are 
shown to have their own endogenous rhythms, and thus, the neurons may potentially be 
entrained by VIP signalling from the SCN. 
 
1.5.6 The role of AVP 
 AVP is a nonapeptide hormone expressed in three main areas of the brain, the PVN, 
SON and SCN. It is commonly associated with its role in antidiuresis and maintenance of blood 
pressure, due to its release from PVN and SON magnocellular neurons into the posterior 
pituitary gland (Bankir, 2001). AVP acts through three main receptors: V1a, V1b and V2 
receptors (V1aR, V1bR, V2R). The V2R is predominantly expressed in the lung and kidney 
tissue to regulate fluid balance (Robben et al., 2004). The V1Rs are localised to the brain, 
though do have some peripheral effects (Koshimizu et al., 2012). V1aR and V1bR within the 
brain are found particularly in the hypothalamus and are associated with behavioural responses 
(Tanoue et al., 2004; Volpi et al., 2004). It is thought, however, that the V1aR, and perhaps to 
some extent the V1bR mediate the effects of the circadian system (Li et al., 2009; Yamaguchi 
et al., 2013). 
 AVP was one of the first neurotransmitters identified within the SCN (Swaab et al., 
1975). It shows a circadian pattern of expression with higher mRNA and immunofluorescence 
noted during the hours following the onset of the light phase and lower expression during the 
dark phase (Jin et al., 1999; van der Veen et al., 2005; Maruyama et al., 2010), mirrored by its 
concentration in cerebrospinal fluid (Schwartz et al., 1983). This is due to activation of the Avp 
gene by the CLOCK/BMAL-1 complex (Jin et al., 1999), which accumulates during the day. 
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This increase in AVP may be synchronising the SCN subregions in response to the onset of the 
light phase (Maywood et al., 2011). Spontaneous activity of SCN neurons is correlated with 
the activity of neurons in the surrounding hypothalamus, and this can be abolished by 
application of an AVP receptor antagonist (Tousson & Meissl, 2004). As such, the activity of 
AVP neurons is likely to control the surrounding hypothalamic nuclei. 
 The exact mechanism of AVP control of circadian rhythms is confounded by conflicting 
results. V1aR-KO mice display impaired circadian locomotor activity (Li et al., 2009), although 
this is not recapitulated simply by antagonism of V1aRs in vivo (Stoynev & Nagai, 1996). 
Further, AVP-deficient Brattleboro rats do not show any behavioural changes (Groblewski et 
al., 1981). Therefore, AVP may not be critical in the circadian control of locomotor behaviour. 
The release of AVP from the SCN is more likely to be important in the circadian control of 
hormonal release. SCN lesions elevate the levels of corticosterone, as do V1R antagonists 
(Kalsbeek et al., 1992; Kalsbeek et al., 1996b); thus, AVP may inhibit the release of 
corticosterone as part of the hypothalamic-pituitary-adrenal axis, likely by changing activity of 
hypothalamic neurons (Kalsbeek et al., 1996a). In contrast, AVP appears necessary to permit 
fertility (Funabashi et al., 1999; Palm et al., 1999; Miller et al., 2006) as will now be discussed. 
 
1.6 Mechanisms for the circadian control of the LH surge 
 The biological clock is clearly implicated in the control of fertility via the HPG axis. 
GnRH neurons and kisspeptin neurons all express the necessary time keeping genes (as outlined 
in Section 1.5.1). GnRH and kisspeptin cell lines in culture show oscillations coupled to peptide 
synthesis (Chappel et al., 2003; Chassard et al., 2015; Jacobs et al., 2016). These changes, 
however, show more subtle effects in brain slice experiments and in vivo, with the circadian 
responses possibly gating hormone and neuropeptide responsiveness (Cai et al., 2008; Williams 
et al., 2011; Piet et al., 2016). Further, specific clock gene knock outs from specific cells in the 
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SCN, kisspeptin neurons, and GnRH neurons, show alterations in the timing (although not the 
complete inhibition) of the LH surge (Bittman, 2019). Peripherally, clock genes in the pituitary 
gonadotropes and ovary regulate GnRHR and LHR density (Sellix et al., 2013), respectively. 
Although these individual clocks may regulate certain circadian aspects of fertility, it is 
important to remember that when they are intact, but the SCN is lesioned, an LH surge is unable 
to be initiated. Thus, axonal outputs from the SCN are critical as a true circadian cue for the 
HPG axis. Anatomical studies of the projections from the SCN have revealed innervation of 
the GnRH neuronal network at different levels: at the GnRH neuron itself, and the upstream 
afferents controlling GnRH neuron activity.  
 
1.6.1 Direct circadian control of the HPG axis 
 The predominant innervation of the GnRH neuron by the SCN is by VIP neurons 
(Horvath et al., 1998; Kriegsfeld et al., 2002). This forms a direct network by which the SCN 
can innervate the HPG axis (Figure 1.6). Immunoreactive appositions have been found between 
VIP-expressing neuronal terminals and GnRH neurons (van der Beek et al., 1997; Horvath et 
al., 1998; Kriegsfeld et al., 2002; Mahoney & Smale, 2005). At the time of the LH surge, VIP-
expressing terminals can also be seen in apposition to GnRH neurons expressing c-FOS, 
indicating that they may be directly influencing GnRH neuron activity. GnRH neurons express 
VPAC2Rs (Olcese et al., 1997; Smith et al., 2000), indicating they are responsive to VIP. 
 The role of VIP in stimulating GnRH release in vivo is unclear. Injection of VIP into 
the brain has been shown to either increase (Vijayan et al., 1979), or decrease the release of 
LH(Samson et al., 1981; Alexander et al., 1985; Kimura et al., 1987; Akema et al., 1988; 
Ohtsuka et al., 1988). When VIP is reduced using antibodies injected into animals, or by 
antisense oligonucleotides, the LH surge is attenuated(Harney et al., 1996; van der Beek et al., 







Figure 1.6: SCN neurons control the hypothalamic-pituitary-gonadal axis. 
GnRH neurons in rPOA receive direct input from the vasoactive intestinal polypeptide (VIP)-expressing 
neurons in the SCN (1). The vasopressin (AVP)-expressing SCN neurons, however, relay their signal 
indirectly to the HPG axis via the RP3V kisspeptin neurons (2). Kisspeptin neurons act as an integrator 
for hormonal signals from the ovary such as oestradiol (E2), as well as circadian signals from the SCN. 
Together, this may coordinate the timing of the LH surge. 
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but VPAC2R-KO mice but have irregular oestrous cycles (Dolatshad et al., 2006; Loh et al., 
2014). Results in vitro are much clearer. VIP, when applied to explants of median eminence 
can cause the release of GnRH (Samson et al., 1981). This has been replicated in slices of 
hypothalamus with pituitary attached to show that it also stimulates the release of LH (Ohtsuka 
et al., 1988). Electrophysiological recordings from GnRH neurons show that VIP excites about 
half of those neurons tested (Christian & Moenter, 2008; Piet et al., 2016). While appositions 
between VIP neuron terminals and GnRH neurons has been established, the percentage of 
GnRH neurons apposed by VIP expressing terminals is significantly lower than the number of 
GnRH neurons activated at the time of the surge (Williams et al., 2011).  
Thus, it is more likely that an indirect pathway is a more potent activator of the LH 
surge. AVP is likely a contributor to the development of the LH surge (Funabashi et al., 1999; 
Palm et al., 1999), however, a direct AVP to GnRH neuron projection is unlikely. The relative 
expression of V1Rs and AVP-ir appositions to GnRH neurons is minimal (Kalamatianos et al., 
2004a; Jasoni et al., 2005; Mahoney & Smale, 2005). Further, AVP is unable to excite GnRH 
neurons (Piet & Herbison, unpublished).  
 
1.6.2 Indirect circadian control of the HPG axis 
 The indirect pathway between the SCN and HPG axis involves the relay of SCN 
signals through a secondary neural population. SCN projections to the RP3V have been 
identified (Watson Jr. et al., 1995; de la Iglesia et al., 1999), with AVP-ir fibres in apposition 
to kisspeptin neurons (Figure 1.6) (Williams et al., 2011). A second population of neurons 
expressing (Arg)(Phe)-related peptide-3 (RFRP-3) in the DMH also receive VIP-ir and AVP-ir 
inputs (Gibson et al., 2008; Russo et al., 2015). Both kisspeptin and RFRP-3 neurons do not 
show these immunoreactive appositions when the SCN is ablated, indicating their likely origin 
(Williams et al., 2011; Russo et al., 2015).  
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 RFRP-3 typically inhibits GnRH neurons and LH secretion (Tsutsui et al., 2000; 
Kriegsfeld et al., 2006; Anderson et al., 2009; Ducret et al., 2009). Thus, RFRP-3 and 
kisspeptin would act opposite to each other. SCN outputs to the RFRP-3 neurons are likely 
VIP-mediated, as exogenous VIP inhibits the RFRP-3 neuron activity at the time of the LH 
surge (Gibson et al., 2008; Henningsen et al., 2017). Despite SCN VIP neurons potentially 
inhibiting RFRP-3 neurons, there is very little VPACR expression in the DMH (Russo et al., 
2015), thus the exact mechanism for inhibition of RFRP-3 neurons remains unknown. Although 
there are AVP-ir fibres apposed to RFRP-3 neurons, AVP does not appear to affect RFRP-3 
neuron activity (Russo et al., 2015). While the SCN may act to disinhibit GnRH neurons (via 
inhibition of RFRP-3 activity) at the time of the LH surge, it is more likely that SCN neurons 
stimulate its onset. SCN core rhythms are in phase with kisspeptin neuron activity during the 
surge (Smarr et al., 2012), and as such, it would seem that SCN AVP neurons acting at RP3V 
kisspeptin neurons may be playing a more critical role. 
The role of AVP in the generation of the LH surge has been studied following dialysis 
of AVP into the preoptic area (POA) (Palm et al., 1999, 2001). AVP administration to the POA 
was shown to restore the LH surge in animals with SCN lesions (Palm et al., 1999). This was 
shown to be time-dependent, only working just prior to the expected onset of the LH surge 
(Palm et al., 2001). Interestingly, this is similar to mouse models showing Clock-gene KO. The 
Clock-KO mouse has disrupted oestrous cycles and is sub-fertile (Miller et al., 2004); and has 
reduced AVP expression in the SCN (Miller et al., 2006). Administration of AVP to Clock-KO 
mice rescues the LH surge (Miller et al., 2006). The data suggesting that an AVP-induced surge 
can be blocked with V1R antagonists is conflicting, but may be dependent on the time of 
administration (Funabashi et al., 2000b; Palm et al., 2001; Miller et al., 2006).  
Elegant work by Smarr et al. (2012) resulted in the production of a model of SCN 
desynchronization, where mice housed on an 11-hour light/11-hour dark cycle disrupted the 
coordination of circadian genes between the SCN core and shell; the individual activity of the 
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SCN core and shell could then be determined without interference from the other region. They 
determined that increased activity of the SCN shell occurred at the same time as the initiation 
of the LH surge (Smarr et al., 2012). This increase in activation was coincident with an increase 
in Kiss1 mRNA in the RP3V. There is a putative connection between these effects and AVP, 
as AVP neurons are found in the SCN shell. Thus, the SCN shell, and potentially the AVP 
neuron, input activates the RP3V kisspeptin neurons to drive the surge (Smarr et al., 2012). 
RP3V neurons, as well as identified RP3V kisspeptin neurons, have also been shown to express 
V1aRs, with their number proportional to the serum concentration of oestradiol (Funabashi et 
al., 2000a; Kalamatianos et al., 2004a; Williams et al., 2011). Further, they are able to respond 
to exogenous application of AVP increasing action potential firing (Piet et al., 2015b).  
GnRH neuron activation, as stimulated indirectly by SCN AVP output to RP3V 
kisspeptin neurons, seems to prevail as the key candidate for the integration of hormonal and 
circadian cues driving the preovulatory surge. The integration of these two cues by RP3V 
kisspeptin neurons appears to be necessary to stimulate the GnRH neurons to increase their 
activity resulting in a surge of hormones. As such, this circuit has a high impact for mammalian 
fertility that has not yet fully been explored.  
 
1.6.3 Circadian-disrupted infertility 
As mentioned, lesions of the SCN abolish the oestrous cycle, indicating the SCN is vital 
for fertility. Changes in an animal’s light cycle can also alter ovarian function and oestrous 
cycles (Lawton & Schwartz, 1967), indicating the role normal circadian patterns have in 
fertility. In humans, circadian disruption has anecdotally been attributed to changes in female 
fertility, though scientific evidence for this is not robust (Gamble et al., 2013). Changes in 
menstrual cycle patterns have been reported in female shift-workers who do not work in typical 
daylight hours (Gamble et al., 2013). This results in changes reported in pregnancy and the 
health of offspring (Knutsson, 2003; Bonzini et al., 2011). As such, alterations in circadian 
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behaviour, or changes to the neural circuitry involved with it, could result in drastic conditions 
of infertility. One such condition, that may include pathophysiological disruption to this circuit, 
is PCOS. Women with PCOS show impairments in gonadotropin release and are often 
anovulatory suggesting impairments in the GnRH neuronal network. 
 
1.7 Polycystic ovary syndrome 
PCOS is the most common cause of endocrine-disrupted infertility affecting females 
worldwide (Azziz et al., 2004). Despite its prevalence, the exact aetiology remains unknown. 
There are several competing theories for the cause of PCOS, including genetic abnormalities, 
metabolic abnormalities, and chemical exposure during in utero development (Moore & 
Campbell, 2017). Further, it is still unclear as to whether these changes act alone or whether a 
combination of factors play into disease development.  
 PCOS was first characterised by Stein and Leventhal (1935) in women presenting with 
menstrual abnormalities, androgynous features and the eponymous polycystic ovaries. Despite 
this, however, PCOS is a much more heterogeneous disease than initially suspected. The current 
criteria for the broad diagnosis of PCOS were outlined by the Rotterdam Committee (2004) and 
involve the presence of three cardinal criteria: oligo- or anovulation; hyperandrogenaemia 
without other explanatory factors such as androgen-secreting tumours; and the presence of 
fluid-filled cysts on the ovary. Diagnosis by two or three of these criteria results in reportedly 
5-20% of women of reproductive age having PCOS (Asunción et al., 2000; March et al., 2010; 
Yildiz et al., 2012). 
 Secondary to the cardinal features of PCOS are associated downstream symptoms, 
particularly those caused by hyperandrogenaemia. These include hirsutism, persistent acne and 
alopecia (Apridonidze et al., 2005), as well as other hormonal changes such as increased serum 
concentration of anti-Müllerian hormone (Pigny et al., 2003; Tata et al., 2018). Further, PCOS 
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is associated with coincident diseases such as obesity, cardiovascular disease and insulin 
resistance (Apridonidze et al., 2005). To combat the disease, treatment options are symptom 
based, including hormonal contraceptives and androgen receptor antagonists, anti-diabetic 
drugs to target metabolic changes, or high concentration hormones to restore ovulation (Ndefo 
et al., 2013). 
 In order to help dissect specific causative factors for PCOS, several animal models of 
the PCOS-like phenotype have been developed (Stener-Victorin et al., 2020). To date, the most 
common method for this is androgen administration during foetal development – termed 
prenatal androgen treatment. Prenatal androgen treatment involves delivery of androgens to a 
pregnant mother where the subsequent hyperandrogenism causes changes to the offspring. The 
androgen exposure in utero causes the female offspring to display their own 
hyperandrogenaemia later in life (Silva et al., 2018). Prenatally androgen-treated (PNA) models 
closely resemble the PCOS phenotype, including changes in ovarian function, 
hyperandrogenaemia and metabolic dysfunction; which have been shown in monkeys (Abbott 
et al., 2008), sheep (Birch et al., 2003; Smith et al., 2009), rats (Foecking et al., 2005; Wu et 
al., 2010) and mice (Sullivan & Moenter, 2004; Moore et al., 2013). These changes may be 
programmed in development from prenatal androgen exposure, or stem from their endogenous 
hyperandrogenaemia. Although PCOS may classically be thought of as an ovarian disorder, a 
growing body of evidence now suggests that the prenatal androgen exposure may be altering 
brain circuits linked to fertility. These may either be organisational (i.e. occurring during 
development), or activational (i.e. changes due to the resulting hyperandrogenaemia in the 
offspring) (Figure 1.7). 
 
1.7.1 Neuroendocrine changes in PCOS 
 For an androgen insult to result in the development of PCOS-like symptoms, AR 
activation is required. In AR-KO mice, administration of DHT over 3 weeks, to induce 
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hyperandrogenaemia, does not cause the typical PCOS-like phenotype seen in wild-type mice 
(Caldwell et al., 2017). Interestingly, in tissue-specific knock-out of AR, it is the brain, rather 
than the ovary, that requires AR signalling for the full development of PCOS (Caldwell et al., 
2017). Thus, it is unlikely that androgen-induced changes at the ovary are necessary to induce 
PCOS. The potential change in brain circuitry resulting from AR activation, however, is thought 
to alter the release of gonadotropins. Women with PCOS display markedly higher basal LH 
secretion, along with high frequency LH pulses (Taylor et al., 1997). As such, defects to the 
upstream GnRH network are likely to be mediating the alterations in hormone release. 
 As GnRH neurons do not express AR (Huang & Harlan, 1993). As such, upstream 
neurons regulating GnRH neuron function are more likely to be altered during development in 
response to the prenatal androgen exposure. As RP3V kisspeptin neurons are implicated in 
driving ovulation, it may be expected that periods of anovulation may be due to changes in their 
activity. Prenatal testosterone treatment of rats changes the organisation of the female RP3V 
kisspeptin neurons to display a reduced, more masculine-like pattern of Kiss1 mRNA 
expression (Kauffman et al., 2007), although this may be due to aromatisation of testosterone 
causing defeminisation of the neonatal brain. This change in RP3V kisspeptin neuron 
organisation is not replicated in the PNA (using non-aromatisable DHT) mouse (Prescott & 
Campbell, unpublished), however changes in kisspeptin inputs and projections have not been 
investigated in this model. Higher LH concentration and pulse frequency could be attributed to 
a dysfunction of ARN KNDy neurons, resulting in GnRH neuron hyperactivity. In PNA ewes, 
KNDy neurons display lower NKB receptor expression, indicating that changes in pulse 
generation may be occurring (Ahn et al., 2015).  
Further investigation into the androgenic changes of the ARN, however, have revealed 
changes in GABAergic neurons. ARN GABA neurons mostly colocalise with NPY, tyrosine 








Figure 1.7: Polycystic ovary syndrome as a neuroendocrine disorder. 
a) High frequency GnRH release stimulates the pituitary to cause a high frequency release of LH, with 
little release of FSH (1). This potentially results in changes at the ovary presenting with large fluid filled 
follicles (2). The PCOS follicle also synthesises high concentrations of androgens and does not mature 
normally. The hypothalamus is unable to integrate these changes in gonadal steroid synthesis and thus the 
feedback to the GnRH neuronal network is impaired (3). b) A high level of maternal androgens exposes 
the foetal brain to a prenatal androgen insult it would not otherwise receive. This may change the brain’s 
programming (an organisational effect) to cause the downstream changes seen in PCOS. At puberty, a 
female with PCOS will have greater androgen synthesis than typical counterparts, leading to higher 
androgens in adulthood. The high level of adult androgens may also be causing changes to the reproductive 
axis as an activational effect. 
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Moore et al. (2015) reveals that GABAergic projections arising from the ARN are robustly 
upregulated in PNA mice. This has since been shown to be the same case for the PNA ewe 
(Porter et al., 2019). Further, in mice treated with androgens in adulthood, there is an 
upregulation of a predominately excitatory GABAergic drive to GnRH neurons (Sullivan & 
Moenter, 2004; Berg et al., 2018), indicating a potentially hyperactive network resulting in 
greater GnRH neuron output (Dulka & Moenter, 2017; Dulka et al., 2020). While focus has 
been on this one circuit, there are likely other circuits impacted that have not yet been 
investigated. 
 
1.8 Is there a role for the SCN in PCOS? 
The idea that PCOS may result from underlying changes in brain circuitry (Moore et 
al., 2013; Caldwell et al., 2017) is a relatively new concept, so very little is known about the 
role of the SCN in this condition. As a key symptom in PCOS is oligo-/anovulation, it could be 
that the circuit controlling ovulation, i.e. the SCN-driven preovulatory surge, is disrupted. The 
link between PCOS and the SCN have not been studied previously, however, OVX mice given 
testosterone replacement develop a male-like pattern of AR expression in the SCN (Iwahana et 
al., 2008). This suggests that the SCN is sensitive to androgens via the AR and this sensitivity 
increases in a high androgen environment. A key organisational change in the PNA mouse brain 
is the increase in GABAergic appositions to GnRH neurons (Moore et al., 2015; Silva et al., 
2018). As the SCN is predominately GABAergic, it may be that changes in the SCN may also 
occur.  
The incidence of PCOS is not significantly higher in women who have disrupted 
circadian behaviour, such as shift-workers, although there appears to be a trend towards 
increased symptoms related to PCOS, such as metabolic disturbances (Lim et al., 2016). A 
common treatment for circadian disruption is melatonin. Interestingly, melatonin has been 
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shown to reduce menstrual irregularities and hyperandrogenaemia in women with PCOS 
(Tagliaferri et al., 2018). Further, in a laboratory setting, rats continuously exposed to higher 
intensity light somewhat unexplainably develop polycystic ovaries (Baldissera et al., 1991). 
While this may be initial evidence for disrupted circadian rhythms resulting in PCOS-like 
symptoms, evidence from the behaviour of the PCOS-like animal models is less clear. A mouse 
model that is treated with androgens at puberty shows changes in ovarian cycling and Clock-
gene expression in uterine tissue but does not show any defects in other circadian behaviours 
such as activity patterns (Sellix et al., 2013). It is important to remember that locomotor 
behaviour is likely controlled by a diffusible SCN signal, while oestrous cycling is controlled 
by an axonal signal (Silver et al., 1996). As such, hyperandrogenaemia is likely disrupting the 
axonal, but not the diffusible, output of the SCN. The PNA mouse however, does not show 
specific clock gene defects in the SCN, but displays peripheral clocks that are not in synchrony 
(Mereness et al., 2015). This suggests that the output of the SCN may be affected in the PCOS 
model. 
 
1.9 Research objectives and hypotheses 
This project aims to investigate the role of AVP neurons from the SCN in activating 
the RP3V kisspeptin neuron population in both normal and pathological reproductive 
states in the female. The evidence presented suggests that there is an anatomical and functional 
relationship between the SCN AVP neuron population, and the RP3V kisspeptin neuron 
population, however, various technical difficulties call for the re-evaluation of the extent of the 
SCN-to-RP3V circuit. The exact impact the circuit has is unknown; SCN AVP neurons likely 
produce both AVP and GABA so it is important to determine how these chemicals may impact 
the RP3V kisspeptin neurons, and any changes that may occur across the oestrous cycle. 
Finally, using the PNA mouse model, potential anatomical and functional alterations in the 
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SCN-to-RP3V circuit will be explored to determine whether they are impaired in a common 
neuroendocrine disorder associated with an- or oligoovulation.  
 
Therefore, the specific PhD objectives include: 
1. To determine the innervation of the RP3V by SCN AVP neurons, and the anatomical 
relationship of this projection with the kisspeptin neuron population therein. 
2. To investigate the functional impact of these projections on the electrical activity of 
RP3V kisspeptin neurons across the oestrous cycle. 
3. To examine how this circuitry may be altered in the PNA mouse model of PCOS.  
 
I hypothesise: 
1. There will be a robust anatomical projection from SCN AVP neurons that comes into 
apposition with RP3V kisspeptin neurons. 
2. This projection will have a functional output from SCN AVP neurons to excite 
kisspeptin neurons, which will be more effective at proestrus. 
3. The anatomy and functionality of the projection will be disrupted in the PNA mouse 












All experiments were carried out under either protocol D73/16 or AUP18-180, both of 
which were approved by the University of Otago Animal Ethics Committee. All mice (Mus 
musculus) used were housed in the Hercus-Taieri Resource Unit (University of Otago, Dunedin, 
NZ). Mice (age: 2-6 months) were kept in either open-top or individually ventilated cages with 
sex-matched littermates, in a climate-controlled environment (20ºC/40% humidity) on a 12:12 
hour light:dark cycle. Mice were provided an enriched environment with ad libitum access to 
food and water. Original transgenic lines in this study are listed in Table 2.1. All are from a 




Commercial Name Source Ref 
Avp-cre B6.Cg-Avptm1.1(cre)Hze/J 






Prof. B. Lowell (Harvard Medical 
School, MA, USA) 
2 
Kiss1-hrGFP C57BL/6-Tg(Kiss1-hrGFP)KG26Cfe/J 








Prof. B. Lowell (Harvard Medical 
School, MA, USA) 
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Table 2.1: Primary mouse strains used in this thesis. 
References: 1) Harris et al. (2014); 2) Madisen et al. (2010); 3) Cravo et al. (2013); 4) Lee et al. (2015); 
5) Vong et al. (2011). 
 
 
Homozygous ((+/+)) Avp-cre mice were initially bred for use in these studies. However, 
Avp-cre(+/+) mice were found to have diabetes insipidus, likely due to a lack of vasopressin 
release, and as such, were not used. As such, heterozygous ((+/-)) Avp-cre mice were bred by 
crossing Avp-cre(+/-) mice onto wildtype ((-/-)) littermates. 
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Secondary mouse lines were produced in house by crossing Avp-cre(+/-) mice with either 
tdTomato or Kiss1-hrGFP; Nms-icre with Kiss1-hrGFP; or Vgat-cre with tdTomato. The 
resulting offspring were Avp-cre(+/-):tdTomato, Avp-cre(+/-):Kiss1-hrGFP; Nms-icre:Kiss1-
hrGFP; and Vgat-cre:tdTomato. PCR was performed by assistant research fellows in the Piet 
and Campbell laboratories to confirm the genotype of mice. 
 
2.1.1 Animal husbandry 
Mice were weighed daily, and oestrous cycle was determined by vaginal lavage (4 µL 
H2O). Aqueous vaginal smears were taken between 0800h and 1100h and placed on a glass 
microscope slide to dry. They were then stained with toluidine blue (0.5% v/v) for one minute. 
Light microscopy at 10× magnification was used to examine cells and identify oestrous cycle 
stage. Proestrous smears showed clustered nucleated cells with no leukocytes; oestrous smears 
showed dense anucleated, cornified cells, metoestrous smears showed a combination of 
nucleated and anucleated cells with some leukocytes present; and dioestrous smears showed 
predominantly leukocytes with few nucleated cells (Caligioni, 2009). 
 
2.1.2 Generation of prenatally androgen-treated offspring 
The prenatally androgen-treated (PNA) mouse model of PCOS has been well 
established (Sullivan & Moenter, 2004; Moore et al., 2013). To generate PNA litters, female 
Kiss1-hrGFP mice were bred on the night of a morning’s proestrus smear, with a male Avp-
cre(+/-):Kiss1-hrGFP mouse (Figure 2.1). Following mating, daily weights and vaginal smears 
were recorded. The day of mating was considered to be day 0 of pregnancy or embryonic day 
0 (E0). To determine whether a mating had occurred, seminal plugs were identified the morning 






Figure 2.1: Generation of the prenatally androgen-treated mouse model of PCOS.  
a) Kiss1-hrGFP females were mated on the afternoon of proestrus with Avp-cre(+/-):Kiss1-hrGFP males. 
b) Embryonic day 0 was considered the day of mating. After daily monitoring of weight and oestrous 
cycling, pregnancy could be confirmed at day 10. Injections of either DHT (or the sesame oil vehicle) 
were given in the mornings of days 16, 17 and 18 to prenatally androgen-treat the offspring. Mice typically 
gave birth on day 21 of pregnancy. c) The four genotypes of offspring are shown. 
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Weight and vaginal smears were taken for another ten days after mating. Pregnancy was 
confirmed at E10 if a mouse had increased its weight by 2 or more standard deviations from its 
average pre-mating weight, and if no proestrous smear was observed by that time.  
The pregnant females were then treated with 250 µg of dihydrotestosterone (DHT; 100 
µL subcutaneous injection) on E16-E18. DHT was prepared as a 10× stock solution in 100% 
ethanol, and diluted 1:10 in sesame oil on the day of injection. Control groups were injected 
subcutaneously with 100 µL of the sesame oil vehicle (VEH) on E16-E18, Following the birth 
of the offspring, pups were weaned at postnatal day 21 and caged as described above until 
experimentation. PNA and VEH females were used for experimentation. Tail tips were taken 
at weaning for genotyping to be carried out. 
 
2.2 Surgeries 
This section describes the basic procedure for stereotaxic surgery used for the 
experiments described here. For specific details of particular experiments, please refer to the 
Methods sections of the relevant chapters. 
All surgeries were carried out with sterile instruments and under aseptic conditions. 
Mice were anaesthetised with 2% isofluorane and placed in a stereotaxic apparatus (Total Lab 
Systems, Auckland, NZ), with ear bars and nose cone to hold the head in place. Anaesthesia 
was confirmed by loss of the pedal withdrawal reflex following a toe-pinch with forceps at each 
paw. Mice were subcutaneously injected with 100 µL of carprofen analgesic (1 mg/kg) and 
lubricant oil (Polyvisc, Alcon) was placed in each eye to avoid drying during surgery. 
 
2.2.1 Stereotaxic intracerebral injection 
The fur covering the scalp was trimmed using small scissors, and 4% hibitane was 
applied to the exposed skin. A midline incision was made in the skin using scissors, and the 
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connective tissue covering the skull was cut. The head placement was determined by aligning 
the sagittal suture perpendicular to the ear bars, and with bregma and lambda being within 0.5 
mm of each other in depth. Bregma was then used to zero the stereotaxic apparatus, from which 
the coordinates of the suprachiasmatic nucleus (SCN) were located. Coordinates were 
determined initially using Franklin and Paxinos (2008).  
A pilot study was carried out to confirm targeting of the SCN by injecting 100 nL of 
methylene blue dye to determine the location of the needle. While anaesthetised, the mouse was 
then decapitated and the brain removed. The brain was sliced into 100 µm coronal sections 
using a vibratome (VT 1200S, Leica) and the location of the injection site with respect to the 
SCN was observed. Coordinates were then adjusted as necessary. The final coordinates 
determined for the SCN were as follows: anterior-posterior: + 0.06 mm from bregma, medial-
lateral: ± 0.2 mm from bregma, dorsal-ventral: 5.8 mm from the skull surface. Unilateral 
injections were made at medial-lateral: + 0.2 mm from bregma only, while bilateral injections 
were made at both ± 0.02 mm. 
 One or two small holes were bored in the skull using a surgical drill (Technobox 810, 
Bien Air) at the calculated coordinates. A 25-gauge Hamilton syringe loaded with the viral 
vector (see Appendix III) was lowered to the dorsal-ventral coordinates and left for 3 minutes. 
The viral vector was injected at a rate of 100 nL/min. Following injection, needles were left in 
situ for ten minutes, before being slowly raised out of the skull. This was then repeated for the 
contralateral side. The skin was closed with surgical sutures (Mersilk, Ethicon) and 
postoperative management procedures, outlined by the University of Otago Animal Ethics 






This section describes the basic procedure for immunohistochemistry used within this 
thesis. For specific details of particular experiments and the antibodies used, please refer to the 
Methods sections of the relevant chapters. 
 
2.3.1 Transcardial perfusion fixation and brain sectioning 
Mice were anaesthetised with a lethal dose of pentobarbital between zeitgeber time (ZT) 
4-6 (3 mg/mL, 100 µL intraperitoneal). Following the loss of the pedal withdrawal reflex, 
animals were placed supine, and the heart was exposed from the ventral aspect. The left 
ventricle of the heart was punctured at the apex with a 23-gauge needle, and 20 mL of 4% 
paraformaldehyde (PFA; Appendix I, 1.1/1.2) solution was slowly injected to perfuse the tissue. 
Brains were then carefully removed from the skull and post-fixed in 4% PFA overnight at 4ºC. 
The brains were cryoprotected in a 30% sucrose solution (Appendix I, 1.4) for 72 hours at 4ºC. 
Following cryoprotection, the brains were frozen on dry ice and kept at -80ºC until slicing, or 
sliced immediately. 
 For brain sectioning, a flat base was cut coronally through the cerebellum and brainstem 
allowing the brain to sit upright on a freezing-stage microtome (Leica SM2400). The brains 
were then frozen to -20ºC and two or three series of 40 µm-thick coronal sections were taken 
through the forebrain and hypothalamus. The brain slices were stored in cryoprotectant 
(Appendix I, 1.5) until they were used for immunohistochemistry. 
 
2.3.2 General immunohistochemistry procedure 
Brain slices were taken from cryoprotectant and thoroughly washed in tris-buffered 
saline (TBS; Appendix I, 1.3), 3 times for 10 minutes each, replacing the TBS solution each 
time. Slices were then placed in blocking solution (Appendix I, 1.6), for 30 minutes at room 
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temperature. Following this, the brain slices were incubated in blocking solution containing the 
requisite concentration of primary antibody for 48 hours at 4ºC.  
 The brain slices were washed in TBS 3 times for ten minutes each, replacing the TBS 
each time, to remove the primary antibody solution. The brain slices were then placed in 
incubation solution (Appendix I, 1.7) containing the requisite concentration of secondary 
antibody for 120 minutes at room temperature. Three times ten minute TBS washes were used 
to remove the extra secondary antibody. Those brains for which a biotinylated secondary 
antibody was used were then incubated in a streptavidin-conjugated fluorophore for 60 minutes, 
before being washed in TBS. Brain slices were mounted on gelatine coated microscope slides 
and left, protected from light, to air dry overnight at room temperature. The slides were 
coverslipped with Fluoromount G (ThermoFisher Scientific, MA, USA). Slides were kept in 
the dark at 4ºC until imaging. 
 
2.4 Confocal image acquisition 
Following immunohistochemistry, brain slices were imaged using an inverted Nikon 
A1R confocal microscope (Nikon Instruments Inc., Tokyo, Japan), with lasers of 488 and 543 
nm wavelength. Z-stack images were taken through each region of interest. Images were taken 
through 10× (1 µm Z-step, 1 AU pinhole, 0.5 NA), 20× (1 µm Z-step, 1 AU pinhole, 0.8 NA) 
or 40× (0.5 µm Z-step, 1 AU pinhole, 0.9 NA) lenses. Images were acquired using a camera 
with a further 10× magnification, thus, final images are 100×, 200×, or 400× the original size. 
Images were saved to a high capacity storage drive for offline analysis. 
 
2.4.1 Confocal image analysis 
Images were analysed offline using ImageJ (National Institute of Health, Bethesda, 





This section describes the basic procedure for electrophysiological experiments used 
within this thesis. For specific details of particular experiments, please refer to the Methods 
sections of the relevant chapters. 
 
2.5.1 Brain slice preparation 
Mice were euthanised by cervical dislocation at ZT4-6. Following decapitation, the 
skull was peeled away and the brain was removed, taking care to sever the optic nerves at their 
rostral extent. The brain was then placed into an ice-cold slicing solution (Appendix I, 1.8). The 
brain was then removed, the cerebellum was cut in the coronal plane to form a flat base, on 
which the brain was super-glued to a stage for slicing. The stage and brain were immersed into 
a bath containing the slicing solution, and 200 µm coronal brain slices from the rostral RP3V 
to the caudal SCN were taken using a vibratome (VT 1000S, Leica). Brain slices were placed 
into an artificial cerebrospinal fluid (ACSF; Appendix I, 1.9), warmed to 32ºC, and left to 
recover for at least one hour. 
 
2.5.2 Brain slice electrophysiology 
 Individual brain slices were placed in a tissue bath beneath an upright microscope 
(Slicescope 1000, Scientifica, East Sussex, UK; with Olympus optics), and continuously 
perfused with ACSF at a rate of 1.5 mL/min. Location of specific brain regions was carried out 
using differential interference contrast microscopy at 4× magnification (0.1 NA). Individual 
cells were found using a 40× water-immersion objective (0.8 NA). Fluorophores were briefly 
excited using an LED (pE-300white, CoolLED) with filter cubes for mCherry (excitation: 562 ± 
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40 nm; emission: 641 ± 75 nm) or GFP (excitation: 466 ± 40 nm; emission: 525 ± 50 nm). LED 
light was shone through the 40× objective at an intensity of 20% to excite mCherry, and at 2% 
to excite GFP (LED intensity/power shown in Appendix IV). Identified cells were approached 
using infrared differential interference contrast microscopy. 
 Micropipettes (tip resistance: 2-7 MΩ) were made by pulling borosilicate glass (internal 
diameter: 1.17 mm; external diameter: 1.50 mm) using a Model P-97 Flaming/Brown 
micropipette puller (Sutter Instruments Co., USA). Recordings were made between ZT5-10. 
 
2.5.2.1 On-cell loose-patch recording configuration 
 Micropipettes were filled with ACSF and placed over an AgCl wire to form the 
recording electrode. They were then lowered into the bath using a micromanipulator 
(Scientifica, East Sussex, UK) with a small amount of positive pressure applied to displace 
neuropil. Once a cell was located, the positive pressure was removed allowing some of the 
neuronal membrane to be sucked into the recording electrode. On-cell loose-patch recordings 
were carried out at a tip resistance of 12-20 MΩ. Loose-patch recordings were carried out in 
voltage-clamp mode with no potential imposed on the pipette as not to influence the membrane 
potential at the tip. The resistance of the seal was measured at the start and finish of the 
recording. Cells with membrane resistance changes of more than 20%, or if the baseline noise 
increased significantly throughout the recording, were deemed unfit for analysis as this 
indicated the pipette seal was breaking down.  
 Recordings of action potential activity were amplified five times and filtered at a 3 kHz 
bessel (Multiclamp 700B, Molecular Devices), digitised at a sampling rate of 20 kHz (Digidata 
1440a, Molecular Devices), and recorded (Clampex, Molecular Devices) for offline analysis 
(Clampfit, Molecular Devices). Action potentials were detected using a threshold-crossing 
method, as the action current is larger than background noise (Figure 2.2). Thus, the individual 





Figure 2.2: 10 Hz high pass filtering.  
Example recordings of spontaneous activity from an RP3V kisspeptin neuron before (a) and after (b) 
passing through a 10 Hz high pass bessel filter. This flattens the trace to remove any mechanical noise. 
The red line shown in (b) indicates the amplitude of the threshold analysis. Any signal which crosses this 
threshold (i.e. action potentials) are then recorded for frequency. 
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2.5.2.2 Whole-cell patch-clamp recording configuration 
To look at postsynaptic currents, cells were recorded in the whole-cell voltage-clamp 
configuration. Micropipettes were filled with a KCl solution (Appendix I, 1.9) and placed over 
an AgCl wire to form the recording electrode. This allowed the amplification of chloride-
mediated signals due to the increased intracellular chloride concentration. They were then 
lowered into the bath using a micromanipulator (Scientifica, East Sussex, UK) with positive 
pressure applied to displace neuropil. Once a cell was located, the positive pressure was 
removed and negative pressure was applied to suck up part of the neuronal membrane and 
increase the seal resistance. Once a resistance of 1000 MΩ was reached, sharp negative pressure 
was briefly applied to break into the cell. Whole-cell recordings were carried out in voltage-
clamp mode with a holding potential of -60 mV; series resistance was not compensated. Series 
and input resistance were monitored to ensure recording quality. Postsynaptic currents from 
individual cells were recorded in 20-second sweeps. 
 Recordings of postsynaptic currents were amplified ten times and filtered at a 2 kHz 
bessel (Multiclamp 700B, Molecular Devices), digitised at a sampling rate of 20 kHz (Digidata 
1440a, Molecular Devices), and recorded (Clampex, Molecular Devices) for offline analysis 
(Clampfit, Molecular Devices). For analysis, the 20-second sweeps were overlaid and averaged. 
Where postsynaptic currents faithfully overlapped was considered a response to optogenetic 
stimulation. 
 
2.5.3 In vitro optogenetic stimulation 
 In vitro optogenetic experiments were carried out in brain slices of AAV-ChR2 
transfected mice. Blue LED light was shone through the GFP excitation filter and the 40× 
water-immersion objective at an intensity of 20% (Appendix IV). 




2.6 Statistical analysis 
Statistical analysis was performed using Prism 7 (GraphPad Software, San Diego, CA, 
USA). Data sets were also graphed using Prism. Specific statistical tests and graph parameters 







Characterisation of Cre Expression 





This work has made extensive use of the Avp-IRES2-cre mouse model (henceforth 
referred to as Avp-cre). To date, this mouse strain does not have a published characterisation of 
where cre-recombinase enzyme (cre) is expressed in the adult mouse brain. Therefore, it was 
pertinent to determine whether this model accurately represents vasopressin (AVP) neurons in 
the brain, and thus, is suitable for this project. The Avp-cre mouse has been mutated to contain 
a modified internal ribosome entry site (IRES2) downstream of the Avp gene. This allows 
ribosomal translation in the typically untranslated region following the gene. Downstream of 
the IRES2 construct is the coding sequence for cre (Harris et al., 2014). Due to the proximity 
of IRES2 and the Avp gene, cre is produced when AVP is produced. Thus, the IRES2 allows 
translation of bicistronic mRNA for both cre and Avp, within the same cell (Figure 3.1a).  
 
3.1.1 The cre/loxP system 
Cre is a protein isolated from a bacteriophage that causes cleavage of DNA and 
recombination between specific locus of X-over P1 (loxP) sites (Orban et al., 1992). The 
cre/loxP system has been extensively used in neuroscience to investigate genes of interest and 
their roles (Han et al., 2018). Transgenic insertion of loxP sites surrounding a gene of interest 
(known as floxed) thus allows removal of floxed gene sequences in cells expressing cre. When 
mice with floxed genes are crossed to strains expressing cre in genetically-defined cells, cre-
dependent excision of the floxed sequence results in the conditional manipulation of a gene in 
a specific cell type in the offspring (Figure 3.1b) (Bouabe & Okkenhaug, 2013). 
The use of the cre/loxP system has been extremely fruitful in aiding understanding of 
brain cells and their circuitry. Cre can be used to turn genes on or off, remove stop sequences, 






Figure 3.1: Differences in cre-mediated recombination.  
a) The Avp-cre mouse line produces a bicistronic mRNA strand from one gene locus due to the internal 
ribosome entry site (IRES2). This allows the production of both AVP and cre. b) Insertion of cre 
downstream from a gene of interest allows specific expression of cre conditional to the activation of that 
gene. When cre is expressed, cre can cleave loxP sites excising a floxed gene from the DNA. c) An 
example of this excision is in the Avp-cre:tdTomato mouse, where cre excises the floxed STOP sequence 
resulting in expression of tdTomato in cre-expressing cells. This is driven by the Avp gene, turning on 
tdTomato as soon as it is expressed in development. The pitfall of developmental recombination is that if 
the Avp gene is repressed by adulthood in certain cells, tdTomato remains expressed (red neuron 
expressing false-positive cre expression (bolded) but not AVP expression). d) To overcome this, viral 
injections of fluorescent reporters (such as mCherry) can be used to determine the pattern of cre expression 
in adulthood. Cre is able to cleave the viral construct resulting in recombination in the correct orientation 
for mCherry expression. This method avoids developmental recombination, and provides a more accurate 
readout of where cre is expressed in adulthood.  
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a particular gene; and floxed DNA sequences can be added to the genome (knocked-in) to drive 
expression of reporter proteins, or of a tool to investigate neuronal function, such as a 
channelrhodopsin for optogenetics (Han et al., 2018). A key caveat, however, arises with 
genetic recombination: excision of floxed sequences from the genome is irreversible. Thus, in 
models where mouse strains (one expressing cre and one expressing a floxed sequence) have 
been crossed together, the recombination will be present from the time that the promoter driving 
cre expression was first active. For neuroanatomical studies using cre-driven reporter genes, 
this provides a false-positive readout where the reporter for cre may not be restricted to cells 
currently expressing the gene of interest. Thus, it is important to accurately characterise cre 
expression in mouse models. 
 
3.1.2 The Avp-cre mouse model 
To assess where cre was expressed in the Avp-cre mouse, two methods were carried out 
here; crossing the Avp-cre mouse to a cre-dependent reporter strain (showing lifelong cre 
expression patterns) and viral vector delivery of a cre-dependent reporter (showing the pattern 
of cre specifically at the time of transfection with the vector). The reporter used was the 
tdTomato reporter mouse model (see Section 2.1). The tdTomato mouse strain contains the 
genetic sequence for a red fluorescent protein known as tdTomato downstream of a floxed 
STOP sequence preventing transcription, at a chromosomal locus known as ROSA26 (Figure 
3.1c). When the tdTomato mouse is crossed to the Avp-cre mouse (Avp-cre:tdTomato), Avp-
driven expression of cre should result in excision of the STOP sequence, resulting in AVP 
neuron-specific recombination and expression of tdTomato. As mentioned, the possibility 
remains that Avp may be transiently expressed prior to experimentation. This would result in 
the irreversible expression of tdTomato in neurons where AVP is no longer expressed (Figure 
3.1c). One way to overcome this and target the cells currently expressing cre is with the delivery 
of a viral vector carrying a floxed reporter gene. In this case, Avp-cre mice were injected with 
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an adeno-associated virus (AAV) carrying a double-inverted orientation gene for mCherry 
(Figure 3.1d; henceforth referred to as AAV-mCherry; Appendix III). Viral-mediated 
transfection of genes provides temporal control as to when genes are inserted into the genome 
and is more likely to provide an up-to-date readout of cre expression.  
 
3.1.3 Hypothesis and aim 
As the Avp-cre mouse line has been used successfully for previous investigations, it can 
be hypothesised that the Avp-cre line displays faithful reporter expression to AVP neurons. 
These experiments aimed to identify the pattern of Avp-driven reporter expression (as a 
proxy for the activity of cre) in the Avp-cre mouse model both through development, and 
at a timepoint in adulthood by viral transfection. It was particularly necessary to determine 
the expression within the suprachiasmatic nucleus (SCN), to ensure the reporter-expressing 
population was representative of AVP neurons; as well as to determine any extra-SCN cre 




 General animal information is outlined in Section 2.1. Adult female Avp-cre and Avp-
cre:tdTomato mice (2-6 months old) were used in this study. Oestrous cycle stage was 





 The general surgery procedures are outlined in Section 2.2. Avp-cre mice were 
bilaterally injected with 400 nL of AAV-mCherry per hemisphere of the SCN. Mice were left 




 The general perfusion-fixation, brain slicing, and immunohistochemistry procedures are 
outlined in Section 2.3. Primary antibodies used for this chapter include guinea pig anti-AVP 
(1:2000; Peninsula Laboratories, CA, USA), rabbit anti-VIP (1:5000; Immunostar, WI, USA), 
rabbit anti-GRP (1:1000; Immunostar, WI, USA), and rabbit anti-mCherry (1:5000; AbCam, 
UK). Secondary antibodies include donkey anti-guinea pig 488 (1:200, Jackson 
ImmunoResearch, PA, USA) to visualise AVP-immunoreactivity; donkey anti-rabbit 488 
(1:200, ThermoFisher Scientific, MA, USA) to visualise VIP- and GRP-immunoreactivity; or 
donkey anti-rabbit 568 (1:200, ThermoFisher Scientific, MA, USA) to visualise mCherry-
immunoreactivity.  
 
3.2.4 Microscopy and image analysis 
The general microscopy methods are outlined in Section 2.4. Images shown herein are 
maximum projection confocal Z-stack images unless stated otherwise. 
For mapping of AVP-immunoreactivity and tdTomato expression, location of neurons 
in images taken with a 10× objective lens were mapped to mouse brain atlas from Franklin and 
Paxinos (2008). Bregma coordinates reported in images are taken from Franklin and Paxinos 
(2008). Five female dioestrus Avp-cre:tdTomato mice were used for this mapping. 
For experiments to determine colocalisation between AVP immunoreactivity and 
tdTomato/mCherry, two brain slices through the SCN of individual mice were taken using a 
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20× objective lens. Images were subject to noise processing using the despeckle function and 
outlier removal (outliers are at a radius of 2.0 pixels at 50 threshold brightness; Image J, 
National Institute of Health, Bethesda, Maryland, USA). This removed any brightly labelled 
fibre projections from the neurons, leaving the cell bodies clearly visible and not masked by 
fibres. Regions of interesting (ROIs) were drawn in ImageJ around individual AVP-
immunoreactive (-ir) and tdTomato/mCherry-ir neurons were marked on ImageJ, in individual 
confocal planes and colour channels through the Z-stack. Cells for which ROIs overlapped in 
the two colour channels were considered to colocalise AVP-ir and tdTomato/mCherry-ir. The 
total number of AVP-ir, tdTomato/mCherry-ir, and colocalised neurons were counted. The 
specificity of Avp-cre and Avp-cre:tdTomato models was calculated as the percentage of 
tdTomato/mCherry-ir neurons colocalising AVP-ir. The percentage of AVP-ir cells 
colocalising tdTomato/mCherry-ir was termed the efficacy. For VIP- and GRP-ir images, only 
the neurons that colocalised VIP/GRP-ir and tdTomato were counted. 
 
3.2.5 Statistical analysis 
General analysis methods are outlined in Section 2.7. Percentages were compared using 
a non-parametric comparison using a Wilcoxon signed-rank matched-pairs test. Data are 
graphed as mean ± SEM. In text, data are reported as mean ± SEM. Where 
immunohistochemical data are reliant on the success of a viral injection, the range of upper and 
lower average values has been provided. Individual symbols in graphs represent individual mice 





3.3.1 Anatomical mapping of cre expression in the Avp-cre mouse 
brain 
 Broadly, the expression of the tdTomato reporter and AVP-ir neurons, was strictly 
localised to within the hypothalamus (Figure 3.2). As expected, AVP and tdTomato were 
expressed in the SCN (Figure 3.2), PVN (Figure 3.3a) and SON (Figure 3.3b) (Sofroniew et 
al., 1979). tdTomato expression in the SCN was found in a shell-like arrangement with neurons 
clustered at the rostral/caudal edges (Figure 3.2a, c), and spreading dorsally in the centre of the 
anterior-posterior axis (Figure 3.2b). 
 Outside of the SCN, PVN and SON, tdTomato and AVP-ir neurons were seen scattered 
in the caudal AVPV, dorsal to the SON, SOR, and along the base of the brain (Figure 3.4). No 
tdTomato expressing cells were found in regions where AVP-ir was not expected.  
 
3.3.2 Characterisation of cre expression in the Avp-cre 
suprachiasmatic nucleus 
 For this thesis, the SCN AVP neurons are the predominant AVP population of interest. 
As such, cre expression (as demarcated by the tdTomato reporter) patterns have only been 
characterised in the SCN, rather than all of the aforementioned AVP-expressing regions. In the 
SCN, many colocalised cells were visible (Figure 3.5). There were some neurons visible that 
were only AVP-ir, and others that only expressed tdTomato.  
Immunoreactivity for AVP in the Avp-cre:tdTomato mouse is colocalised with 44.8 ± 
0.8% (n = 5 mice) of the total tdTomato-expressing population in the SCN. Of the AVP-ir 
population, 60.0 ± 2.0% (n = 5 mice) expressed tdTomato (Figure 3.5; Table 3.1). To determine 
whether the relatively low specificity of tdTomato expression was due to transient 







Figure 3.2: SCN distribution of AVP-immunoreactivity and cre expression.  
a) tdTomato expression throughout the hypothalamus of the Avp-cre:tdTomato mouse. b-c) The SCN has 
a 3D shell-like expression of tdTomato (red) indicating cre activity and AVP-immunoreactivity (green) 
surrounding the central core. In the rostral-caudal axis, neurons cluster at the rostral (b, c) and caudal (bii, 
cii) ends, but spread out into a shell around the edges in the centre (bi, ci). d) The relative SCN neuron 
positions have been diagrammatically mapped to Franklin and Paxinos, 2008. Scale bars = 100 µm. 3V = 






Figure 3.3: PVN/SON distribution of AVP-immunoreactivity and cre expression.  
a, b) As expected, tdTomato expression (red) indicating cre activity, and AVP immunoreactivity (green) 
are seen in magnocellular populations of the PVN (a) and SON (b). c) The relative cell positions have 
been diagrammatically mapped to Franklin and Paxinos, 2008. Scale bars = 100 µm. 3V = third ventricle. 































































































































































































































































































































































































































Figure 3.5: Colocalisation between immunoreactive AVP peptide and cre recombinase enzymes as 
shown by tdTomato. 
a-c) Maximally projected Z-stack image of immunohistochemistry showing AVP-ir (green, a) and cre as 
reported by tdTomato (red, b) in the SCN (thick border). The two images are merged (colocalised neurons 
in yellow/orange) in c. Boxes in each image are shown in ai-ci as higher magnification images of a single 
plane in the Z-stack. ai) AVP-ir. bi) tdTomato. ci) merge. Empty arrowheads indicate AVP-ir only 
neurons. Filled arrow heads indicate tdTomato only neurons. Arrows indicate colocalised cells. d) The 
efficacy of cre expression in AVP neurons indicates how much of the AVP population were expressing 
cre (as reported by tdTomato); the specificity indicates how specific tdTomato (as a marker of cre 
expression) was to the AVP population rather than other cells types. Symbols represent individual mice 
(see Table 3.1 for specific details). Data shown as mean ± SEM. a-c) scale bars = 100 µm. ai-ci) scale 






















■ 13543 98 160 70 
     ⃝  13544 108 145 59 
★ 13610 142 156 76 
▼ 14304 127 235 94 
⨉ 14305 180 209 109 
 
Table 3.1: AVP-ir neurons vs tdTomato expressing neurons in the Avp-cre:tdTomato mouse SCN. 
Raw numbers of counted neurons either AVP-ir or cre-expressing as marked by endogenous tdTomato 
fluorescence. Figure symbols are associated with Figure 3.4. 
 
AAV carrying a cre-dependent construct for the red fluorescent reporter, mCherry, to determine 
the activity of cre at the time of the experiment. In animals injected at the SCN with mCherry, 
colocalised cells were clearly visible, along with groups of neurons that were only AVP-ir, and 
groups that were only expressing mCherry (Figure 3.6). The specificity of mCherry expression 
was 49.7 ± 2.1% (n = 5 mice; range = 30.5% - 55.8%) (Figure 3.6). The AVP-ir population 
colocalised with 40.3 ± 5.3% (n= 5; range = 23.9% - 52.5%) of mCherry-expressing cells 
(Figure 3.6; Table 3.2). 
There was no difference in the specificity when viral transfection of mCherry is used as 
a marker of cre expression, compared to the transient reporter expression of tdTomato (Figure 
3.6d; p = 0.37, unpaired t-test). The efficacy in the AAV-mCherry infected mice was 
significantly less than that colocalising with tdTomato (Figure 3.6d; p = 0.014, unpaired t-test). 
In this case, the efficacy reflects how well the surgery targeted the SCN and Avp-cre neurons, 
rather than how well mCherry reflects cre expression in the neurons. 
 These data show that cre is expressed in the majority of AVP-ir neurons in the SCN, but 








Figure 3.6: Colocalisation between immunoreactive AVP peptide and cre recombinase enzymes as 
shown by virally transfected mCherry. 
a-c) Maximally projected Z-stack image of immunohistochemistry showing AVP-ir (green, a) and cre 
as reported by mCherry-ir (red, b) in the SCN (thick border). The two images are merged (colocalised 
neurons in yellow/orange) in c. Empty arrowheads indicate AVP-ir only neurons. Filled arrow heads 
indicate mCherry-ir only neurons. Arrows indicate colocalised cells. d) There is a significant decrease 
in the efficacy of reporter expression in AVP-ir neurons between the Avp-cre:tdTomato and AAV-
mCherry transfected Avp-cre mouse line. There is no difference in the specificity of the reporter to AVP-
ir neurons. Symbols represent individual mice (see Table 3.1/3.2 for specific details). tdTomato data 
from Figure 3.5. Data shown as mean ± SEM. Scale bars = 100 µm. * p < 0.05. 3V = third ventricle. OX 























 14256 137 95 71 
 14332 58 44 25 
▲ 14337 73 63 27 
 14360 139 92 49 
+ 13585 83 56 20 
 
Table 3.2: AVP-ir neurons vs mCherry-ir neurons in the AAV-mCherry injected Avp-cre mouse 
SCN.  
Raw numbers of counted neurons either AVP-ir, or cre expressing as marked by mCherry-ir. Figure 
symbols are associated with Figure 3.5, and those seen in Chapter 4. 
 
3.3.3 Cre expression in the Avp-cre:tdTomato suprachiasmatic 
nucleus does not colocalise with other SCN peptides  
 In order to assess the peptide expression of SCN neurons that reported cre, but not AVP-
ir, immunohistochemistry for VIP and GRP two well-characterised peptides within the SCN, 
was carried out. The VIP- and GRP-ir neurons were compared to cre-expression (as reported 
by tdTomato). It was found that no tdTomato-expressing neuron in the SCN was 
immunoreactive for VIP or GRP (Table 3.3, Figure 3.7). These data show that the reporter-
expressing neurons with unidentified peptide content are not expressing AVP, VIP nor GRP, at 
the time of euthanasia. 
 
 Mouse Number 
Total VIP-ir/tdTomato  
Colocalised neurons 









13032 0 0 
13698 0 0 
 
Table 3.3: VIP-ir and GRP-ir neurons vs tdTomato expressing neurons in the Avp-cre:tdTomato mouse 
SCN.  
Raw numbers of colocalised VIP-ir/GRP-ir neurons with tdTomato. The lack of colocalisation between the 





   
 
Figure 3.7: No colocalisation between immunoreactive VIP and GRP and tdTomato expression. 
a) Maximally projected Z-stack image of immunohistochemistry showing labelling of VIP (green) and 
endogenous tdTomato (red) in the SCN (thick border). Empty arrowheads indicate VIP-ir only neurons. 
Filled arrow heads indicate tdTomato only neurons. There is no colocalisation between the two cell types. 
Inset (ai) shows 40× magnification single plane image of the two cell types. b) Maximally projected Z-
stack image of immunohistochemistry showing labelling of GRP (green) and tdTomato (red) in the SCN 
(thick border). Empty arrowheads indicate GRP-ir only neurons. Filled arrow heads indicate tdTomato 
only neurons. There is no colocalisation between the two cell types. Inset (bi) shows 40× magnification 
single plane image of the two cell types. For further details, see Table 3.3. Scale bars = 100 µm. 3V = third 




 This chapter anatomically characterised the expression of cre in AVP neuron 
populations using two methods of cre-driven reporter expression. Specifically, the location of 
reporter-expressing cells has been mapped within the hypothalamus, as well as characterising 
how well reporter-expression maps to AVP-ir cells within the SCN. 
 
3.4.1 AVP-ir neurons and reporters for cre colocalise in the SCN of 
female Avp-cre mice 
 The work carried out here relied heavily on the use of immunohistochemistry to report 
for AVP-ir neurons. When AVP-ir was compared to tdTomato that reported cre expression, it 
was found that the SCN AVP-ir population only accounts for approximately 45% of tdTomato-
expressing neurons. Thus, there is a percentage of neurons that express cre, but are not AVP-
ir. 
A key limitation of immunohistochemistry is that a peptide must be present in the region 
of interest to be visualised. Staining for AVP in the SCN may be hindered by the fact that Avp 
mRNA and AVP peptide are circadian in their expression (van der Veen et al., 2005; Maruyama 
et al., 2010; Yoshikawa et al., 2015). Thus, there is a possibility that the mice were euthanised 
at a time where there is low AVP expression and could not be visualised with 
immunohistochemistry. The expression of AVP peptide is expected to peak at ZT6-ZT10 
(Yoshikawa et al., 2015). These experiments were carried out with that consideration in mind, 
with tissue collected between ZT4-ZT8. As such, there is a possibility that a low expression of 
AVP peptide in some cells at that time would result in low to no AVP present to bind to the 
antibody during immunohistochemistry. In situ hybridisation for AVP mRNA, however, could 
be used to detect changes at the pre-protein level for potentially better specificity. 
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A second possibility for a low AVP immunoreactivity in the SCN could be that once 
AVP has been synthesised, the peptide is exported from the cell body to the projections and 
synaptic terminal. Some cell bodies would, therefore, not be visible by immunohistochemical 
staining. To overcome the potential export of peptide, intracerebroventricular colchicine 
treatment could be used to depolymerise microtubules in axons and inhibit the movement of 
AVP. This would result in its accumulation in the cell body and allow for greater intensity 
staining in the SCN AVP neuron cell bodies.  
Finally, it could be that the tdTomato-expressing neurons that do not colocalise with 
AVP may not produce AVP at all. The data here have also shown that it is unlikely that they 
express either VIP or GRP instead of AVP, however.  
In comparison to AVP expression, tdTomato expression (as a reporter for cre) has been 
reported to represent approximately 60% of the SCN AVP-ir neurons. This result is almost 20% 
greater than what has been reported previously (Gizowski et al., 2016). Thus, there is a group 
of SCN AVP-ir neurons which are not expressing cre. There is a chance that the Avp-cre mouse 
line does not report all the AVP neurons in the SCN. One cause of a low reporter expression 
could be the arrangement of chromatin in the neurons may make cre inaccessible to ribosomes 
for translation, thus would not be able to be reported. Another possibility is that cre could be 
removed from some neurons during genetic recombination throughout generations. Thus, like 
AVP-ir neurons, cre expression would also be underreported.  
The AAV-mCherry-injected Avp-cre mouse does not show a significant difference in 
cre expression in adulthood compared to what is reported by tdTomato throughout 
development. This indicates that cre expression likely does not change throughout the SCN 
over time. Using a viral vector to transfect a reporter into cre-expressing neurons, however, 
provides an idea of the temporal resolution of SCN cre expression. There is a significant 
decrease in the efficacy of reporter expression, indicating that less of the total AVP neuron 
population is being reported. This result, however, is unsurprising as it relies on surgical 
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technique and the viral vector adequately accessing the cre-expressing neurons. Compared to 
tdTomato which is inserted into the genome and will be present in all cells, the viral 
transfection, will only reach a certain spread from the injection site, and may not transfect all 
the cells in the given area. As such, the lower efficacy is indicative of how well the injection 
and the virus have targeted the SCN Avp-cre neurons. This is further shown by the variability 
in the efficacy of mCherry, which displays a wider range than the tdTomato. For this thesis, 
SCN Avp-cre neurons will refer to the cre-expressing neurons that can be targeted in this model, 
where SCN AVP neurons will refer to the general AVP-expressing population in the SCN 
 
3.4.2 Expression of tdTomato and AVP-ir neurons in the 
hypothalamus of female Avp-cre mice 
 There have been extensive reports surrounding the distribution of AVP neurons, 
particularly in rodent species (Sofroniew et al., 1979; Rhodes et al., 1981; Hou-You et al., 
1986; Rood & de Vries, 2011), with which this work agrees. What has not been reported, 
however, are the many, seemingly random, expressions of AVP neurons throughout the 
hypothalamus, such as those seen in the PeN and lateral hypothalamic area. The possibility 
exists that these populations may produce AVP at the time of experimentation for a yet 
unknown physiological function; although the expression of tdTomato (indicative of cre 
expression) matches the distribution of AVP peptide in these mice. A broad overview of 
tdTomato expression reveals expression in similar areas to that of the AVP peptide. There is 
clear tdTomato expression in the PVN and SON, which make up the major AVP neuron 
populations outside the SCN. The tdTomato expression outside of these two nuclei, is along the 
base of the brain and along the magnocellular projection fibres. These populations are known 
as the AVP accessory nuclei (Rood & de Vries, 2011). Overall, however, no ectopic tdTomato 
(in brain areas without AVP peptide) is present in this mouse line. 
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 Of interest to this thesis is the distribution of AVP neurons in the SCN. It has been well 
reported that SCN AVP neurons form a dorsomedial shell surrounding the core of the SCN (van 
den Pol, 1980; van der Zee & Bult, 1995; Morin et al., 2006; Rood & de Vries, 2011). 
Interestingly, it has been shown here that SCN Avp-cre neurons are not as well localised to this 
pattern as has been reported. The typical shell structure only holds true for coronal sections 
taken through the centre of the SCN. The Avp-cre neurons cluster at the caudal and rostral 
extents. This suggests that the shell is a 3D structure surrounding the entire SCN core. This 
shell-like structure also does not appear to be strictly dorsomedial as described previously 




 To date, this Avp-cre mouse model has been used to investigate the physiology and 
downstream effects of AVP neurons (Gizowski et al., 2016; Jiang-Xie et al., 2019). Despite 
this, no group has published a full characterisation of cre expression to determine the specificity 
of the model. It was important to carry out this characterisation, as fluorescent neurons, 
indicative of cre expression and the resulting viral transfection, will be used as a marker of the 
AVP population for future experiments. Here, it has been shown that the distribution of AVP 
neurons in the mouse brain largely reflects cre distribution. In particular, however, cre 








Anatomical Characterisation of the 
SCN Avp-cre Neuronal Projections 





 The preovulatory surge of luteinising hormone, necessary for ovulation, is dependent 
upon RP3V kisspeptin neuron stimulation of GnRH neurons (Smith et al., 2006; Clarkson et 
al., 2008; Piet et al., 2018). This is regulated by a circadian input, to coordinate the surge to a 
particular time point (Murr et al., 1973; McElhinny et al., 1999). This circadian network has 
been shown to originate from the SCN (Wiegand et al., 1980; Wiegand & Terasawa, 1982), 
most likely axonal projections from the SCN shell where AVP neurons reside (de la Iglesia et 
al., 2003; Smarr et al., 2012).  
 
4.1.1 Tracing the SCN-to-RP3V network 
 Previous work to identify the projection between AVP neurons in the SCN and the 
RP3V kisspeptin neurons has been associated with several challenges. The original lesion 
studies identified the SCN as the starting point from where the circadian cue for ovulation may 
originate (Wiegand et al., 1980; Wiegand & Terasawa, 1982). Early tracing studies used the 
anterogradely trafficked plant lectin Phaseolus vulgaris leucoagglutinin (Pha-L) injected into 
the SCN to demarcate its projections (Watts et al., 1987; de la Iglesia et al., 1995; Vida et al., 
2010). The projection revealed a dense fibre plexus around the RP3V (Watts et al., 1987), 
coming into apposition with oestrogen receptor-expressing neurons (de la Iglesia et al., 1995). 
Neither of these studies, however, determined the peptide content of these projections, so were 
unable to conclude if these were AVP-expressing fibres. Vida et al. (2010) overcame this by 
coupling injections of Pha-L in the SCN with immunohistochemistry for AVP and kisspeptin. 
Electron microscopy revealed Pha-L and AVP coupled projections in apposition to RP3V 
kisspeptin neurons (Vida et al., 2010). While this provides strong evidence for SCN AVP 
neurons innervating RP3V kisspeptin neurons, Pha-L injections are not specific for defined 
neuronal populations and can spread throughout brain regions indiscriminately. This can result 
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in projections from off target neurons being revealed. To determine whether the SCN AVP 
neurons themselves were those that came into apposition with the RP3V kisspeptin neurons 
Williams et al. (2011) identified that following SCN lesions, AVP-immunoreactive appositions 
to RP3V kisspeptin neurons were not present, compared to non-lesioned controls.  
These studies used different rodent species (mouse, rat and hamster) with known 
differences in their SCN projections (Table 1.1), thus, for the purpose of this thesis, it was 
important to map out the extent of the Avp-cre projection to RP3V kisspeptin neurons in the 
mouse. Further, this will establish a tool that allows for a comparisons of Avp-cre projections 
in a pathological condition (Chapter 7). 
 
4.1.2 Genetically mediated viral tract-tracing 
 To delineate the projections of SCN AVP neurons to RP3V kisspeptin neurons, this 
work used cre/loxP based, viral vector-mediated tract-tracing allowing for the selective 
targeting of SCN Avp-cre neurons. As explained in Chapter 3, the use of the Avp-cre mouse 
provides greater specificity for targeting a single population of neurons to specifically express 
virally transfected cre-dependent mCherry. This experiment allows us to get a more accurate 
representation of the projections of SCN AVP neurons to the RP3V. Compared to prior studies, 
injection of the viral vector causes less damage and less disruption to the animal’s physiology 
than lesions of the SCN. Further, the genetically mediated expression of the fluorescent 
reporter, mCherry means that projections from cre-expressing neurons will be revealed, 
independent of the AVP peptide content that immunohistochemistry relies on. The presence of 
mCherry-expressing fibres within the RP3V and in association with kisspeptin neurons is 
indicative of a direct anatomical projection from SCN-to-RP3V.  
As mCherry expression is through the length of the fibre projection, this allows for 
visualisation of the projection pattern of the SCN Avp-cre neurons. Innervation of the HPG axis 
by the SCN is thought to be through two pathways: indirectly through RP3V kisspeptin neurons 
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as discussed, and directly at GnRH neurons (Williams & Kriegsfeld, 2012). While the direct 
innervation is thought to be VIP mediated (Simonneaux & Piet, 2018), it is unclear whether 
GnRH neurons are innervated by SCN AVP neurons at all (Mahoney & Smale, 2005). 
 
4.1.3 Hypothesis and aim 
  Based on the literature presented above, it can be hypothesised that there will be a 
robust projection from SCN Avp-cre neurons to the RP3V, and they will interact 
anatomically with RP3V kisspeptin neurons. These experiments aimed to determine the 
extent to which SCN Avp-cre neurons project to the RP3V, and the level of interaction 
these fibres have with the resident kisspeptin neurons. Further, the interaction the SCN Avp-




 General animal information is outlined in Section 2.1. Adult female Avp-cre (2-6 
months old) were used in this study. Oestrous cycle stage was determined by daily vaginal 
lavage and tissue was collected in dioestrus. 
 
4.2.2 Surgery 
 The general surgery procedures are outlined in Section 2.2. Avp-cre mice were 
bilaterally injected with 400 nL/side of AAV-mCherry at the SCN. Mice were left for at least 





 The general perfusion-fixation, brain slicing and immunohistochemistry procedures are 
outlined in Section 2.3. Primary antibodies used for this chapter include rabbit anti-mCherry 
(1:5000; AbCam, UK), sheep anti-kisspeptin (1:1000; Prof. A. Caraty, INRA, France) and 
guinea pig anti-GnRH (1:5000, Prof. G. Anderson, University of Otago, NZ). Secondary 
antibodies include donkey anti-rabbit 568 (1:200, ThermoFisher Scientific, MA, USA) to 
visualise mCherry and donkey anti-guinea pig 488 (1:200, Jackson ImmunoResearch, PA, 
USA) to visualise GnRH. Kisspeptin was visualised by the biotinylated donkey-anti sheep 
secondary antibody (1:1000, ThermoFisher Scientific, MA, USA), followed by a streptavidin-
conjugated 488 tertiary antibody (1:1000, ThermoFisher Scientific, MA, USA). 
 
4.2.4 Microscopy and image analysis 
The general microscopy methods are outlined in Section 2.4. Images shown herein are 
maximum projection confocal Z-stack images unless stated otherwise. 
 
4.2.4.1 Fibre density analysis 
Two sets of confocal Z-stacks were taken through the rostral and caudal slices of the 
RP3V using the 10× objective lens. The rostral margin was termed the AVPV, and the caudal 
termed the PeN. Using ImageJ (National Institute of Health, Bethesda, Maryland, USA), the 
maximally projected RP3V images were binarised using a threshold function between 1.0 - 
1.5%. Binarisation assigns each pixel as either positive for immunoreactivity (black) or 
negative for immunoreactivity (white). This was used to estimate the transfection level of 
hypothalamic nuclei (SCN, PVN and SON) and the immunoreactive fibre density in the RP3V. 
A region of interest (ROI) was drawn around the RP3V (containing 100 µM from the third 
ventricle) and the measure function was used. This analysed the percentage of black pixels in 
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the RP3V (representing mCherry-ir fibres) in the ROI. The percentage of pixel density in one 
slice containing the AVPV and one since containing the PeN per mouse was then averaged for 
a percentage of total RP3V innervation. This was carried out on both sides of the third ventricle.  
The same protocol was applied to a single slice through the centre of the SCN, or in 
another section through the hypothalamus containing PVN/SON in the same mouse. Each side 
of the SCN or hypothalamus was analysed to determine the percentage of fluorescence (as a 
proxy for viral transfection) seen in the individual nuclei. It was empirically determined that 
successful transfection of a region was considered as greater than 5% area of pixel density in 
the region of interest. As such, anything less than 5% density was termed a miss. To determine 
the relative level of transfection, the percentage transfection in the most transfected slice was 
considered as the upper limit. From this upper limit, 5% was subtracted, and the remainder 
divided into three. The upper, middle and lower third of this was then considered the high, 
medium and low (+++, ++ or +) transfection used for Table 4.1. 
 
4.2.4.2 Apposition analysis 
As above, two confocal Z-stacks of the RP3V containing AVPV or PeN were imaged 
using 10× and 40× objective lenses. Using ImageJ (National Institute of Health, Bethesda, 
Maryland, USA), the kisspeptin neurons in each Z-stack were counted. In individual planes of 
the Z-stack, each kisspeptin neuron was magnified 4 times, and any appositions with mCherry-
ir fibres were counted. A close apposition was defined as an mCherry-ir fibre in the immediate 
vicinity of a kisspeptin-ir cell body, with no black pixel between the two colour signals. This is 
based on a method of apposition counting used previously (Moore et al., 2015; Yip et al., 2015). 
The percentage of kisspeptin neurons with an apposition, and the number of appositions to those 
kisspeptin neurons, in the AVPV and PeN slice were then averaged for each mouse. This was 
carried out on both sides of the third ventricle. 
93 
 
For appositions between GnRH-ir neurons and mCherry-ir fibres, one confocal Z-stack 
from the medial septum (MS), rostral preoptic area (rPOA) and anterior hypothalamic area 
(AHA) were taken using a 10× objective lens, per mouse. In individual planes of the Z-stack, 
each GnRH neuron was magnified by 4×, and any appositions to mCherry-ir were counted, as 
above. 
 
4.2.5 Statistical analysis 
General analysis methods are outlined in Section 2.7. Correlation analyses were carried 
out to compare the mCherry-ir fibre expression, as well as the proportion of kisspeptin neurons 
with close appositions, to the ipsilateral SCN, PVN and SON, using a linear regression. Data 
for these experiments are presented as linear regression line ± 95% confidence interval. The 
percentage of mCherry-ir fibres, percentage of kisspeptin neurons with appositions, and the 
number of appositions per neuron were compared using a Wilcoxon signed-rank matched-pairs 
test. In text, these data are reported as mean ± SEM. Where immunohistochemical data are 
reliant on the success of a viral injection, the range of upper and lower average values has been 




4.3.1 The RP3V is densely innervated by SCN Avp-cre neuron 
projections 
To determine whether SCN Avp-cre neurons project to the RP3V, viral-mediated tract-
tracing was carried out by stereotaxic injection of cre-dependent AAV-mCherry into the SCN 
of female Avp-cre mice. Cre-dependent mCherry expression fills the neuron cell body and 
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fibres allowing the projections to be visualised. Immunohistochemistry against mCherry was 
used to enhance visualisation of the fibres.  
Of the 9 dioestrous females used for this experiment, 7 were transfected by the viral 
vector. Two mice had less than 5% of mCherry expression in the SCN and were considered as 
misses (i.e. the injected viral vector had not transfected the SCN; Table 4.1). Due to the 
proximity of the SCN with the SON and PVN, in which AVP and cre are also expressed, it was 
difficult to solely target the SCN with stereotaxic surgery. Thus, most mice expressed mCherry 






SCN Transfection PVN Transfection SON Transfection 
■ 14078 +++ ++ +++ 
 14360 +++ + + 
▲ 14337 ++ - + 
▼ 13585 ++ + - 
 14256 ++ ++ - 
 14332 ++ - +++ 
★ 13584 ++ +++ + 
O 14255 - +++ ++ 
× 14333 - + - 
 
Table 4.1: Avp-cre mice injected for viral tract tracing.  
Mice injected with AAV-mCherry were unlikely to only transfect the SCN. This table outlines the AVP-
expressing nuclei in the brain, and the relative level of transfection (+++, ++ or +) in each where - indicates 
no transfection, ipsilateral to the most densely transfected half of the SCN. The figure symbols indicate 
the individual mice seen in the graphs shown in the figures of Chapter 4. 
 
In mice where the SCN Avp-cre neurons sufficiently expressed mCherry (Figure 4.1a), 
mCherry-ir fibres were found densely surrounding the third ventricle in the RP3V (Figure 
4.1ai). The mCherry-ir fibre density in the RP3V was 10.5 ± 2.1% (Figure 4.1c; n = 7 mice, 
range = 3.8% - 19.3%). There was a similar mCherry-ir fibre density in the anatomical 
subdivisions of the RP3V (Figure 4.1c; AVPV: 9.6 ± 2.8%, n = 7 mice, range = 3.6% - 25.0%; 




   
 
Figure 4.1: Viral vector-mediated tract tracing reveals SCN Avp-cre neurons project to the RP3V.  
a) Accurate targeting of the SCN shows mCherry expression in the typical shell pattern of Avp-cre 
neurons. ai) Confocal Z-stack image of the RP3V from the same animal in a). The mCherry-ir fibres are 
visible along the edge of the third ventricle within the RP3V. b) An example of an animal with poor 
mCherry expression in the SCN due to inaccurate needle placement. Notice the high level of mCherry 
expression in the PVN and SON. bi) Confocal Z-stack image of the RP3V from the same animal in b). 
Little to no mCherry-ir fibres can be seen in the RP3V. c) The percentage area of RP3V innervation is 
similar in the AVPV and the PeN. Mice with a poorly transfected SCN (‘miss’) have little RP3V 
fluorescence. The thick white boundaries in the confocal images represent the regions of interest used for 
pixel density analyses. Symbols represent individual mice. Data shown as mean ± SEM. Scale bars = 100 
µm. 3V = third ventricle. OX = optic chiasm. 
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pairs test). In mice where the SCN was not accurately targeted (Figure 4.1b), there was little to 
no mCherry-ir fibres visible in the RP3V (Figure 4.1bi; 0.40 ± 0.02% pixel area, n = 2 mice, 
range = 0.38% – 0.43%). As mentioned, injection of the viral vector often resulted in expression 
of mCherry in SON and PVN Avp-cre neurons. As such, it was important to determine the exact 
origin of the fibre projection seen in the RP3V. A linear regression analysis was carried out to 
correlate the amount of mCherry expression seen in the SCN, PVN and SON with the density 
of mCherry-ir fibres in the RP3V. A positive correlation between transfection in the SCN and 
RP3V density was found (Figure 4.2a, b; n = 9 mice, p < 0.0001, R2 = 0.70, linear regression). 
This indicates that greater targeting of the SCN with the mCherry vector results in greater 
mCherry-ir fibre density in the RP3V. In contrast, neither transfection in the PVN nor in the 
SON showed any correlation to innervation of the RP3V by mCherry-ir fibres (Figure 4.2c; 
PVN: n = 9 mice, p = 0.92, R2 = 0.001; Figure 4.2d; SON: n = 9 mice, p = 0.15, R2 = 0.12, 
linear regression). This suggests that mCherry-ir fibres in the RP3V may originate in the SCN, 
and not in the PVN or SON. 
Specific attention should be drawn to mouse 14255 (indicated by the empty arrowhead 
in Figure 4.2) that showed high mCherry expression in the PVN/SON but not the SCN. When 
compared to mouse 14360 (indicated by the filled arrowhead in Figure 4.2), it appears that 
relatively high mCherry expression in the PVN/SON does not contribute to the innervation of 
the RP3V by mCherry-ir fibres. As mouse 14360 shows relatively high mCherry expression in 
all three nuclei analysed, and a high level of fibre density in the RP3V, it is unlikely that the 
confounding influence of PVN/SON transfection would contribute to mCherry-ir fibre density. 
As such, these data show that the mCherry-ir fibres within the RP3V likely come solely from 






   
 
Figure 4.2: Avp-cre neurons from the SCN, but not PVN or SON, project fibres into the RP3V.  
a) Schematic representation of the analysis. Dark red indicates the most densely transfected half of the 
SCN, while the light red is the least densely transfected half of the SCN. The density of mCherry 
expression in the PVN and SON, ipsilateral to the SCN half, were also compared to the mCherry-ir fibre 
density in the RP3V. b) Linear regression analysis reveals a positive correlation between transfection in 
the SCN and the fibre density in the RP3V. c, d) There is no such correlation between the transfection of 
the PVN or SON and the respective RP3V fibre density. Data shown as line of best fit ± 95% confidence 
interval. Representative brain slices taken from Franklin and Paxinos (2008). 
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4.3.2 Kisspeptin neurons in the RP3V are closely apposed by SCN 
Avp-cre neuron projections 
As the SCN Avp-cre expressing neurons are clearly projecting to the RP3V, it was 
important to determine their anatomical interaction with the kisspeptin neurons. Dual 
fluorescence immunohistochemistry for kisspeptin and mCherry showed that mCherry-ir fibres 
in the RP3V form a dense plexus surrounding the kisspeptin-ir neurons (Figure 4.3b).  
Closer inspection of the RP3V revealed that the mCherry-ir fibres made close 
appositions to 44.6 ± 6.6% of the kisspeptin-ir neurons in the RP3V ipsilateral to the most 
transfected SCN half (Figure 4.3c; n = 6 mice, range= 22.3% - 68.6%). Similar proportions of 
kisspeptin neurons were apposed by mCherry-ir fibres in the AVPV and PeN (Figure 4.3c; 
AVPV: 40.5 ± 6.2%, range = 16.7% - 53.3%; PeN: 48.7 ± 8.7%, range = 18.8% - 83.9%; p = 
0.69, Wilcoxon signed-rank matched-pairs test). Of the RP3V kisspeptin neurons apposed by 
mCherry-ir fibres, there were 1.40 ± 0.13 close appositions per neuron (Figure 4.3d). Again, no 
difference was found between the anatomical subdivisions of the RP3V (Figure 4.3d; AVPV: 
1.33 ± 0.09/neuron; PeN: 1.48 ± 0.17/neuron, p = 0.16, Wilcoxon signed-rank matched-pairs 
test). Consistent with these fibres originating in the SCN, the proportion of RP3V kisspeptin 
neurons receiving close appositions was positively correlated with the transfection in the 
ipsilateral SCN; that is to say, more viral transfection in the SCN revealed more close 
appositions to RP3V kisspeptin neurons (Figure 4.3e; n = 6 mice, p = 0.0003, R2 = 0.74, linear 
regression).  
These data suggest that SCN Avp-cre neurons may establish synaptic inputs onto 








Figure 4.3: SCN Avp-cre neurons make putative synaptic inputs onto RP3V kisspeptin neurons.  
a) Relative brain positions from where mCherry-ir appositions to kisspeptin neuron were taken. b) Confocal 
Z-stack image of the RP3V showing kisspeptin-ir neurons (green) with the mCherry-ir fibres (red) innervating 
the region. bi) Single confocal plane image of the RP3V alongside the third ventricle showing kisspeptin 
neurons with the mCherry-ir fibres coming into close apposition. Close appositions to kisspeptin neuron 
somata (empty arrowheads) are shown in bii) and biii). c) Proportion of kisspeptin neurons apposed in either 
the RP3V subdivision (with the fraction of the total counted above), and for the entire RP3V. d) The number 
of appositions per apposed kisspeptin neuron in either the RP3V subdivisions, and for the entire RP3V. e) 
There is a positive correlation between the fluorescence of the transfected SCN to the proportion of kisspeptin 
neurons apposed in the ipsilateral RP3V. Symbols represent individual mice. Dark and light green indicate 
measurements taken ipsilateral to the most and least transfected side of the SCN, respectively. Data shown as 
mean ± SEM, or linear regression ± 95% confidence interval. Scale bar = 100 µm. 3V = third ventricle. OX 
= optic chiasm. Representative brain slices taken from Franklin and Paxinos (2008).  
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4.3.3 SCN Avp-cre neurons do not appose GnRH neurons 
 Viral tract-tracing was used to determine whether SCN Avp-cre neurons project directly 
to GnRH neurons, in addition to the RP3V kisspeptin neurons. GnRH neurons are scattered 
across the rostral hypothalamus (Herbison, 2015). As such, brain slices containing the MS, 
rPOA and AHA were chosen for examination of the GnRH neurons (Figure 4.4a). In each of 
these areas, there was very little mCherry-ir innervation (Figure 4.4c-e). Of all the GnRH 
neurons analysed, only 4/74 (5.4%) showed close appositions to mCherry-ir fibres (Figure 4.4b; 
MS: 1/25 (4.8%) neurons apposed; rPOA: 2/30 (6.7%) neurons apposed; AHA: 1/19 (5.6%) 
neurons apposed; n = 3 mice). As these animals were also used in Section 4.3.2, it is interesting 
to note that they had 32.2 – 52.5% of RP3V kisspeptin neurons with close appositions. This 
indicates that the SCN Avp-cre neurons do not directly innervate GnRH neurons in the mouse, 
supporting the proposed model (Williams & Kriegsfeld, 2012; Simonneaux & Piet, 2018). 
 
4.4 Discussion 
 To determine whether SCN AVP neurons project to the RP3V and its resident kisspeptin 
neurons, the cre expressing neurons in the Avp-cre mouse SCN were targeted for viral tract 
tracing. Here it has been shown that there is a dense fibre projection to the RP3V from SCN 
Avp-cre neurons and that their projection fibres come into close apposition with kisspeptin-ir 
neurons. It has also been shown that this is not the case for GnRH neurons.  
 
4.4.1 SCN AVP neurons innervate the RP3V 






Figure 4.4: GnRH neurons show few close appositions from SCN Avp-cre neuron projections. 
a) Relative brain positions from where GnRH neuron counts were taken. b) Quantitative analysis of the 
proportion of GnRH neuron cell bodies apposed by mCherry-ir fibres. Numbers above bars represent the 
number of neurons with a close apposition to a mCherry-ir fibre as a fraction of the total neurons counted. 
c-e) Cyan pseudocoloured GnRH neurons in the MS, rPOA and AHA show almost no appositions with 
mCherry-ir fibres. Thin projection fibres are present in each area and are indicated by arrowheads along 
their length. Symbols represent individual mice. Data shown as mean ± SEM. Scale bars = 100 µm. AHA 
= anterior hypothalamic area. MS = medial septum. OVLT = organum vasculosum of the laminar 




(de la Iglesia et al., 1995; Vida et al., 2010), the viral tract tracing method used here allows 
specific tracing of a genetically defined population of neurons, to investigate the input from the 
SCN Avp-cre neurons to the RP3V. These findings are consistent with others showing 
innervation of RP3V kisspeptin neurons by AVP (Vida et al., 2010; Williams et al., 2011). 
Further, these findings reveal a higher proportion of innervation to RP3V kisspeptin neurons 
(roughly 33% and 37% in Vida et al. (2010) and Williams et al. (2011), respectively), likely 
due to the more specific tract tracing rather than immunohistochemical methods. Interestingly, 
the potential AVPergic innervation of the RP3V appears to be solely from the SCN, although 
it is impossible to determine whether these projections are solely ipsilateral, due to transfection 
across hemispheres. The method used here allows selective targeting of regions of interest and 
provides evidence that the AVP-expressing neurons in the PVN and SON do not innervate the 
RP3V. This supports previous immunohistochemical work by Vida et al. (2010), where co-
staining of peptides was used to discriminate between the magnocellular and suprachiasmatic 
projections. As the PVN/SON neurons do not appear to innervate the RP3V, this provides a 
level of confidence that any effect caused by AVP neurons at the level of RP3V kisspeptin 
neuron (particularly for later chapters), must be originating from the SCN AVP population. 
 
4.4.2 SCN AVP neurons indirectly target GnRH neurons 
 The tract tracing shown here provides evidence that the SCN Avp-cre neurons do not 
substantially innervate the GnRH neurons. This, however, is based on appositions at the level 
of the cell body. GnRH neurons have been shown to receive synaptic input along their 
projection fibres (Campbell et al., 2009; Herde et al., 2013) that may have been missed in this 
analysis. As the projection pattern of SCN AVP neurons is more typically dorsal/rostral (Rood 
& de Vries, 2011), it is unlikely that they would innervate the caudal projections of GnRH 
neurons. Consistent with the lack of innervation, GnRH neurons lack V1Rs (Kalamatianos et 
al., 2004a; Jasoni et al., 2005), and a do not respond to AVP application (Piet & Herbison, 
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unpublished). Despite this, dialysis of AVP into the preoptic area can trigger the LH surge via 
excitation of the GnRH neuronal network (Palm et al., 1999, 2001). This work provides 
evidence that the SCN Avp-cre neurons are in apposition to RP3V kisspeptin neurons, which 
may then relay circadian cues necessary for generating the LH surge. The viral tract-tracing 
work confirms the model that SCN Avp-cre neurons are in apposition to kisspeptin neurons, but 
not GnRH neurons. This is indicative of a direct circuit from SCN AVP neurons to RP3V 
kisspeptin neurons, and an indirect pathway which mediates the excitation of GnRH neurons 
and thus, the LH surge. 
 
4.4.3 SCN Avp-cre neurons appose RP3V kisspeptin neurons 
Almost half of the RP3V kisspeptin neurons appear to be in apposition to mCherry-ir 
fibres from the SCN, however, as mentioned above in regard to GnRH neurons, these 
appositions are only taken at the level of the cell body. There is a possibility that the SCN may 
be innervating kisspeptin neurons at more distal dendritic regions, resulting in an 
underestimation of the apposed kisspeptin neurons. Given the characterisation of the mouse 
model from Chapter 3, Avp-cre mCherry-ir fibres are likely to represent 60% of the SCN AVP 
neurons potentially underrepresenting the true number of close appositions from SCN AVP 
neurons to kisspeptin neurons.  
 The appositions at kisspeptin neurons are defined as those lacking a black pixel between 
fibre and cell body in the images. However, an apposition is not definitive as a functional 
synapse. It could be that these projections, although coming close to kisspeptin neurons, are not 
establishing an actual synapse in the RP3V. Due to the brain having been sliced, it is impossible 
to determine whether the fibres are ending at the RP3V, or passing by. An 
immunohistochemical stain for a synaptic marker such as synaptophysin, electron microscopy, 
or a transsynaptic retrograde viral tracer would provide greater evidence for synaptic contact 
between mCherry and kisspeptin. There is also a possibility that a potential input from the SCN 
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AVP neurons may not be strictly synaptic. Magnocellular and SCN AVP neurons have been 
shown to release peptides in a non-synaptic manner from the dendrites (Pow & Morris, 1989; 
Castel et al., 1996). Thus, it could be that these neurons release their content in an extrasynaptic 
manner near to kisspeptin neurons as opposed to synaptically. 
 
4.5 Summary 
SCN AVP neurons are thought to be critical for the timing of the LH surge. Here, the 
projection from cre-expressing neurons from the SCN of the Avp-cre mouse has been traced to 
show an anatomical pathway between the SCN and RP3V. This provides evidence for a 
potential pathway by which the SCN may relay circadian cues to kisspeptin neurons. As GnRH 
neurons receive no such innervation from SCN Avp-cre neurons, this confirms an indirect 
pathway from SCN neurons to GnRH neurons, via the RP3V kisspeptin neurons. Further, these 
experiments have shown that at least half of these kisspeptin neurons are potentially innervated, 








Examination of Fast Synaptic 
Communication Between SCN Avp-cre 





 The previous chapter provided anatomical evidence that SCN Avp-cre neurons project 
to, and come into close apposition with, RP3V kisspeptin neurons. This suggests that a synaptic 
circuit may exist between the SCN AVP neurons and RP3V kisspeptin neurons. The 
experiments in this chapter aimed to determine whether this anatomical projection is 
functionally active, communicating with RP3V kisspeptin neurons by the release of fast 
neurotransmitter. 
 Functional communication between the two populations of neurons is typically 
synaptic, relying on the release of neurotransmitter to either excite or inhibit the postsynaptic 
target. In brief, an influx of sodium drives action potentials which propagate along neuronal 
projections to activate voltage-gated calcium channels in presynaptic terminals. The influx of 
calcium to presynaptic terminals drives vesicles containing neurotransmitter/neuropeptides to 
the synaptic membrane where they can be released into the synaptic cleft. Their binding to 
postsynaptic receptors allows for the transmission of the electrical message across the synapse, 
resulting in postsynaptic currents (Figure 5.1). 
Neurons within the SCN are thought to be GABAergic (Card & Moore, 1984; Okamura 
et al., 1989; Moore & Speh, 1993; Gao & Moore, 1996; Abrahamson & Moore, 2001), along 
with co-expressing neuropeptides, thus may release GABA onto postsynaptic targets. Released 
GABA binding to GABAA receptors (GABAARs) typically causes the influx of chloride 
resulting in an inhibitory postsynaptic current (IPSC). Recording IPSCs from the postsynaptic 
neuron, in response to presynaptic depolarisation, is the easiest method to determine whether 
two neuronal populations are synaptically linked. Therefore, recording GABAergic 
neurotransmission onto RP3V kisspeptin neurons, in response to SCN Avp-cre neuron 
stimulation would provide irrefutable evidence that these neurons establish synaptic input in 





Figure 5.1: The mechanism of neurotransmission. 
Electrical stimulation of a presynaptic neuron opens voltage-gated sodium channels (VGNC) which drives 
the generation of action potentials (1a). Optogenetic activation of neurons by blue light through 
channelrhodopsins (ChR2) also drives the influx of sodium to evoke action potentials (1b). This results 
in depolarisation of the presynaptic terminal. The depolarisation opens voltage-gated calcium channels 
(VGCC) to drive the influx of calcium (2). Calcium causes the vesicles at the membrane bind and release 
their content into the synaptic cleft (3). The released transmitters bind postsynaptic receptors, opening an 
ion channel (letting chloride ions through in the case of the GABAA receptor). The resulting postsynaptic 
current can be detected using whole cell voltage clamp electrophysiology (4). In optogenetic experiments, 
recorded postsynaptic currents occurring with a short and constant latency provide evidence that the 
presynaptic light stimulation evokes neurotransmitter release and thus evidence of the presence of 




5.1.1 Channelrhodopsin-assisted circuit mapping 
 Over the past decade, optogenetics has proved to be a critical method to help define 
neuronal circuitry. Optogenetics is a powerful method whereby genetically defined populations 
of neurons can be activated in a non-invasive manner using light (Fenno et al., 2011). Typically, 
light-sensitive proteins are expressed by a viral vector into neurons of interest, which can then 
be activated by specific wavelengths of light to selectively excite or inhibit neurons (Han et al., 
2018). One specific method of optogenetics uses channelrhodopsin (ChR2), a blue light-gated 
non-selective cation channel. Light stimulation opens the channel causing movement of Na+ 
and Ca++ into, and K+ out of the neuron. This results in positive charge entering the cell to cause 
depolarisation of the membrane and, if this depolarisation is strong enough, activation of 
voltage-dependent ion channels for the generation of action potentials (Figure 5.1). Here, a 
double mutant channelrhodopsin known as ChR2(ET/TC) has been used. The double mutant 
speeds up ChR2 kinetics and enhances ChR2 conductance (Berndt et al., 2011). This advantage 
allows for high-fidelity responses to fast light stimulation and precise stimulation of action 
potentials.  
 Channelrhodopsin-assisted circuit mapping (CRACM) takes advantage of this light 
sensitivity to non-invasively depolarise neuron terminals whilst electrophysiological recordings 
are carried out in putative downstream neuronal populations (Petreanu et al., 2007). The 
detection of post-synaptic currents evoked by light-stimulation thus provides unequivocal 
functional evidence that there is an input from one neuronal population to the next. 
 CRACM is an invaluable tool when coupled with the cre/loxP system. Here, cre-
dependent viral vector for ChR2(ET/TC) (Appendix III; herein referred to as AAV-ChR2) was 
injected into the Avp-cre mouse SCN to enable specific expression of ChR2 in cre-expressing 
SCN neurons. As ChR2 spreads along the neuronal projections (analogous to the tract-tracing 
experiments from Chapter 4) and inserts into the membrane, ChR2-expressing axons will still 
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be present and functional even when severed from their cell bodies. Although the full circuit is 
not intact, potential synaptic inputs would still be detected in the neurons of interest (Petreanu 
et al., 2007; Betley & Sternson, 2011; Lim et al., 2013), in this case, RP3V kisspeptin neurons. 
Using CRACM with the Avp-cre mouse model provides a level of specificity that would not be 
attained using more electrical stimulation, which activates axons indiscriminately (Yizhar et 
al., 2011). 
 
5.1.2 The Kiss1-hrGFP mouse model 
 To carry out experiments recording from kisspeptin neurons specifically in living brain 
slices, this work used the Kiss1-hrGFP mouse. The mouse line was generated by insertion into 
the mouse genome of a bacterial artificial chromosome containing parts of the kisspeptin gene, 
modified to contain a humanised renilla (hr) GFP cassette (Cravo et al., 2013). The Kiss1-
hrGFP model has been characterised in ovariectomised conditions by in situ hybridisation 
(Cravo et al., 2013). Immunohistochemical analyses of GFP to kisspeptin-ir were carried out 
in intact mice, in the Piet laboratory by Anaëlle Braine. It was found that 86.5 ± 2.4% of 
kisspeptin-ir neurons expressed GFP, while 64.4 ± 3.2% of GFP-expressing cells were 
kisspeptin-ir (Appendix VII), identifying this as a good model to visualise kisspeptin neurons. 
 When the Kiss1-hrGFP mouse is crossed to the Avp-cre mouse strain, the offspring 
(Avp-cre:Kiss1-hrGFP) makes a perfect model for interrogating how stimulation of Avp-cre 
neurons affects RP3V kisspeptin neurons. Here, CRACM has been carried out with ChR2-
transfected Avp-cre neurons, whilst recording from identified Kiss1-hrGFP neurons in brain 
slices. 
 
5.1.3 Oestrous cycle-dependent changes in input activity 
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Changes in neuronal electrical activity have been reported in females across the oestrous 
cycle, particularly in the way that neurons respond to upstream activity. Differences have been 
recorded in the hippocampus (Warren et al., 1995; Scharfman et al., 2003), nucleus accumbens 
(Proaño et al., 2018), and in the hypothalamus (Liu & Herbison, 2011). The changes in 
electrical activity across the oestrous cycle provide a mechanism by which neurons might 
regulate the activity of their downstream targets or may change their receptivity to incoming 
signals. This could be particularly important at proestrus as a mechanism to help elicit the LH 
surge.  
As activity of neurons in the RP3V is highly influenced by the sex steroid environment, 
it may be that changes in hormone concentration may affect how the neurons integrate upstream 
signals. At the ultrastructural level, synapses to RP3V neurons change in number across the 
oestrous cycle, with an increase at oestrus, and a decrease at met-/dioestrus (Langub Jr. et al., 
1994). Vida et al. (2010) have also shown that AVP-immunoreactive appositions to kisspeptin 
neurons increase with oestradiol treatment in OVX mice. It remains to be determined, however, 
if these appositions are synapses, and whether any functional plasticity exists across the 
oestrous cycle. Any plasticity, particularly around proestrus when the LH surge is generated 
would be relevant to the neuroendocrine regulation of ovulation. Here, recordings over different 
stages of the oestrous cycle indicate any potential change that could be occurring in the way 
that RP3V kisspeptin neurons integrate synaptic signals from the SCN Avp-cre neurons. 
 
5.1.4 Hypothesis and Aim 
 Due to the anatomical interactions presented in Chapter 4, it was hypothesised that these 
close appositions will be points of fast synaptic communication between SCN Avp-cre 
neurons and RP3V kisspeptin neurons. The experiments in this chapter aimed to determine 
whether RP3V kisspeptin neurons respond to GABAergic synaptic transmission from 
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SCN Avp-cre neurons and to whether there may be synaptic plasticity due to the changing 




 General animal information is outlined in Section 2.1. Adult female Avp-cre, Avp-
cre:Kiss1-hrGFP, Vgat-cre:tdTomato and Nms-icre:Kiss1-hrGFP mice (2-6 months old) were 
used in this study. Oestrous cycles were determined by daily vaginal lavage and tissue was 
collected in oestrous stages outlined in each experiment. 
  
5.2.2 Surgery 
 The general surgery procedures are outlined in Section 2.2. For Section 5.3.1, Avp-cre 
mice were unilaterally injected with 400 nL of AAV-ChR2 at the SCN. For the remainder of 
experiments, mice were injected bilaterally with 400 nL/side of AAV-ChR2 at the SCN. Mice 
were left for at least two weeks to allow sufficient transduction of the viral vector prior to 
experimentation.  
 
5.2.3 Acute brain slice preparation 
The brain slicing procedure for electrophysiology is outlined in Section 2.5.1.  
 
5.2.4 Brain slice electrophysiology 
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The general brain slice electrophysiology procedure and recording configurations are 
outlined as part of Section 2.5.2. Prior to experimentation, the level of ChR2 transduction was 
determined by examining mCherry expression in the SCN. Mice were used for experiments 
when mCherry expressing neurons were easily visible in the SCN.  
 
5.2.5 Optogenetic and electrophysiological protocols 
5.2.5.1 Identification of kisspeptin neurons 
By using blue light to excite the GFP in kisspeptin neurons, a significant issue could be 
encountered whereby the light may also activate the blue-light sensitive ChR2. This issue has 
been encountered previously (Qiu et al., 2016; Piet & Herbison, 2018; Piet et al., 2018), and 
has been mitigated by two key approaches used here. First, identification of kisspeptin neurons 
was carried out at the lowest light intensity sufficient to excite GFP (in this case 0.8 mW). This 
light intensity limits the level of ChR2 activation as the intensity may not be high enough to 
stimulate some/all of the ChR2 present. Secondly, the wait time following blue light stimulation 
(5-10 mins) ensures the recovery of the system. Identification of kisspeptin neurons, followed 
by the recovery period ensures that 1) ChR2 and ChR2-expressing projections fully recover 
from activation, 2) the effects of any neurotransmitters or neuropeptides released during the 
illumination would have subsided, and 3) the potentially released chemicals would have been 
cleared from the extracellular space (Piet et al., 2018). Thus, the combination of brief 
illumination and the recovery period minimised potential unwanted effects of ChR2 activation. 
 
5.2.5.2 Characterisation of ChR2 function 
To carry out a characterisation of the efficacy of the ChR2 at responding to light 
stimulation, ChR2-transfected SCN neurons, as identified by mCherry expression, were 
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targeted for on-cell loose-patch electrophysiological recordings. Trains of ten 5 ms blue light 
(14.1 mW) pulses at 1, 2, 5, 10, 20 and 50 Hz were shone onto the SCN, and the resulting action 
potentials were recorded. All neurons recorded were stimulated at each frequency in a random 
order but finishing with 50 Hz. The recordings were examined to determine when light pulses 
faithfully elicited action potential firing. Where an action potential followed a light pulse 
(within 10 ms), this was considered a response.  
 
5.2.5.3 Fast synaptic responses 
Neurons in the RP3V were targeted for whole-cell patch-clamp electrophysiological 
recordings. As a control for the issue of potential ChR2 excitation whilst identifying GFP-
expressing neurons, unidentified RP3V neurons, from Avp-cre mice that did not express the 
Kiss-hrGFP transgene, were targeted to determine their response. Once a whole-cell patch 
configuration was attained, the neurons were left to recover for several minutes prior to baseline 
recordings for two minutes. Two pulses of blue light were then shone onto the RP3V for 5 ms 
each, with 200 ms between pulses (5 Hz). This was repeated every 20 s, 25-50 times per neuron.  
 
5.2.5.4 Testing for a monosynaptic circuit 
 To determine whether the input from ChR2-transfected SCN neurons was 
monosynaptic, a protocol modified from Petreanu et al. (2009) was used. Once a postsynaptic 
response was measured, tetrodotoxin (0.5 µM; TTX) was bath applied resulting in inhibition of 
that postsynaptic response. 4-aminopyridine (100 µM; 4-AP) was then bath applied with TTX 





 The general perfusion-fixation, brain slicing and immunohistochemistry procedures are 
outlined in Section 2.3. The antibodies used in this Chapter have been reported in Chapter 3.  
 
5.2.7 Microscopy and image analysis 
The general microscopy methods are outlined in Section 2.4. General colocalisation 
analysis methods are outlined in Section 3.2.4. ChR2-expressing neurons were imaged in the 
SCN using a 20× objective for Figure 5.2. For Section 5.3.3, AVP-ir neurons were counted and 
the proportion colocalised with tdTomato (as a marker of the vesicular GABA transporter, 
vGAT) was determined. Images shown herein are maximum projection confocal Z-stack 
images unless stated otherwise. 
 
5.2.8 Statistical analysis 
General analysis methods are outlined in Section 2.7. The recorded sweeps were 
overlaid and inspected to determine the presence of a time-locked postsynaptic current (within 
10 ms of the light stimulation onset). Neurons that showed time-locked IPSCs in response to 
light stimulation were considered as ‘responding’ neurons. Those neurons that did not show 
IPSCs in response to light stimulation were termed ‘non-responding’. Comparisons of the 
proportions of responding and non-responding neurons across transgenic mouse strains were 
carried out using a chi-squared test. In this chapter, where n-values are reported, n refers to 
neurons recorded, while N refers to the number of animals used in the experiments. 
 
5.3 Results 
5.3.1 Characterisation of ChR2 function in Avp-cre neurons 
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First, it was necessary to determine whether SCN Avp-cre neurons expressed functional 
ChR2. mCherry (a reporter of ChR2 transduction) was expressed in SCN neurons in acute brain 
slices, indicating that the viral construct was successfully transfected. mCherry-expressing Avp-
cre neurons were recorded in the on-cell loose-patch configuration and stimulated with 10-
pulse trains of blue light illumination delivered at various frequencies (Figure 5.2a). Blue light 
elicited action potentials in SCN Avp-cre neurons with perfect fidelity at all frequencies from 
1-20 Hz. At the highest frequency tested (50 Hz), the fidelity of the response was still near 
perfect at 95.3 ± 3.2% success (Figure 5.2b, c; n = 7 neurons, N = 3 dioestrous mice). As such, 
ChR2 can successfully be transfected in SCN Avp-cre neurons and action potential firing can 
be reliably controlled over a range of frequencies by blue light-stimulation. 
 
5.3.2 SCN Avp-cre neurons do not communicate with RP3V 
kisspeptin neurons via fast-synaptic transmission 
 GFP-expressing neurons in the RP3V were recorded using whole-cell patch-clamp 
electrophysiology. The ChR2-expressing projections were then stimulated with paired pulses 
of blue light to evoke neurotransmitter release (Figure 5.3a). Interestingly, only 1 out of 14 
kisspeptin neurons from mice in dioestrus (7.1%) was found to respond to a fast-synaptic input 
from SCN Avp-cre neurons (Figure 5.3b, c; N = 4 dioestrous mice). This response was inhibited 
by gabazine (GBZ), showing it was mediated by activation of GABAAR (Figure 5.3c). 
It has been suggested that elevated oestrogen can increase the innervation of RP3V 
kisspeptin neurons by AVP neurons (Vida et al., 2010). Thus, at proestrus when circulating 
oestrogen is higher there could be more fast-synaptic transmission from the SCN Avp-cre 
neurons to RP3V kisspeptin neurons. However, it was found that only one out of 12 recorded 







Figure 5.2: ChR2 function in the Avp-cre mouse SCN.  
a) Experimental setup. b) Maximum projection image of a confocal Z-stack of the SCN showing ChR2 
expression (from a bilaterally injected mouse) as demarcated by mCherry. ChR2/mCherry-expressing 
neurons can be seen in the left SCN along the upper and left-hand sides, outlining the SCN shell. Grey 
bars indicate positions of the needle track. c) Example recordings showing 5, 10 and 20 Hz stimulation of 
ChR2 transfected SCN AVP neurons. Blue lines indicated 5 ms light pulses. Sharp deflections in the trace 
indicate action potential firing. d) Quantification of the fidelity of action potential firing in response to 1, 
2, 5, 10, 20 and 50 Hz stimulations. Data shown as mean ± SEM. Scale bar in b) = 100 µm. 3V = third 
ventricle. OX = optic chiasm. n = 7 neurons, N = 3 mice. Representative brain slice taken from Franklin 





Figure 5.3: RP3V kisspeptin neurons rarely exhibit fast synaptic input from SCN Avp-cre neurons. 
a) Experimental setup. b) Example traces of a non-responding RP3V kisspeptin neuron. c) One recorded 
kisspeptin neuron exhibited IPSCs in response to blue light stimulation of the ChR2-expressing Avp-cre 
projections. This response was blocked by the GABAAR antagonist gabazine (ci) indicating this is a 
GABA-mediated postsynaptic current. d) There was no difference in the proportions of responding 
kisspeptin neurons over different stages of the oestrous cycle. Traces displayed as 10 sweeps with the 
average overlaid in red. Scale bars = 200 ms/50 pA.  Di: N = 4 mice, Pro: N = 4 mice, Oestrus: N = 4 
mice. Representative brain slice taken from Franklin and Paxinos (2008). 
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N = 4 proestrous mice). Later in the oestrous cycle, during oestrus when oestradiol levels are 
low, none of the ten recorded kisspeptin neurons displayed blue-light evoked postsynaptic input 
(Figure 5.3d; N = 4 oestrous mice). There was no difference between the proportion of neurons 
responding in any stage of the oestrous cycle (Figure 5.3d; dioestrus vs proestrus: p = 0.91; 
dioestrus vs oestrus: p = 0.90; proestrus vs oestrus: p = 0.98; chi-squared tests). 
 As GFP and ChR2 have overlapping excitation spectra, there is a chance that the blue 
light needed to identify GFP-expressing neurons may deplete neurotransmitters in synapses. In 
dioestrous Avp-cre mice not expressing the Kiss1-hrGFP transgene, unidentified RP3V 
neurons were recorded using whole-cell patch-clamp electrophysiology. (Figure 5.4a). 
Following paired-pulse blue light stimulation of ChR2-expressing projections, it was found that 
only one of the 14 recorded neurons (7.1%) displayed fast synaptic input from SCN Avp-cre 
neurons (Figure 5.4b, N = 6 mice). This response was blocked by application of GBZ (Figure 
5.4c). These results are not different to that seen in the Avp-cre:Kiss1-hrGFP mouse (Figure 
5.4d; p = 0.83, chi-squared test), with GFP expression in kisspeptin neurons. 
 
5.3.3 SCN AVP neurons colocalise with the vesicular GABA 
transporter 
Although Avp-cre neurons form putative inputs to RP3V kisspeptin neurons, there is a 
rarely fast synaptic transmission occurring. One potential possibility may be that these Avp-cre 
neurons do not release GABA. In order to be released at synapses, GABA must be packaged 
into vesicles by the vesicular GABA transporter (vGAT). Thus, absence or presence of vGAT 
in SCN AVP neurons would indicate whether or not these neurons are equipped to release 
GABA. In dioestrous Vgat-cre:tdTomato mice, where vGAT expression is reported by red 







Figure 5.4: Unidentified RP3V neurons rarely exhibit fast synaptic input from SCN Avp-cre 
neurons.  
a) Experimental setup. b) Example traces from a non-responding RP3V neuron. c) One recorded RP3V 
neuron exhibited postsynaptic currents in response to blue light stimulation of the ChR2-expressing Avp-
cre projections. This response was blocked by the GABAAR antagonist gabazine (ci). d) There was no 
difference in the proportions of responding neurons seen in the Avp-cre or the Avp-cre:Kiss1-hrGFP 
mouse. Traces displayed as 10 sweeps with the average overlaid in red. Avp-cre:Kiss1-hrGFP data from 
Figure 5.3. Scale bars = 200 ms/50 pA. Avp-cre: N = 6 mice, Avp-cre:Kiss1-hrGFP: N = 12 mice. 
Representative brain slice taken from Franklin and Paxinos (2008). 
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whether SCN AVP neurons express vGAT. It was found that 58.7 ± 2.8% of AVP-ir neurons 
in the SCN colocalise with tdTomato (Figure 5.5; N = 4 mice). This indicates that a majority, 
but certainly not all, of the SCN AVP neurons express vGAT, and are equipped to release 
GABA. Absence of vGAT, therefore, perhaps does not fully account for the lack of fast synaptic 
transmission between SCN Avp-cre neurons and RP3V kisspeptin neurons. 
 
5.3.4 Nms-icre neurons make monosynaptic inputs onto RP3V 
kisspeptin neurons 
 Due to the lack of blue light-evoked postsynaptic currents in RP3V kisspeptin neurons, 
as well as evidence suggesting that the majority of SCN AVP neurons can package GABA into 
vesicles for release, it was necessary to ensure that the light stimulation of ChR2 could drive 
neurotransmitter release onto RP3V kisspeptin neurons. Preliminary findings in the Piet 
laboratory suggest that SCN NMS neurons release GABA onto RP3V neurons. Therefore, Nms-
icre:Kiss1-hrGFP mice were used as a positive control to determine whether the experimental 
approach was technically sound. As mentioned in Chapter 1, the NMS-expressing neurons of 
the SCN are thought to comprise up to 40% of SCN neurons and 96% of the SCN AVP neuron 
population, as well as producing NMS (Lee et al., 2015). 
 Paired-pulse blue light stimulation of ChR2-expressing Nms-icre axons and terminals 
(Figure 5.6a) resulted in IPSCs in 11 of the 13 (84.6%) kisspeptin neurons recorded (Figure 
5.6b; N = 1 proestrous and 2 dioestrous mice). This proportion was significantly greater than 
that seen in the Avp-cre and Avp-cre:Kiss1-hrGFP mouse models (Figure 5.6c; p < 0.0001 vs 
Avp-cre, p < 0.0001 vs Avp-cre:Kiss1-hrGFP, chi-squared tests). 
To determine whether the NMS projection to the RP3V was direct, a second experiment, 





   
 
Figure 5.5: Over half of SCN AVP neurons colocalise the vesicular GABA transporter, vGAT.  
a-c) Maximally projected Z-stack image of showing immunolabelling of AVP (green, a) and endogenous 
tdTomato fluorescence (red, b) in the SCN (thick border). The two images are merged (colocalised 
neurons in orange) in c. Box insets show higher magnification single plane images of AVP-ir (ai), 
endogenous tdTomato fluorescence (bi) and merged labels (ci). Empty arrowheads indicate AVP-ir only 
neurons. Filled arrow heads indicate tdTomato only neurons. Arrows indicate colocalised cells. d) 
Colocalisation of AVP-ir with tdTomato fluorescence. Data shown as mean ± SEM. a-c scale bars = 100 
µm. ai-ci scale bars = 10 µm. 3V = third ventricle. OX = optic chiasm. 
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Figure 5.6: RP3V kisspeptin neurons receive monosynaptic fast synaptic input from SCN Nms-icre 
neurons. 
a) Experimental setup. b) Blue light stimulation of ChR2-expressing Nms-icre projections evokes IPSC 
in a kisspeptin neuron, which was blocked by application of TTX (bi). When 4-AP was added, the IPSC 
was restored (bii) indicating that this is a monosynaptic pathway (n = 3 neurons, N = 2 mice). c) There 
was a significantly greater proportion of responding kisspeptin neurons receiving in Nms-icre mice that 
in Avp-cre or Avp-cre:Kiss-hrGFP mice (data from Figures 5.3 and 5.4). Fractions in bars indicate the 
number of responding neurons responses over the total number of recorded neurons. **** p < 0.0001. 
Traces displayed as 10 sweeps with the average overlaid in red. Scale bars = 200 ms/50 pA.  Avp-cre: N 
= 6 mice, Avp-cre:Kiss1-hrGFP: N = 12 mice, Nms-cre:Kiss1-hrGFP: N = 3 mice. Representative brain 
slice taken from Franklin and Paxinos (2008). 
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could be evoked, TTX was bath applied to block sodium channels, and thus action potential 
propagation. This will essentially block blue light-evoked synaptic transmission. When TTX is 
coupled with the potassium channel blocker, 4-AP, potassium is unable to be extruded from the 
cell. This results in a build-up of intracellular K+ which increases the net positive charge, 
increasing the excitability of the neuron, as well as inhibiting the K+-mediated repolarisation. 
ChR2 activation at the synaptic terminal allows the influx of cations to further depolarise the 
terminal. No action potentials are conducted, but the depolarisation is sufficient to activate 
voltage-gated calcium channels. The resulting calcium influx can then drive synaptic 
transmission in an action potential-independent manner.  
When ChR2 is activated, there are two possible outcomes. The first is that the IPSC is 
recorded in the postsynaptic cell. This shows that there is no propagation of the signal through 
a second neuron and, as such, this is unequivocal evidence that this is a monosynaptic circuit 
from the SCN to the RP3V. The second is that no postsynaptic current is recorded at the 
kisspeptin neuron. As it has been shown that blue light-stimulation is sufficient to evoke IPSCs 
onto kisspeptin neurons, no IPSC recorded would suggest that activation of the Nms-icre 
terminals results in neurotransmitter release onto a second neuron, which then, in turn, would 
release GABA onto the kisspeptin neuron. Due to the presence of TTX, that second neuron 
would be unable to propagate the electrical signal (i.e. action potentials) and, therefore, it could 
not release neurotransmitter onto the kisspeptin neuron. Thus, no IPSC would be recorded, 
indicating that this is a polysynaptic circuit, with one or several interneurons between the SCN 
and RP3V. 
In this experiment, the application of TTX inhibited the postsynaptic currents seen in 
response to the blue light (Figure 5.6bi). Co-application of 4-AP, however, was able to restore 
the postsynaptic currents indicating that neurotransmission could be driven in the absence of 
action potentials, revealing that this circuitry was monosynaptic (Figure 5.6bii; n = 3 neurons, 
N = 2 mice). These data show that activating ChR2 in the presynaptic terminal is sufficient to 
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drive neurotransmitter release. Further, it suggests an additional SCN input to RP3V kisspeptin 
neurons from a population expressing NMS, that are distinct from the Avp-cre neurons. 
 
5.4 Discussion 
Chapter 4 revealed a dense innervation of the RP3V by Avp-cre neurons and close 
appositions to kisspeptin neurons, suggestive of putative synaptic input. Here, however, it has 
been shown that despite this projection, and despite 60% of AVP neurons expressing the vGAT 
to package GABA into vesicles for release, SCN Avp-cre neurons rarely communicate by fast 
synaptic neurotransmission to RP3V kisspeptin neurons. These findings may reflect technical 
issues due to the methodology; a lack of synapses; or the presence of non-functional synapses 
that either lack presynaptic GABA release; or lack of postsynaptic GABAARs. Each of these 
will now be discussed.  
 
5.4.1 Technical considerations 
Using CRACM, this study found minimal evidence for synaptic input from SCN Avp-
cre neurons to RP3V kisspeptin neurons. One possibility for a lack of synaptic responses is a 
limitation of the CRACM method. All mice used in these experiments had mCherry-expressing 
neurons in the SCN determined by eye before experiments were carried out. Thus, it is unlikely 
that the ChR2 was not sufficiently expressed, although no specific counting or colocalisation 
was carried out. The ChR2 variant used here was found to faithfully respond to light stimulation 
over a variety of frequencies, including the 5 Hz used for the paired-pulse stimulation paradigm. 
However, recordings of ChR2 activity were made in the SCN, at the Avp-cre cell body. There 
is a chance that stimulation at the cell body does not accurately represent the activity of the 
ChR2 in the projection fibres. However, activation of projection fibres in the Nms-icre mouse 
model indicates that the ChR2 does indeed function to drive synaptic release (Figure 5.6). SCN 
125 
 
Nms-icre neurons were observed to readily communicate to RP3V kisspeptin neurons by fast-
synaptic transmission. In contrast, it seems that the SCN Avp-cre neurons do not relay 
information to RP3V kisspeptin neurons by GABAergic fast-synaptic transmission. 
 
5.4.2 Are the Avp-cre SCN neurons projecting to the RP3V 
GABAergic? 
It has been well reported, across multiple species, that SCN neurons produce GABA 
(Card & Moore, 1984; Okamura et al., 1989; Moore & Speh, 1993; Gao & Moore, 1996; 
Abrahamson & Moore, 2001). Interestingly, however, the secondary phenotype (i.e. 
coexpression of peptides) of these GABAergic neurons remains contentious. Initially, it was 
reported that nearly all SCN neurons produce GABA (Okamura et al., 1989; Moore & Speh, 
1993; Abrahamson & Moore, 2001). Castel and Morris (2000), however, suggest that at most, 
70% of the SCN neurons produce GABA. Further, GABA preferentially colocalises with VIP, 
rather than AVP (Castel & Morris, 2000).  
 The data presented here shows expression of the transgenic reporter of vGAT in almost 
60% of AVP-ir neurons in the SCN. This supports the idea that a majority of AVP neurons in 
the SCN can package GABA in vesicles. Whether these vesicles are shuttled to synaptic sites 
for release, however, is unknown. Indeed, electron microscopy studies have shown that 
although SCN AVP somata do produce GABA, small synaptic vesicles containing GABA are 
rare at AVP-expressing terminals (Buijs et al., 1995; Castel & Morris, 2000). Instead, GABA 
is found co-packaged into large dense-core vesicles (LDCVs), typically thought to be 
neuropeptide specific (Castel & Morris, 2000). These GABA/peptide-containing LDCVs do 
not cluster at synaptic terminals, thus providing a mechanism whereby GABA could be released 
but not within a synaptic cleft. It is important to note that the terminals examined in these studies 
are intra-SCN microcircuits rather than projections to other brain regions.  
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For GABA to be packaged into LDCVs in projections, vGAT must still be present, 
however. Likewise, we cannot be certain that the projection fibres we see express vGAT. Cre 
expression is sufficient to turn on the tdTomato reporter throughout the neuron (in the Vgat-
cre:tdTomato mouse line) as a whole but cannot tell us exactly where in the neuron vGAT is 
being expressed. Further, as discussed in Chapter 3, tdTomato expression is an indirect reporter 
of vGAT expression, and thus cre may have been expressed transiently prior to 
experimentation. Thus, whether these AVP neurons produce GABA may not entirely answer 
whether they are releasing it at these RP3V projections.  
Using an anterograde tracer, like that in Chapter 4, to label those SCN Avp-cre neurons 
projecting to the RP3V, coupled with immunohistochemistry for vGAT would provide strong 
evidence as to whether vGAT is expressed at the projections near to kisspeptin neurons. The 
possibility exists that the presence of vGAT may be to transport GABA to LDCVs rather than 
small synaptic vesicles. Further, GABA is also able to be packaged via a second mechanism, 
the vesicular monoamine transporter 2 (vMAT2) (Tritsch et al., 2012), however, the presence 
of vMAT2 in the SCN itself appears to be minimal, if at all present (Allen Brain Atlas: 
http://mouse.brain-map.org/experiment/show/79591703). 
 
5.4.3 Limited synaptic innervation by Avp-cre neurons 
The study in this chapter suggests that although an anatomical projection from Avp-cre 
neurons was observed (Chapter 4), these fibres do not largely constitute functional synaptic 
connections between the SCN and RP3V. Advances in viral vector-mediated delivery by 
retrograde monosynaptic rabies viruses (Callaway & Luo, 2015; Kim et al., 2016) allow for 
viral vectors to be carried across a synapse from a specific population of cells to transfect the 
presynaptic neuronal populations. This tool could be used to target kisspeptin neurons in the 
RP3V to reveal whether the SCN AVP projections were, in fact, forming synapses. A second 
approach would be to use a viral vector that targets cre-dependent fluorescent proteins to 
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synapses in an anterograde method. Thus, injection of this virus to Avp-cre neurons would 
reveal whether there are synapses adjacent to kisspeptin neurons. 
The electrophysiological evidence here suggests minimal synaptic communication 
between SCN Avp-cre and RP3V neurons, however, this does not exclude the fact that synapses 
may be present but not functional. It could be that Avp-cre-to-kisspeptin synapses lack 
GABAARs explaining the lack of fast synaptic transmission (Figure 5.7a). There is, however, 
clear evidence that kisspeptin neurons are receiving GABAAR-mediated inputs. The recordings 
shown in Figures 5.3, 5.4 and 5.6, actively demonstrate IPSCs onto RP3V neurons, indicating 
that the neurons recorded do receive GABAergic synaptic inputs from afferent populations, and 
these are releasing GABA acting at GABAARs (Figures 5.2, 5.3). Further, there is clear synaptic 
innervation of the RP3V kisspeptin neurons from SCN Nms-icre neurons. The possibility 
remains that Avp-cre projections are forming silent synapses (i.e. those lacking postsynaptic 
receptors). Silent synapses are typically glutamatergic synapses lacking postsynaptic glutamate 
receptors (Vincent-Lamarre et al., 2018); however, a subtype known as ‘mute synapses’ where 
postsynaptic GABAARs are present, but there is no presynaptic GABA (or presynaptic GABA 
is unable to be released) have also been identified (Figure 5.7b) (Losonczy et al., 2004; Bekkers, 
2005). We cannot rule out the possibility that these Avp-cre neurons are forming synapses but 
are unable to functionally cause synaptic transmission. 
The final possibility is that Avp-cre neurons are producing and releasing GABA, just 
not at synapses. Packaging of GABA to LDCVs would suggest they are released at sites in Avp-
cre projection away from a synapse (Figure 5.7c) (Morris & Pow, 1991). Further, these LDCVs 
would require greater stimulation for release, rather than the paired pulses used here (Salio et 
al., 2006). It has been shown that LDCVs in the SCN can be released from both dendrites and 







Figure 5.7: Potential mechanisms explaining minimal GABAergic synaptic transmission. 
a) If synapses between Avp-cre neurons and kisspeptin neurons are present, they may be silent synapses 
where, even if GABA is released, the kisspeptin neuron cannot respond to it due to a lack of receptors. b) 
In contrast to that, the opposite may be true, where the kisspeptin neurons do have GABAARs, but GABA 
is not released from Avp-cre synapses. c) A third possibility is that the close appositions between Avp-cre 
projections and kisspeptin neurons are not synapses, but axonal swellings containing large dense-core 
vesicles (LDCVs). These vesicles may contain GABA, and GABAARs may be present at the kisspeptin 
neuron, however, the stimulation used here was not intense enough to drive the release of the LDCVs. 
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exocytose LDCVs containing AVP at distant nuclei (Pow & Morris, 1989; Ludwig & Leng, 
2006; Son et al., 2013). Thus, a possibility remains that these Avp-cre projections (whether 




Despite robust anatomical evidence for innervation of RP3V kisspeptin neurons by SCN 
Avp-cre neurons, limited evidence was found for functional fast synaptic input. This suggests 
that these fibres may be sites of extrasynaptic release of GABA, or drive the activity of 
kisspeptin neurons through a mainly peptidergic mechanism. Interestingly, GABAergic 
synaptic transmission was seen from a second SCN population, comprised of Nms-icre neurons, 
to kisspeptin neurons. Of the 51 neurons recorded in the RP3V, only 3 exhibited Avp-cre-
mediated inhibitory postsynaptic currents. Again, this is highly surprising as most of these Avp-
cre neurons express vGAT, the membrane transporter that packages GABA into vesicles for 
release. As such, GABAergic synaptic transmission is not a means for SNC Avp-cre neurons to 
communicate with RP3V kisspeptin neurons. In the next chapter, the impact the SCN Avp-cre 








Regulation of Kisspeptin Neuron Action 





For successful ovulation in mammals, there must be a surge in the concentration of 
luteinising hormone (LH), occurring when oestradiol levels are highest. Kisspeptin neurons in 
the rostral periventricular region of the third ventricle (RP3V) are the key mediator of the LH 
surge, showing clear patterns of excitation in proestrus, at the time of the surge (Clarkson & 
Herbison, 2009). The integration of sex steroid feedback from the ovary, with a timing signal 
from the suprachiasmatic nucleus (SCN), makes kisspeptin neurons a key candidate in 
investigating the role that SCN-derived signals have at the RP3V, and how this may change 
throughout the oestrous cycle. 
The key peptide from the SCN thought to drive an increase in the activity of kisspeptin 
neurons, prior to ovulation, is vasopressin (AVP). AVP can stimulate the LH surge in rodents 
lacking a functional SCN (Palm et al., 2001; Miller et al., 2006), and intracerebroventricular 
injection of an AVP receptor antagonist can significantly blunt the surge in intact animals 
(Funabashi et al., 1999); although this has not been a consistent finding (Palm et al., 2001; 
Miller et al., 2006). There is evidence that changes in oestradiol concentrations affect AVP 
neuron interaction with kisspeptin neurons. Oestradiol treatment to ovariectomised (OVX) 
rodents increases the number of AVP-ir appositions to kisspeptin neurons (Vida et al., 2010) 
and V1R gene expression in the RP3V (Kalamatianos et al., 2004a; Smarr et al., 2013). Further, 
AVP-mediated excitation of kisspeptin neurons is reduced following OVX, and enhanced in 
OVX mice treated with oestradiol (Piet et al., 2015b), indicating that changes in oestradiol may 
underlie changes in functionality of the SCN to RP3V circuit. Together, these studies show that 
oestradiol is a critical regulator, to enhance the receptivity of this network. As oestradiol 
concentrations increase across the oestrous cycle, it could be that endogenous oestradiol 
feedback sets up, or primes this network at proestrus for optimal functionality at the time for 
the LH surge. However, little work has investigated how endogenous AVP released from SCN 
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neurons influences RP3V kisspeptin neurons, or how this may be dependent on oestrous cycle 
stage.  
The studies in Chapter 4 of this thesis showed that Avp-cre projections from the SCN 
are in a prime position to release neuropeptides in the vicinity of the RP3V kisspeptin neurons. 
The studies in Chapter 5 showed that these projections rarely form functional GABAergic 
synapses onto RP3V kisspeptin neurons. Therefore, the experiments in this chapter sought to 
determine whether AVP is released from SCN Avp-cre projections in the RP3V, and how it 
influences the kisspeptin neuron activity over the oestrous cycle. The increase in oestradiol 
secretion from dioestrus to proestrus may drive changes in the excitability of the circuitry. Post 
ovulation, during oestrus, the drop in oestradiol secretion, and the rise in circulating 
progesterone, may also have an impact on the regulation of RP3V kisspeptin neuron activity by 
SCN AVP neurons. Measuring the functionality of this circuit across the oestrous cycle will 
determine how sex steroid feedback patterns may impact kisspeptin neuron responses to 
endogenous AVP release.  
 
6.1.1 Frequency-dependent optogenetic stimulation 
 To drive the release of AVP from the projection fibres, a different stimulation protocol 
to that used in Chapter 5 was employed. AVP is packaged into large dense-core vesicles 
(LDCVs)which do not necessarily locate at synaptic release sites (Buijs et al., 1999; Castel & 
Morris, 2000). The influx of calcium necessary to drive their release, therefore, must be greater 
than for small synaptic vesicles, which are adjacent to the membrane (van den Pol, 2012). Thus, 
a stimulation paradigm of greater frequency is necessary to drive the LDCV and, as such, AVP 
release. This has been shown previously to be necessary for neuropeptide release (Liu et al., 




6.1.2 Hypothesis and aim 
 It was hypothesised that Avp-cre neurons release AVP onto RP3V kisspeptin 
neurons and that the impact of this communication pathway fluctuates across the oestrous 
cycle such that RP3V kisspeptin neurons are optimally activated on the day the surge is 
generated. The experiments carried out in this chapter aimed to determine how stimulation 
of SCN Avp-cre projections impacts the action potential firing of RP3V kisspeptin 
neurons. Further, the experiments aimed to determine whether the effects vary throughout 
the oestrous cycle in a manner consistent with a role for this circuit in activating RP3V 




 General animal information is outlined in Section 2.1. Adult female Avp-cre:Kiss1-
hrGFP mice (2-6 months old) were used in this study. Oestrous cycles were determined by 
daily vaginal lavage and were used in stages outlined in each experiment. 
 
6.2.2 Surgery 
 The general surgery procedures are outlined in Section 2.2. Here, mice were injected 
bilaterally with 400 nL/side of AAV-ChR2. Mice were left for at least two weeks to allow 
sufficient transduction of the viral vector prior to experimentation. Mice without transfection 




6.2.3 Acute brain slice preparation, identification of kisspeptin 
neurons and electrophysiology 
The brain slicing procedure and electrophysiology has been outlined in Chapter 2. 
Identification of kisspeptin neurons has been outlined in Section 5.2.5. Prior to experimentation, 
the level of ChR2 transduction was determined by examining mCherry expression in the SCN. 
Mice were used for experiments when mCherry expressing neurons were easily visible in the 
SCN.  
 
6.2.4 Optogenetic and electrophysiological protocols 
The general brain slice electrophysiology procedure and recording configurations are 
outlined as part of Section 2.5.2. General optogenetic procedures are outlined in Chapter 5. 
 
6.2.4.1 Neuropeptide bath application 
Following patching of the kisspeptin neuron, baseline action potential activity was 
recorded for two minutes. AVP (500 nM; Sigma Aldrich) was then bath applied for two minutes 
to the brain slice. Recordings continued for another 9 minutes post-application. 
 
6.2.4.2 Train optogenetic stimulation 
As above, baseline kisspeptin neuron action potential activity was recorded for two 
minutes. Blue light was shone onto the RP3V for 60 s, at a frequency of 20 Hz (5 ms/pulse). 
Action potential frequency was then recorded for a further ten minutes post-stimulation.  
 
6.2.5 Statistical analysis 
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General analysis methods are outlined in Section 2.7. Action potentials were analysed 
using threshold analysis in Clampex (see Section 2.5.2.1). In this chapter, where n-values are 
reported, n refers to neurons recorded, while N refers to the number of animals used in the 
experiments. 
 
6.2.5.1 Analysis of kisspeptin neuron firing  
Action potentials were grouped into 10-second bins and their average frequency in Hz 
was determined. The baseline frequency was the average frequency of the 120 s prior to the 
onset of stimulation or AVP wash. Immediate effects were considered those occurring during 
high-frequency light stimulation (HFLS) or the first 60 s of AVP wash. Delayed effects were 
those occurring within the five-minute period following the immediate effect period (Figure 
6.1). Effects were qualified as either excitation (response exceeded baseline + 2 SD), inhibition 
(response exceeded baseline – 2 SD), or no change (response did not exceed baseline ± 2 SD). 
Where firing frequency varied by ≥ ± 2 SD of baseline firing rate in a single 10 s bin, two bins 
(20 s) immediately before and after were considered, and firing frequency over the entire 50 s 
period was averaged (Figure 6.1). In a number of recordings, multiple 10 s bins had changes 
greater than ± 2 SD of baseline. If those were not contiguous, the first bin varying by ≥ ± 2 SD 
of the 50 s averaged effect (Figure 6.1). If the bins were contiguous, the greatest change from 
baseline was considered the centre the 50 s average (Figure 6.1). The 50 s average was then 
compared to baseline to determine whether it still exceeded ± 2 SD; and was then considered 
either excitation, inhibition, or no change. No recording displayed responses comprised of both 
an inhibition and an excitation. Some recordings did not display a bin of greater than ± 2 SD. 
These cells were considered to not change. To determine the average response the bin with the 
greatest change (less than ± 2 SD) from baseline and the two contiguous bins either side were 













































































































































































































































































































































































































































































6.2.5.2 Comparisons of firing rates 
Action potential firing changes as a percent of baseline frequency were compared using 
a Friedman test with post hoc Dunn’s multiple comparisons tests. Comparisons between 
oestrous cycle stages at specific time points were carried out using a Kruskal-Wallis test with 
post hoc Sidak test. Comparisons between oestrous cycle and bath application of drugs were 
carried out using Mann-Whitney tests. Comparisons of proportions of different neuron 
responses were carried out using a chi-squared test. 
 
6.3 Results 
6.3.1 Kisspeptin neurons do not change firing rate in response to 
high-frequency light stimulation in off-target control mice 
First, to ensure that the ChR2 was able to be activated for 60 s, recordings of SCN Avp-
cre neurons expressing ChR2 were made. Using on cell recordings of Avp-cre neurons with 60 
s of 20 Hz light stimulation (Figure 6.2a) revealed that the ChR2 faithfully responded to blue 
light 86.7 ± 8.7% of the time (Figure 6.2b-c; n = 6 neurons, N = 2 mice).  
Previous reports have suggested that HFLS of neuronal tissue can cause non-opsin 
mediated effects on neuronal activity (Stujenske et al., 2015; Owen et al., 2019). Thus, it was 
necessary to determine whether the HFLS used here would affect kisspeptin neuron activity. 
Dioestrous and proestrous Avp-cre:Kiss1-hrGFP mice, with off-target needle placement (i.e. 
AAV-ChR2 injected outside of the SCN resulting in no ChR2 expression in SCN Avp-cre 
neurons) were used to test this (Figure 6.3a).  
 None of the recorded neurons showed changes from baseline that met the criteria for 






Figure 6.2: ChR2 function with high-frequency light stimulation.  
a) Experimental setup. b) Example trace showing 60 s of 20 Hz stimulation of a ChR2-expressing Avp-
cre neuron. Blue lines indicated 5 ms light pulses. Sharp deflections in the trace indicate action potential 
firing. c) Quantification of the fidelity of action potential firing at 20 Hz stimulation for 60 s. Scale bars 
= 20 pA/5 s (upper) and 20 pA/20 ms (lower). n = 6 neurons, N = 2 mice. Data shown as mean ± SEM. 







Figure 6.3: High-frequency light stimulation of Avp-cre neuron projections in animals with off 
target ChR2 transfection does not cause changes to kisspeptin action potential firing. 
a) Experimental setup. b) Representative trace illustrating the effect of HFLS on action potential firing in 
a kisspeptin neuron in an Avp-cre mouse that had no detectable SCN transfection. c) Average time-course 
of action potential frequency over the recording period. d) Quantified changes of kisspeptin action 
potential frequency as a percentage of baseline frequency during the effect periods. Scale bars = 60 s/50 
pA. Blue bars in b) and c) represent light stimulation. Data presented in c) and d) as mean ± SEM, dotted 


















Control 6.3 0 10 0 
91.7 ± 
2.8% 




Dioestrus 6.4 1 13 0 
87.7 ± 
7.3% 














6.6 0 10 1 
90.6 ± 
5.7% 




Oestrus 6.7 0 3 9 
57.3 ± 
8.9% 




Table 6.1: Individual and mean responses across the oestrous cycle to high frequency light 
stimulation. 
The number of neurons showing responses in both the immediate and delayed effect periods, as per the 
criteria outlined in Section 6.2.6.3, are tabulated. The mean response from baseline from all the neurons 
recorded is also provided and presented as mean ± SEM. Yellow boxes indicate mean responses that are 
significantly different from baseline. Associated figures are referenced in the Fig. column.   
 
firing rate in either the immediate or delayed response periods (Figure 6.3b-d; immediate: 91.7 
± 2.8% of baseline, p = 0.36; delayed: 100.4 ± 3.7% of baseline, p = 0.99; n = 10 neurons; N = 
2 dioestrous and 2 proestrous mice; Friedman test with post hoc Dunn’s multiple comparisons 
tests). These data show that the HFLS protocol used here, on its own, does not have any effect 
on RP3V kisspeptin neuron electrical activity.  
 
6.3.2 Optogenetic stimulation of Avp-cre projections in dioestrus 
does not change kisspeptin neuron action potential firing 
 AAV-ChR2 was targeted to SCN Avp-cre neurons as shown previously (Figure 5.2). 
Although the Avp-cre projections were severed from the somata during brain slice preparation, 
ChR2-expressing fibres were still present in the RP3V (similar to the mCherry-expressing 
fibres shown in Chapter 4). Thus, HFLS of ChR2-expressing Avp-cre projections was carried 






Figure 6.4: Kisspeptin neurons do not change action potential firing in response to high-frequency 
light stimulation of ChR2-expressing Avp-cre projections during dioestrus. 
a) Experimental setup. b) Representative trace illustrating the effect of HFLS of ChR2-expressing Avp-cre 
projections on action potential firing from a kisspeptin neuron from a dioestrous mouse. c) Average time-
course of action potential frequency over the recording period. d) Quantified changes of kisspeptin action 
potential frequency as a percentage of baseline frequency during the effect periods. Scale bars = 60 s/50 
pA. Blue bars in b) and c) represent light stimulation. Data presented in c) and d) as mean ± SEM, dotted 





During the delayed effect period, there were varied effects of HFLS on kisspeptin 
neuron activity, with neurons some excited while others were inhibited (Table 6.1). Overall, 
HFLS did not result in significant changes to kisspeptin action potential firing in dioestrus 
(Figure 6.4b-d; immediate: 87.7 ± 7.3% of baseline, p > 0.99; delayed: 113.1 ± 13.8% of 
baseline, p = 0.56; n = 14 neurons; N = 6 mice; Friedman test with post hoc Dunn’s multiple 
comparisons tests). These data suggest that while Avp-cre projections may either excite or 
inhibit individual RP3V kisspeptin neurons during dioestrus, the overall activity of the 
population is unaffected by HFLS of ChR2-expressing Avp-cre projections. 
 
6.3.3 Optogenetic stimulation of Avp-cre projections in proestrus 
increases kisspeptin neuron action potential firing 
 The increasing oestradiol concentration and development of positive feedback in 
proestrus may increase the responsiveness of the RP3V kisspeptin neuron population. HFLS in 
proestrus caused the majority of kisspeptin neurons to be excited during the delayed period 
(Table 6.1). There was no group mean difference in action potential firing during the immediate 
response period (Figure 6.5; 106.0 ± 12.8% of baseline, p > 0.99, n = 16 neurons, N = 7 mice, 
Friedman test with post hoc Dunn’s multiple comparisons test); however, there was a 
significant increase in the mean firing rate during the delayed response period (Figure 6.5; 169.5 
± 16.9% of baseline, p = 0.001, n = 16 neurons, N = 7 mice, Friedman test with post hoc Dunn’s 
multiple comparisons test).  
 These data show that activating SCN Avp-cre projections excites RP3V kisspeptin 







Figure 6.5: Kisspeptin neurons increase action potential firing in response to high-frequency light 
stimulation of ChR2-expressing Avp-cre projections during proestrus.  
a) Representative trace illustrating the effect of HFLS of ChR2-expressing Avp-cre projections on action 
potential firing from a kisspeptin neuron from a proestrous mouse. b) Average time-course of action 
potential frequency over the recording period. c) Quantified changes of kisspeptin AP frequency as a 
percentage of baseline frequency during the effect periods. Scale bars = 60 s/50 pA. Blue bars in a) and 
b) represent light stimulation. Data presented in b) and c) as mean ± SEM, dotted lines represent baseline.  
n = 16 neurons, N = 7 mice. ** p < 0.01. 
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6.3.4 V1R antagonism prevents the increase in kisspeptin neuron 
action potential firing during proestrus 
To address whether the activation of kisspeptin neurons in proestrus is due to AVP 
release, the V1R (and oxytocin receptor (OTR)) antagonist, Manning Compound (MC, 1 µM), 
was continuously bath applied to brain slices from proestrous Avp-cre:Kiss1-hrGFP mice 
throughout the recording period and the effect of HFLS tested. This experimental design was 
chosen due to the delayed and long-lasting nature of the effects seen in RP3V kisspeptin 
neurons in proestrus (Figure 6.5), which made repeated stimulation impractical. 
During and following HFLS, the majority of kisspeptin neurons did not change their 
firing rate when ChR2-expressing SCN Avp-cre projections were stimulated in the presence of 
MC (Table 6.1; Figure 6.6a-c; immediate: 90.6 ± 5.7% of baseline, p > 0.99; delayed: 109.9 ± 
7.7% of baseline, p = 0.11; n = 11 neurons; N = 4 mice; Friedman test with post hoc Dunn’s 
multiple comparisons tests).  
Furthermore, the delayed effect of HFLS in the presence of MC was significantly 
different to that seen in proestrus in the absence of the antagonist (Figure 6.6d; p = 0.007, Mann-
Whitney test). There was also a non-significant trend towards a decrease in the proportion of 
kisspeptin neurons that were excited by HFLS in the presence of MC (Figure 6.6e; p = 0.053 
vs proestrus, chi-squared test). These observations are consistent with the idea that AVP 







Figure 6.6: Manning Compound inhibits the increase in kisspeptin neuron action potential firing in 
response to high-frequency light stimulation of ChR2-expressing Avp-cre projections during 
proestrus.  
a) Representative trace illustrating the effect of HFLS of ChR2-expressing Avp-cre projections on action 
potential firing from a kisspeptin neuron from a proestrus mouse in the presence of 1 µM Manning 
Compound (MC). b) Average time-course of action potential frequency over the recording period. c) 
Quantified changes of kisspeptin action potential frequency as a percentage of baseline frequency during 
the effect periods. d) The proportion of kisspeptin neurons responding in the absence or presence of MC, 
in proestrus. Data in proestrus from Figure 6.5. Scale bars = 60 s/50 pA. Blue bars in a) and b) represent 
light stimulation. Data presented in b), c) and d) as mean ± SEM, dotted lines represent baseline.  Pro: n 
= 14 neurons, N = 6 mice; Pro + MC: n = 11 neurons, N = 4 mice. ** p < 0.01. 
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6.3.5 Optogenetic stimulation of Avp-cre projections in oestrus 
decreases kisspeptin neuron action potential firing 
 Next, it was investigated how kisspeptin neurons respond to HFLS of SCN Avp-cre 
projections during oestrus. First, it was noted that kisspeptin neurons in oestrus were 
predominantly silent (i.e. not firing action potentials). As such, only neurons that had a baseline 
firing frequency of 0.2 Hz or greater were used in this experiment.  
The results seen following HFLS of SCN Avp-cre projections in oestrus were 
remarkably different to those seen in dioestrus and proestrus. During HFLS, 75% of kisspeptin 
neurons recorded were inhibited; this effect did not persist during the delayed period where 
hardly any neuron changed their firing frequency. No neuron was excited during or following 
HFLS (Table 6.1). This resulted in a significant decrease in kisspeptin action potential firing 
during the immediate effect period but not the delayed period following HFLS (Figure 6.7; 
immediate: 57.3 ± 8.9% of baseline, p > 0.0002; delayed: 78.4 ± 7.1% of baseline, p = 0.063; 
n = 12 neurons; N = 5 mice; Friedman test with post hoc Dunn’s multiple comparisons tests) 
These data indicate a switch in the impact of Avp-cre projections on RP3V kisspeptin 
neuron electrical activity: an inhibitory factor may rapidly dampen kisspeptin neuron firing, 









Figure 6.7: Kisspeptin neurons decrease action potential firing in response to high-frequency light 
stimulation of ChR2-expressing Avp-cre projections during oestrus. 
a) Representative trace illustrating the effect of HFLS of ChR2-expressing Avp-cre projections on action 
potential firing from a kisspeptin neuron from an oestrous mouse. b) Average time-course of action 
potential frequency over the recording period. c) Quantified changes of kisspeptin AP frequency as a 
percentage of baseline frequency during the effect periods. Scale bars = 60 s/50 pA. Blue bars in a) and 
b) represent light stimulation. Data presented in b) and c) as mean ± SEM, dotted line at 100% represents 
baseline.  n = 12 neurons, N = 5 mice. *** p < 0.001. 
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6.3.6 Oestrous cycle-dependent plasticity in RP3V kisspeptin 
neuron firing rates in response to light stimulation of SCN Avp-cre 
projections 
The data presented thus far show differing responses throughout the oestrous cycle. 
There are two distinct response types with opposing effects on kisspeptin neuron electrical 
activity: an inhibitory response occurring during the light stimulation, almost exclusively 
during oestrus, and a delayed, excitatory response mediated by V1R activation mainly seen 
during proestrus. Figure 6.8 summarises these findings.  
The immediate inhibitory response is significantly greater in oestrus than in proestrus 
(Figure 6.8a; p = 0.015, Kruskal-Wallis test with post hoc Dunn’s multiple comparisons test). 
When looking at the proportions of cells which change their firing during this immediate period, 
there is a clear difference between oestrus and other experimental groups (Figure 6.8a; p = 
0.0003 vs dioestrus, p = 0.0008 vs proestrus, chi-squared tests). There was no difference 
between the responses seen in dioestrus and proestrus (Figure 6.8a; p = 0.64, chi-squared test).  
The delayed excitatory effect is significantly greater in proestrus compared with 
dioestrus or with oestrus (Figure 6.8b; p = 0.013 vs dioestrus, p = 0.0006, vs oestrus, Kruskal-
Wallis test with post hoc Dunn’s multiple comparisons tests). The proportions of neuron did 
not reach statistical significance between proestrus and dioestrus, (Figure 6.8b; p = 0.061, chi-
squared test), although, responses in proestrus were significantly different compared to oestrus 
(Figure 6.8b; p = 0.002, chi-squared test). Further, the proportions of responses differed 
significantly between dioestrus and oestrus (Figure 6.8b; p = 0.001, chi-squared test). 
Together, these data show a change in the patterns in which RP3V kisspeptin neurons 





Figure 6.8: Summary of kisspeptin neuron response to HFLS of ChR2-expresing Avp-cre 
projections across the oestrous cycle. 
a) During the immediate effect period, kisspeptin neurons in oestrus are inhibited by HFLS of ChR2-
expressing Avp-cre projections. This response is significantly lower than that in proestrus. The proportion 
of neurons that are inhibited in oestrus is significantly higher than any response seen in neurons in 
di/proestrus. b) During the delayed effect period, kisspeptin neurons in proestrus are excited by HFLS of 
ChR2-expressing Avp-cre projections. This response is significantly greater than that seen in dioestrus 
and oestrus. The proportion of neurons that are excited in proestrus is significantly higher than the 
responses seen in oestrus. Data presented as mean ± SEM. Dotted line at 100% represents baseline. * p < 
0.05, ** p < 0.01, *** p < 0.001. 
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6.3.7 GABAAR antagonism mitigates the decrease in kisspeptin 
neuron action potential firing in oestrus 
 Kisspeptin neurons in oestrus show an inhibition in their firing following HFLS of SCN 
Avp-cre projections with kinetics suggestive of amino acid neurotransmission (Schöne et al., 
2014; Piet et al., 2018). As such, it was investigated whether the inhibitory neurotransmitter 
GABA, could be mediating this immediate effect. GABA has two main receptors, GABAA and 
GABAB receptors (GABAAR, GABABR), both of which are expressed and have inhibitory 
effects in RP3V kisspeptin neurons (DeFazio et al., 2002; Zhang et al., 2013; Di Giorgio et al., 
2019). As the inhibitory response seen in oestrus is immediate, it is more likely that is it 
mediated by GABAAR, a fast ion channel-mediated receptor, than by GABABR, a slow GPCR. 
Thus, the activation of GABAAR by Avp-cre projections during oestrus was investigated. 
For this, a dual stimulation design was adopted, in which HFLS was carried out to 
identify kisspeptin neurons that were inhibited during light stimulation and was repeated in the 
absence or in the presence of 5 µM gabazine (GBZ), a GABAAR antagonist (Figure 6.9a, b). 
This allows for direct comparisons within the same recording of individual neurons. To ensure 
that the second stimulation was sufficient to drive inhibition of kisspeptin neurons, a second 
HFLS was repeated 12 minutes after the first HFLS in the absence of any drugs. Both the first 
and second HFLS resulted in action potential firing in RP3V kisspeptin neurons significantly 
inhibited below baseline, with no difference in the extent of inhibition between stimulations 
below baseline (Figure 6.9a, c; first: 72.7 ± 6.2% of baseline, p = 0.028; second: 77.2 ± 8.2% 
of baseline, p = 0.028, n = 6 neurons, N = 3 mice, Friedman test with post hoc Dunn’s multiple 






Figure 6.9: Gabazine reduces the decrease in kisspeptin neuron action potential firing in response 
to high-frequency light stimulation of ChR2-expressing Avp-cre projections during oestrus.  
a) Representative trace illustrating the effect of two HFLS of ChR2-expressing Avp-cre projections on 
action potential firing from a kisspeptin neuron from an oestrous mouse (oestrus control). b) 
Representative trace illustrating the effect of two HFLS of ChR2-expressing Avp-cre projections on action 
potential firing from a kisspeptin neuron from an oestrous mouse, the second stimulation being in the 
presence of 5 µM gabazine (GBZ; oestrus ± GBZ). c) Quantified changes of kisspeptin AP frequency as 
a percentage of baseline frequency during the first (1) and second (2) HFLS in oestrus control and oestrus 
± GBZ. d) Ratio of normalised firing rates comparing the second HFLS to the first. e) The proportion of 
kisspeptin neurons inhibited during HFLS in the presence of GBZ is significantly lower than without 
GBZ. Scale bars = 60 s/50 pA. Blue bars in a) and b) represent light stimulation. Data presented in c) and 
d) as mean ± SEM, dotted line in c) represents baseline, dotted line at 1 in d) indicates the value at which 
both first and second stimulations had an equal effect. Control: n = 6 neurons, N = 3 mice; ± GBZ: n = 9 






Excitation No Change Inhibition Group mean 
Oestrus - GBZ 0 0 9 59.2 ± 8.0% 
Oestrus + GBZ 0 8 1 89.8 ± 17.4% 
 
Table 6.2: Individual and mean responses during oestrus with and without gabazine, to high-
frequency light stimulation. 
The number of neurons showing responses in the immediate effect period, as per the criteria outlined in 
Section 6.2.6.3, are tabulated. The mean response from baseline from all the neurons recorded is also 
provided and presented as mean ± SEM. Yellow boxes indicate mean responses that are significantly 
different from baseline. This table is associated with Figure 6.9. 
 
In a group of neurons, GBZ was bath applied after the first HFLS until the end of the 
recording (including throughout the second HFLS). While the first HFLS significantly 
decreased firing during the immediate period, the second HFLS in the presence of GBZ did not 
(Table 6.2, Figure 6.9b, c; first: 59.2 ± 8.0% of baseline, p = 0.007; second + GBZ: 89.8 ± 
17.4% of baseline, p = 0.19, n = 9 neurons, N = 5 mice, Friedman test with post hoc Dunn’s 
multiple comparisons tests). The ratio of the responses with and without GBZ was 1.70 ± 0.38 
(Figure 6.9d). There was no difference between the extent of inhibition before and during GBZ 
application (Figure 6.9c; HFLS 1 vs HFLS 2: p = 0.72, Friedman test with post hoc Dunn’s 
multiple comparisons test), nor between the response ratios in the two groups (Figure 6.9e; p = 
0.22, Mann-Whitney test). There was a significant difference, however, in the proportion of 
neuron inhibited by HFLS (Figure 6.9e; p = 0.0009, chi-squared test).  
Together the results of these experiments suggest that the immediate inhibition may be 
driven by activation of GABAARs. 
 
6.3.8 AVP has oestrous cycle-dependent effects on kisspeptin 
neuron firing  
The findings presented here show an effect for AVP released from SCN projections 
exciting kisspeptin neurons during proestrus. There is no delayed excitation seen in either 
dioestrus or oestrus. This could be due to either 1) AVP not being released, 2) AVP released 
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but not able to cause an effect by not interacting with receptors, 3) V1Rs not responding to 
released AVP because they are not present on the kisspeptin neurons, or due to impaired 
downstream signalling. To gain insight into this, kisspeptin neuron responsiveness to 
exogenous AVP across the oestrous cycle was investigated to test the third possibility. 
As found previously (Piet et al., 2015b), 500 nM AVP excited the majority of RP3V 
kisspeptin neurons in dioestrus and proestrus (Table 6.3). Both groups were similarly excited 
with significant increases in action potential firing following AVP application (Figure 6.10a, c, 
d, f, g; dioestrus: 228.8 ± 28.6% of baseline, n = 8 neurons, N = 3 mice, p = 0.004, proestrus: 
184.2 ± 20.1% of baseline, n = 11 neurons, N = 3 mice, p = 0.0008, Friedman test with post 
hoc Dunn’s multiple comparisons tests; dioestrus vs proestrus: p > 0.99, Kruskal-Wallis test on 
effect values with post hoc Dunn’s multiple comparisons test; p = 0.91, chi-squared test on 
proportions responding). 
During oestrus, however, a contrasting response was found, where kisspeptin neurons 
no longer responded to AVP application. While some kisspeptin neurons still responded to AVP 
during oestrus, the majority did not (Table 6.3). The mean response, however, was not 
significantly different to baseline (Figure 6.10b, e; 91.44 ± 16.5% of baseline, n = 10 neurons, 
N = 3 mice, p > 0.99, Friedman test with post hoc Dunn’s multiple comparisons test). The 
response seen in oestrus was significantly lower than the responses seen in dioestrus and 
proestrus (Figure 6.10f; p = 0.002 vs dioestrus, p = 0.013 vs proestrus, Kruskal-Wallis test with 
post hoc Dunn’s multiple comparisons test). When the proportions of neurons responding were 
compared, the proportion responding to AVP application was significantly lower in oestrus than 









Figure 6.10: AVP application to kisspeptin neurons has different effects over the course of the 
oestrous cycle. 
a) Representative trace illustrating the effect of 500 nM AVP on action potential firing from a kisspeptin 
neuron from a dioestrous mouse. b) Representative trace illustrating the effect of 500 nM AVP on action 
potential firing from a kisspeptin neuron from an oestrous mouse. c-e) Average time-course of action 
potential frequency over the recording period in dioestrus, proestrus and oestrus. f) Quantified changes of 
kisspeptin action potential frequency as a percentage of baseline frequency during the delayed effect 
period. g) The proportion of kisspeptin neuron responses to AVP, over the oestrous cycle. Scale bars = 
60 s/50 pA. Green bars in a) to e) represent AVP application. Data presented in c) - f) as mean ± SEM, 
dotted lines represent baseline. Di: n = 8 neurons, N = 3 mice; Pro: n = 11 neurons, N = 3 mice; Oestrus: 
n = 10 neurons, N = 3 mice. †† p < 0.01 compared to baseline, ††† p < 0.001 compared to baseline, * p < 






Excitation No Change Inhibition Group mean 
Dioestrus 8 0 0 228.8 ± 28.6% 
Proestrus 10 1 0 184.2 ± 20.1% 
Oestrus 4 5 1 91.4 ± 16.5% 
 
Table 6.3: Individual and mean responses across the oestrous cycle to AVP application. 
The number of neurons showing responses in both the immediate and delayed effect periods, as per the 
criteria outlined in Section 6.2.6.3, are tabulated. The mean response from baseline from all the neurons 
recorded is also provided and presented as mean ± SEM. Yellow boxes indicate mean responses that are 
significantly different from baseline. This table is associated with Figure 6.10. 
 
As such, the data here show that kisspeptin neurons are less responsive to AVP in 
oestrus, compared to preovulatory cycle stages. This may explain the lack of a delayed response 
to HFLS in kisspeptin neurons in oestrus. In kisspeptin neurons in dioestrus, however, other 
mechanisms may be at play. 
 
6.4 Discussion 
 The data presented in this chapter show contrasting responses of RP3V kisspeptin 
neuron action potential firing following stimulation of SCN Avp-cre neuron projections, 
throughout the murine oestrous cycle. In dioestrus, when sex steroids predominantly drive 
negative feedback, some kisspeptin neurons were excited in response to stimulation of SCN 
Avp-cre projections (Table 6.1; Figure 6.4), while in proestrus, when positive feedback occurs, 
a greater number of kisspeptin neuron increased their firing HFLS (Table 6.1; Figure 6.5). 
Following ovulation, the excitatory effects of stimulating SCN Avp-cre projections were lost, 
and a striking immediate inhibition of kisspeptin neurons occurs (Figure 6.7). During dioestrus, 
some neurons were inhibited by HFLS, although this inhibition was kinetically distinct to that 
seen in oestrus. This suggests that there is a cyclical, progressive shift in the different actions 






Figure 6.11: A working model of plastic changes in SCN AVP- and GABA-mediated effects occur 
over the oestrous cycle. 
Dioestrus: There is a period of quiescence, where there is no overall change in the firing rate of the RP3V 
kisspeptin neuron population. Proestrus: As the concentration of E2 rises, there is a concurrent increase 
in the proportion of RP3V kisspeptin neurons excited by AVP released from SCN neurons. This drives 
an overall excitation of the GnRH neuronal network to trigger the LH surge at the end of proestrus. 
Oestrus: As the concentration of E2 falls, and the concentration of P4 rises, there is a switch at the level 
of the SCN, whereby the projections begin releasing GABA. This results in an inhibition of the kisspeptin 
population, inhibiting the GnRH neuronal network. 
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 The excitation seen at proestrus is mediated by action at the V1R (Figure 6.6). AVP 
application excited kisspeptin neurons to a similar extent between dioestrus and proestrus 
(Figure 6.10), indicating no change in V1R signalling in kisspeptin neurons prior to ovulation, 
but potentially a change in the AVP release from the SCN, or poor access to V1Rs in dioestrus.  
The immediate inhibition in oestrus is not seen in any other oestrous cycle stages. When SCN 
Avp-cre projections are stimulated in proestrus in the presence of Manning Compound, that 
immediate inhibition is not revealed. Thus, this suggests that is solely an effect at oestrus, rather 
than one masked by the AVP-mediated excitation. This inhibition at oestrus may be attributed 
to the release of GABA, acting at GABAARs (Figure 6.9) 
Together these data suggest a functionally plastic circuitry whereby SCN Avp-cre 
neurons can either excite or inhibit RP3V kisspeptin neurons in an oestrous cycle stage-
dependent manner.  
 
6.4.1 Technical caveats 
 To identify the kisspeptin neurons, blue light must be shone on the brain slice to excite 
GFP. The excitation spectrum of the GFP and that of ChR2 overlap, thus, it cannot be ruled out 
that visualising kisspeptin neurons may also drive electrical activity in ChR2-expressing 
terminals and, consequently, the release of neurotransmitters and neuropeptides. In order to 
overcome this, the intensity of blue light was different for identification of GFP-expressing 
cells (0.8 mW) and stimulation of ChR2-expressing axons (14.1 mW). Identification of the 
kisspeptin neurons may still drive neurotransmitter release due to activation of the ChR2. 
Between identification and recording, there was a wait period of 5-10 minutes before recording. 
This method has been used previously to ensure that no response to the initial light stimulus is 
ongoing when a loose-patch recording is formed (Piet et al., 2018). Further, as the delayed 
excitation effect seen in Section 6.3.3 appears to last for less than ten minutes, this wait time 
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was likely sufficient for the neuron to recover from any stimulation of ChR2- expressing Avp-
cre fibres. 
 Light sources in optogenetics have recently come under criticism for potential non-
opsin-mediated effects due to heating of the tissue (Stujenske et al., 2015; Owen et al., 2019). 
These experiments have been carried out using LED lighting through a 40× immersion 
objective. Prolonged light stimulation can cause undesirable thermal effects due to heating of 
tissues (Stujenske et al., 2015; Dong et al., 2018), however, it appears that the light stimulation 
paradigm used in these experiments, 20 Hz for 60 s, does not result in negative effects of light 
stimulation (such as heat altering the activity of neurons). The control experiments carried out 
in Section 6.3.1 confirm that there are no unintended light-mediated effects. Interestingly, 
higher intensity light stimulation (53.9 mW, compared to 14.1 mW in these experiments) was 
found to completely inhibit kisspeptin neuron electrical activity (Appendix VIII), possibly due 
to heat or phototoxicity of neurons from the light source. 
SCN neurons typically fire between 1-12 Hz (Green & Gillette, 1982; Pennartz et al., 
2002; Schaap et al., 2003), peaking during the subjective afternoon of the light phase (Inouye 
& Kawamura, 1979; Green & Gillette, 1982; Schaap et al., 2003). This afternoon increase in 
firing rate, is correlated to when AVP could be released, and potentially initiate the LH surge. 
The stimulation frequency used here can be considered paraphysiological, as it is above the 
expected peak firing rate, but can still reliably drive neuropeptide release without negatively 
affecting the tissue. 
 As this is a circadian network, one potentially important caveat to consider is the role 
of time as a confound. Prior work has not found a significant impact of time on how kisspeptin 
neurons respond to AVP (Piet et al., 2015b), thus, it is unlikely that time is affecting how 
kisspeptin neurons respond to the endogenous AVP. As such, however, the expression of AVP 
is certainly circadian (van der Veen et al., 2005; Maruyama et al., 2010; Yoshikawa et al., 
2015). While these studies have examined AVP expression in the cell bodies of the SCN, there 
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is a possibility that export of the peptide occurs later in the day, closer to the time of the LH 
surge. As such, when brain slices were taken during the peak of AVP expression, export of 
AVP to projections in the RP3V may not be complete. As such, the responses seen here may 
be due to limited projection peptide content. If brain slices were taken later in the day, there is 
a possibility that the endogenous AVP release may drive greater effects, particularly in 
proestrus resulting in a more pronounced excitatory effect.  
 
6.4.2 A delayed excitation of kisspeptin neurons is mediated by 
AVP 
The results presented in this chapter show oestrous cycle-dependent changes in the 
manner that SCN Avp-cre projections can alter the activity of RP3V kisspeptin neurons. The 
experiments in Chapter 5 revealed that there is little or no functional synaptic input from SCN 
Avp-cre neurons to RP3V kisspeptin neurons, regardless of oestrous cycle stage. Taking this 
into consideration, the effects observed in this chapter must, therefore, be due to non-synaptic 
release of neuropeptides and neurotransmitters. 
 Fast synaptic neurotransmitters are localised near the synaptic membrane, thus 
individual action potentials are sufficient to cause low concentration calcium fluxes which drive 
their release at the synaptic terminal. This can be seen in Chapter 5 where single stimulations 
can evoke GABA release (Section 5.3.5). Neuropeptides, however, typically display a distinct 
uncoupled response to action potentials (Salio et al., 2006). Due to neuropeptide packaging in 
LDCVs away from the synaptic membrane, a diffuse calcium signal due to repeated local 
depolarisation (i.e. multiple action potentials driving prolonged calcium influx) is necessary for 
their release. In vitro, short high-frequency stimulation of presynaptic terminals has been used 




 Exocytosis of LDCVs away from synaptic membranes allows for neuromodulators to 
be released more diffusely to influence nearby neurons in a paracrine manner, rather than as a 
direct, synaptically targeted action (Morris & Pow, 1991). SCN neurons have been shown to 
release peptides from dendritic and axonal projections (Castel et al., 1996), thus, it could be 
that the SCN Avp-cre neurons are releasing AVP from their projections identified in Chapter 4, 
which then diffuses to the nearby kisspeptin neurons. This is a feature that has been seen for 
AVP release by magnocellular AVP neurons from the PVN/SON onto their downstream targets 
(Ludwig & Leng, 2006; Son et al., 2013).  
 Stimulation of SCN Avp-cre projections increased kisspeptin neuron firing, a response 
that was delayed and long-lasting, typical of GPCR-mediated effects. As the data presented in 
Chapter 4 indicate that PVN and SON neurons do not project to the RP3V, it is unlikely that 
this increase was mediated by anything other than a peptide released from SCN Avp-cre 
neurons. The excitation of kisspeptin neurons following HFLS of the Avp-cre projections is 
prevented in the presence of Manning Compound. Manning Compound is an antagonist of both 
V1Rs and the OTR (Manning et al., 2012; Busnelli et al., 2013). RP3V kisspeptin neurons 
express V1aRs (Williams et al., 2011), but probably not V1bRs (Funabashi et al., 2000a). 
Furthermore, previous electrophysiological studies suggest that RP3V kisspeptin neurons do 
not express OTRs (Piet et al., 2015b). As the SCN does not synthesise oxytocin, it is, therefore, 
likely that this excitation is solely mediated by AVP. 
 The key question remaining is the mechanism behind how HFLS-induced excitation 
varies throughout the oestrous cycle. This could be due to several possibilities: changes in V1R 
function and/or expression on kisspeptin neurons, changes in the release of AVP from the SCN, 
or changes in the access of AVP to V1Rs on kisspeptin neurons. These will now be discussed 
in turn. 
 
6.4.2.1 Changes in V1R expression across the oestrous cycle 
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Over the course of the oestrous cycle, the fluctuating hormone concentrations may be 
impacting the function and/or expression of V1R on the RP3V kisspeptin neurons. V1aRs have 
been shown to be present on kisspeptin neurons in oestradiol-treated hamsters (Williams et al., 
2011); as well as being responsive to AVP application at kisspeptin neurons (both here and by 
Piet et al. (2015b)). Interestingly, however, it appears that ovariectomy (OVX) is sufficient to 
inhibit the action of AVP at kisspeptin neurons, which is restored by oestradiol replacement 
(Piet et al., 2015b). OVX is a blunt method of removing the influence of ovarian hormones, 
thus the loss of hormones, correlated to the loss of V1R signalling at the kisspeptin neurons 
suggests some sex steroid-mediated regulation of V1R expression. Kalamatianos et al. (2004a) 
provide some indication that V1aR in the RP3V restored by oestradiol replacement following 
OVX. Thus, it appears that the concentration of oestradiol may be a key driving factor in the 
expression of V1aRs.  
Considering that kisspeptin neurons are able to respond to AVP application in dioestrus 
and proestrus to similar extents, the increasing oestradiol concentration does not appear to 
potentiate or upregulate V1R activity. However, the fall in oestradiol during oestrus may 
account for the loss of V1R-mediated effects at kisspeptin neurons. Oestrus is further 
characterised by a high progesterone concentration. However, no studies to date have addressed 
the effects of progesterone or its metabolites on V1R expression or function.  
 
6.4.2.2 Changes in AVP synthesis and release across the oestrous cycle 
 A second possibility (although not an exclusive one) may be that the production and 
release of AVP from Avp-cre neurons fluctuates over the oestrous cycle. The data in dioestrus 
point to this possibility, as although RP3V kisspeptin neurons can respond to exogenous AVP, 
the release of endogenous AVP may not be driven by HFLS, like it can in proestrus. In oestrus, 
it is harder to determine how AVP release is impacted. In this case, V1R-mediated responses 
(as mentioned above) are the proxy for AVP release and action. As kisspeptin neurons no longer 
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respond to exogenous AVP in oestrus, the proxy to determine AVP release is no longer able to 
be used. Thus, it remains unknown whether AVP release is occurring in oestrus and is simply 
unable to exert an effect. Advances in sniffer cell techniques, where cells are transfected with 
V1Rs provides a fluorescent insight mediated by calcium flux as to whether AVP is released 
and acts at receptors (Son et al., 2013; Gizowski et al., 2016; Zaelzer et al., 2018), would 
provide a more conclusive result as to changes in AVP release across the oestrous cycle. 
 The change in hormone profile across the oestrous cycle could be linked to changes in 
AVP production (Figure 6.12). If SCN AVP production is linked to oestradiol concentrations 
it must be through activation of ERβ. As mentioned, the SCN has little to no ER⍺ (Shughrue et 
al., 1997; Vida et al., 2008). This is not unheard of, with AVP cells in culture increasing the 
production of Avp mRNA in response to ERβ activation (Shapiro et al., 2000; Pak et al., 2007). 
Thus, the increase in oestradiol towards proestrus could increase the amount of AVP produced. 
During oestrus, the rise in progesterone may also play a role in the inhibition of AVP release. 
Activation of PR in AVP neurons has been shown to inhibit the production of AVP (Auger & 
Vanzo, 2006), potentially acting as a second mechanism (along with the fall in oestradiol at 
oestrus) to stop the release of AVP. It is important to note here that these studies looking at 
hormone action on AVP production have predominantly been carried out on AVP neurons from 
elsewhere in the brain, rather than the SCN; however, this does not rule out the possibility that 
similar effects may happen at SCN AVP neurons. 
 A further point to consider is that AVP release from these projections may not have 
access to V1Rs. Vida et al. (2010) suggest that increased concentrations of oestradiol (similar 
to proestrus) may increase the number of appositions between kisspeptin and AVP-ir fibres. 
The fall in oestradiol concentration between proestrus and oestrus, may result in ultrastructural 
remodelling of the appositions resulting in their withdrawal (Figure 6.12). Thus, any AVP 







Figure 6.12: Potential changes to the SCN AVP system across the oestrous cycle. 
Dioestrus: An intermediate period between oestrus and proestrus. The basal levels of E2 maintain V1R 
expression on RP3V kisspeptin neurons. Some AVP is released from Avp-cre projections which is 
sufficient to excite some RP3V kisspeptin neurons, but the whole population overall. Proestrus: 
Increased E2 concentrations may increase V1R expression on RP3V kisspeptin neurons, as well as 
increasing the production and release of AVP. Further, there is a possibility that increased astrocyte 
density in the RP3V forms a barrier to limit AVP diffusion targeting it to kisspeptin neurons. As a result, 
RP3V kisspeptin neurons are activated overall by SCN Avp-cre neurons. Oestrus: Post-ovulation, the fall 
in E2 may decrease V1R expression on RP3V kisspeptin neurons. Further, it may also result in the 
withdrawal of AVP-producing appositions to the kisspeptin neurons, meaning that AVP, if it is released, 
cannot access the kisspeptin neurons. Increased P4 in oestrus may inhibit AVP synthesis. It remains 
unknown what P4 is doing to V1Rs, if anything. Overall, the kisspeptin neurons are no longer activated 
by SCN Avp-cre neurons. 
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manner. The change in hormones across the oestrous cycle may also be altering the glial 
coverage of neurons within the RP3V. Glia have been shown to increase their coverage of 
neurons in other brain regions at proestrus (Garcia-Segura et al., 1994; Struble et al., 2006; 
Arias et al., 2009). Considering the extra synaptic release of AVP from the Avp-cre projections, 
it may be that increased glial coverage acts as a barrier to AVP diffusion (Figure 6.12). Released 
AVP would then be specifically concentrated towards RP3V kisspeptin neurons, rather than 
diffusing throughout the region.  
 
6.4.3 An immediate inhibition of kisspeptin neurons is mediated by 
GABA 
Potentially the most striking observation in this chapter is the appearance of an 
immediate inhibition, mediated by GABA acting at GABAARs, during stimulation of the Avp-
cre projections, in oestrus. As this response is not seen at any other stage of the oestrous cycle, 
it is likely specifically associated with the postovulatory phase. Studies of how hormones 
influence GABA synthesis have shown different effects in different brain regions (Weiland, 
1992; Souza et al., 2009; Noriega et al., 2010), but changes in the SCN are unknown. Hormonal 
feedback may contribute to changes in SCN GABA synthesis (Figure 6.13). Here, however, the 
focus will be on how there may be changes in how GABA can act at kisspeptin neurons, or a 
change in how kisspeptin neurons respond across the oestrous cycle. Both of these will now be 
discussed in turn. 
 
6.4.3.1 Changes in GABA action across the oestrous cycle 
The most obvious idea for the appearance of an inhibition would be the oestrus-driven 
production and/or release of an inhibitory neurotransmitter. As the SCN AVP neurons are likely 
GABAergic, the release of GABA would make sense in this context. One other potential fast 
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inhibitory neurotransmitter that may be released is glycine. It has been suggested that SCN 
explants can release glycine (Shinohara et al., 1998) which would act as an inhibitor at efferent 
targets. The glycine receptor acts as a chloride channel, similar to the GABAAR (Burgos et al., 
2016), and can be inhibited by GBZ at high concentrations – albeit higher than those used here 
(Beato, 2008). Thus, it is more likely that this inhibition is GABA-mediated rather than glycine-
mediated. 
It is unlikely that there is GABA release in each cycle stage, which is being masked by 
the excitatory effect of AVP. As GABA and AVP show different response kinetics due to 
differences in their receptor mechanisms (ion channel vs. GPCR) the two responses would 
unlikely overlap. Further, the Manning Compound experiments in Section 6.3.4 do not reveal 
a masked immediate inhibition. Thus, the question remains, how is GABA being release at 
oestrus, but not during other oestrous cycle stages?  
Being a small amino acid neurotransmitter, GABA is typically released from small 
synaptic vesicles into the synaptic cleft. Although GABAergic synaptic transmission from Avp-
cre neurons onto the kisspeptin neurons was not detected, this could be due to several 
possibilities that have been outlined in Chapter 5. These, however, do not rule out the possibility 
that the release of GABA is occurring at synapses at distant dendritic zones where whole-cell 
recordings of IPSCs, like those in Chapter 5, would be unable to pick up the transient dendritic 
current. Despite this, however, a dendritic IPSC might still contribute to an overall inhibition 
of the kisspeptin neuron which would be recorded by the loose-patch configuration used in 
these experiments. Thus, if a dendritic synapse was constantly present (i.e. not plastic over the 
oestrous cycle), it would likely be detected here in dioestrus and proestrus.  
It may be the case, however, that GABA is released extrasynaptically (Figure 6.13). 
GABA would, therefore, have to act at GABA receptors outside of a synaptic cleft. 
Extracellular GABAARs are relatively common throughout the central nervous system and 
mediate a tonic inhibition of neuronal activity predominantly from synaptic cleft spill over 
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(Farrant & Nusser, 2005; Brickley & Mody, 2012). In saying this, GABABRs are also found 
commonly in extrasynaptic regions, however, due to their action as a GPCR, this does not match 
the time course of the immediate inhibition seen here (Bowery et al., 2002). GABA from an 
LDCV could drive the rapid and short-lasting inhibition that is seen here in recordings from 
oestrus kisspeptin neurons. The kisspeptin neurons at oestrus are not responding to AVP, thus 
it could be that the GABA takes a preferential effect. This would involve the co-packaging of 
AVP and GABA into LDCVs, which has been shown at SCN AVP neuron terminals (Castel & 
Morris, 2000). As the inhibitory response is not seen in any other oestrous cycle stage, however, 
it could be that there is a postovulatory drive in vGAT expression at the SCN Avp-cre neuron 
terminal to drive this co-packaging mechanism (Figure 6.13).  
 
As the results here do not show a complete reduction of the inhibitory drive when GBZ 
is applied, the possibility remains that a second receptor might be present along with GABAAR 
to mediate the HFLS-induced decrease.  
 
6.4.3.2 Changes in GABAR expression across the oestrous cycle 
One key point differentiating oestrus from other oestrous cycle stages is the rise in levels 
of progesterone. Progesterone has been implicated in several studies concerning GABA, 
predominantly in its role of sensitising GABAARs. Once progesterone has been brought into a 
neuron, its metabolites act to sensitise and enhance GABAergic inhibitory currents (Callachan 
et al., 1987; Brussard & Koksma, 2003; Wang, 2011). This would potentiate any GABAergic 
current that was present (Figure 6.13). Despite this, however, progesterone metabolites are 
likely to be washed from the slice in the bath solution. This does not exclude the role of 
astrocyte-derived neuroprogesterone that may still be causing an effect at the neurons 







Figure 6.13: Potential changes to the SCN GABA system across the oestrous cycle. 
Dioestrus: An intermediate period between oestrus and proestrus. Some GABA may be released from 
Avp-cre projections but does not drive an immediate inhibition. Proestrus: Increased E2 concentrations 
may decrease GABA synthesis in SCN Avp-cre neurons. It remains unknown if GABA is released at all 
from the SCN Avp-cre neurons during proestrus. Oestrus: Post-ovulation, the increase in P4 may increase 
vGAT expression on LDCVs in Avp-cre neuron projections. P4 metabolites may also be enhancing 
GABAAR conductance and expression, as well as GABA synthesis. 
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transcription of GABAAR subunit mRNA in the hypothalamus, suggesting there may be greater 
numbers of GABAARs (Noriega et al., 2010). 
 
6.5 Summary 
 The data presented in this chapter provide the first insight into how SCN Avp-cre 
projection fibres to the RP3V can influence the activity of kisspeptin neurons across the 
oestrous cycle. As oestradiol levels rise, the transition to positive feedback at proestrus 
correlates to AVP-mediated effects SCN Avp-cre projections acting at kisspeptin V1Rs, which 
can, in turn, drive an excitation of RP3V kisspeptin neurons. This has potentially uncovered a 
mechanism by which the onset of the LH surge, as driven by the central biological clock, can 
be driven. A novel finding was discovered during oestrus, where those same SCN Avp-cre 
neurons enact a second mechanism to inhibit the RP3V kisspeptin neurons. With the fall in 
oestradiol concentration, coupled to a rise in progesterone concentration, this inhibition may 
help to dampen the electrical activity of kisspeptin neurons in order to stop their further 
unnecessary activation following the LH surge. Between these stages, there appears to be a 
period of quiescence where there is little activation or inhibition of the kisspeptin neurons; 
essentially a transition period between the inhibition at oestrus, and the excitation at proestrus. 
This period correlates well to the period of oestradiol negative feedback necessary for 
maintaining the low level of LH secretion.  
Together, these data suggest a model of bidirectional control of RP3V kisspeptin neuron 
electrical activity, involving two different neuromodulators, over the course of the murine 
oestrous cycle. The SCN AVP neurons, therefore, may act as a potential mechanism that gates 







Alterations to the SCN Avp-cre Neuron 
Projection to RP3V Kisspeptin Neurons in a 





The experiments carried out as part of the previous chapters have demonstrated the 
presence and functionality of the SCN Avp-cre neuron projection to the RP3V kisspeptin 
neurons. To determine the importance of this circuit for the LH surge, this projection was 
remapped in a mouse model of pathological subfertility which does not generate an endogenous 
LH surge. Understanding this circuit in a pathological condition provides a better understanding 
of its critical role in the neural regulation of the LH surge. The experiments in this chapter have 
thus been carried out using the prenatal androgen-treated (PNA) model of polycystic ovary 
syndrome (PCOS).  
Polycystic ovary syndrome (PCOS) is the most common neuroendocrine disorder 
resulting in female sub- or infertility (Azziz et al., 2004). It is typically characterised by 
hyperandrogenaemia, polycystic ovaries, and impaired ovulation; along with other distressing 
symptoms and comorbidities such as acne and hirsutism (Stein & Leventhal, 1935; Rotterdam, 
2004). Despite the prevalence of PCOS and its symptoms, there remains no clear aetiology for 
its development. Prior animal work modelling PCOS has revealed disruptions in brain circuitry 
controlling the GnRH neuronal network (Sullivan & Moenter, 2004; Cernea et al., 2015; Moore 
et al., 2015; Porter et al., 2019) suggesting a neuronal origin for the impairments in fertility 
seen in PCOS. As PCOS is associated with impaired ovulation, the SCN-to-RP3V circuit, 
critical to ovulation, may also be impaired.  
 
7.1.1 The prenatally androgen-treated mouse model of PCOS 
Prenatal androgen treatment involves the injection of androgens to the mother during 
pregnancy. While some groups use testosterone treatment, others (including the work presented 
in this chapter) use dihydrotestosterone (DHT) which is an androgen that cannot be aromatised 
(Santen, 1975; Steckelbroeck et al., 2004). Aromatisation of androgens (particularly 
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testosterone) by the aromatase enzyme converts the androgens to oestrogen. Thus, the use of 
DHT in PNA models ensures that the resulting alterations to the developing brain are likely 
solely AR-mediated rather than ER-mediated. Further, DHT action solely at brain ARs is 
necessary to drive PCOS-like features (Caldwell et al., 2017). 
During foetal development, the developing brain is highly sensitive to circulating sex 
steroids (Schwarz & McCarthy, 2008). In mothers with hyperandrogenaemia, the high 
circulating androgen concentration is thought to alter the programming of the developing brain 
circuitry (Xita & Tsatsoulis, 2006). Thus, it is hypothesised that prenatal androgen exposure 
may underlie both the aetiology and pathophysiology of the PCOS. To investigate this, prenatal 
androgen treatment has been a key method to cause PCOS-like symptoms in animal models, 
and determine PNA-induced changes in the brain of the offspring (Stener-Victorin et al., 2020). 
Prenatal androgen treatment has modelled PCOS in several species to date including the 
mouse (Birch et al., 2003; Sullivan & Moenter, 2004; Foecking et al., 2005; Abbott et al., 2008; 
Smith et al., 2009; Wu et al., 2010; Moore et al., 2013). The PNA mouse model displays defects 
to the GnRH neuronal network which are consistent with the altered LH secretion seen in PCOS 
(Sullivan & Moenter, 2004; Moore et al., 2015; Silva et al., 2018; Silva et al., 2019). Along 
with central alterations, PNA mice display thickened ovarian theca cell layers (potentially 
underlying an increase androgen production), hyperandrogenaemia and subfertility (Sullivan & 
Moenter, 2004; Moore et al., 2013; Moore et al., 2015; Silva et al., 2018). Together these 
symptoms match the diagnostic criteria for PCOS in women (Rotterdam, 2004).  
From a neuroendocrine perspective, the PNA mouse model has impaired oestrogen and 
progesterone feedback to the GnRH neuronal network (Moore et al., 2013) as well as a loss of 
progesterone sensitivity (Moore et al., 2015). Further, there is an increase in LH pulse 
frequency, similar to that seen in women with PCOS (Moore et al., 2015). The PNA mouse 
model does not display regular oestrous cycles, instead remaining in one cycle stage for 
extended periods of time. Further, they rarely show a proestrous vaginal smear, indicating that 
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PNA mice are unlikely to naturally mount an LH surge (Sullivan & Moenter, 2004; Moore et 
al., 2013; Silva et al., 2018). 
Although the PNA mouse model shows clear reproductive impairments, it does not fully 
recapitulate all the symptoms of PCOS. Despite the thickening of the theca cell layer 
surrounding the follicle, the PNA mouse model does not have cystic ovaries. Further, it does 
not display overt metabolic dysfunction (i.e. does not display obesity or insulin resistance) and, 
as such, is termed the lean PCOS phenotype (Moore et al., 2013; Roland & Moenter, 2014). 
Despite this, however, the PNA mouse model allows for exquisite dissection of alterations in 
reproduction features without interference from metabolic effects, such as brain circuits that 
could be impaired in PCOS, resulting in disrupted ovulation. 
 
7.1.2 Prenatal androgen treatment disrupts hypothalamic neural 
circuits  
 As mentioned, women with, and animal models of, PCOS display a heightened 
frequency of LH pulses (Coyle & Campbell, 2019). As such, the majority of work has focussed 
around disruption to the LH pulse generating ARN in PCOS. Prenatal androgen treatment has 
commonly shown an increase in GABAergic innervation of GnRH neurons, originating at least 
in part from the ARN (Moore et al., 2015; Silva et al., 2018), coupled with an increased 
GABAergic synaptic transmission to GnRH neurons (Sullivan & Moenter, 2004). This has also 
been shown in a model of PCOS induced by prenatal anti-Müllerian hormone treatment (Tata 
et al., 2018). Activation of GABAARs on GnRH neurons results in excitation (Herbison & 
Moenter, 2011), thus increased GABAergic drive in PNA models likely contributes to an 
increased excitation of GnRH neurons and, as such, heightened LH secretion. 
 ARN KNDy neurons are thought to be the pulse generator driving pulsatile GnRH and 
LH secretion (Clarkson et al., 2017). There is disagreement about how they may change in 
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PCOS. Some animal models of PCOS report increased ARN kisspeptin cell number by 
immunohistochemistry (Aliabadi et al., 2017; Osuka et al., 2017) or increased Kiss1 mRNA 
(Matsuzaki et al., 2017). Other groups, however, using the same animal models report no 
change in ARN kisspeptin number (Cheng et al., 2010) or Kiss1 mRNA (Caldwell et al., 2015). 
There is no data on the actual electrical activity of PCOS-like ARN kisspeptin neurons. There 
does, however, appear to be an increased GABAergic innervation to KNDy neurons, similar to 
the GnRH neurons (Porter et al., 2019) along with a decrease in glutamatergic inputs (Cernea 
et al., 2015).  
Research on the RP3V kisspeptin population in PCOS-like animal models have reported 
either no change in their cell number (Cheng et al., 2010; Caldwell et al., 2015; Osuka et al., 
2017), or Kiss1 mRNA (Caldwell et al., 2015; Kauffman et al., 2015; Matsuzaki et al., 2017; 
Osuka et al., 2017). Some groups, however, have reported a decrease in RP3V kisspeptin cell 
number (Brown et al., 2012; Aliabadi et al., 2017). With regard to the innervation of RP3V 
kisspeptin neuron, Cernea et al. (2015) report a decreased innervation (in the analogous region 
to the RP3V in the PNA sheep), likely from a GABAergic population, but do not specify from 
where it originates. While the sheep LH surge is not circadian in nature, relying on seasonal 
cues instead, this does not exclude the fact that the SCN may still project to the sheep RP3V 
analogue. Keeping in mind the anatomical projection from the SCN to RP3V, which is 
GABAergic, it could be that this circuit is diminished in the PNA model of PCOS.  
 
7.1.3 Hypothesis and aim  
As the SCN-to-RP3V circuitry is critical for the generation of the LH surge, it is 
important to see how the circuit may be affected in a model of pathology with ovulatory 
dysfunction. As the SCN-to-RP3V circuitry is critical for ovulation, it was hypothesised that 
there would be a decrease in the innervation of the RP3V by SCN Avp-cre neurons. The 
experiments carried out in this chapter aimed to determine how the anatomy and 
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functionality of the SCN Avp-cre projection to RP3V kisspeptin neurons may be impacted 




 General animal information is outlined in Section 2.1. Generation of prenatally 
androgen-treated animals is outlined in Section 2.1.2. Adult PNA and control oil vehicle-treated 
(VEH) female Avp-cre mice (2-6 months old) were used in this study. Oestrous cycles were 
determined by daily vaginal lavage and were used in dioestrus.  
 
7.2.2 Other methods 
 Surgery, immunohistochemistry, microscopy, electrophysiology and optogenetics, and 
analyses have all been described previously in Chapters 2-6. Images shown herein are 
maximum projections of confocal Z-stack images unless stated otherwise. Where 
immunohistochemical data are reliant on the success of a viral injection, the range of upper and 
lower average values has been provided. For electrophysiology experiments in this chapter, 
where n-values are reported, n refers to neurons recorded, while N refers to the number of 
animals used in the experiments.  
 
7.3 Results 




As in Section 4.3.1, viral-mediated tract-tracing of the SCN Avp-cre neurons to the 
RP3V was carried out to determine whether the projection was affected in the subfertile PNA 
mouse model. Due to the disruption in PNA mouse oestrous cycles (Figure 7.1), dioestrous 
PNA mice were compared to dioestrous VEH mice. In VEH mice, there was a clear fibre 
projection in the RP3V when SCN Avp-cre neurons were successfully transfected (Figure 7.2a). 
This lies in stark contrast to the PNA mice where SCN Avp-cre projections were reduced by 
about half (Figure 7.2b). There was a significantly reduced mCherry-ir fibre density in the 
RP3V of PNA mice, compared to their VEH counterparts (Figure 7.2c; VEH: 12.8 ± 2.2%, n = 
8 mice, range = 7.1 – 25.0%; PNA: 7.0 ± 1.0%, n = 6 mice, range = 3.3 – 9.7%; p = 0.043, 
Mann-Whitney test). This is a particularly compelling finding when it is considered that the 
level of SCN transfection in those VEH and PNA animals is not significantly different (Figure 
7.2d; VEH: 18.1 ± 2.1%, n = 8 mice, range = 10.5 – 27.6%; PNA: 16.1 ± 2.6%, n = 6 mice, 
range = 8.8 – 25.1%; p = 0.66, Mann-Whitney test).  
Linear regression analysis revealed that both VEH and PNA mice showed significant 
positive correlations between the level of transfection in the SCN and the mCherry-ir fibres 
innervating the RP3V (Figure 7.2e; VEH: n = 9 mice, p < 0.0001, R2 = 0.84; PNA: n = 9 mice, 
p = 0.004, R2 = 0.41). Importantly, this correlation, as assessed by the slope of the fitted line, 
was significantly reduced in PNA mice (Figure 7.2e; PNA slope: 0.24 ± 0.07; VEH slope: 0.84 
± 0.09; p < 0.0001, linear regression slope comparison). These data suggest that the SCN Avp-






Figure 7.1: The PNA mouse model of PCOS is acyclic. 
Four representative graphs of mouse oestrous cycles from VEH control mice (a) and PNA mice (b). The 
PNA mice tend to stay in one cycle stage for extended periods of time (usually dioestrus), where VEH 
mice show typical 4-5 day long oestrous cycles. c) Graphed data showing days spent in each cycle stage. 
Note also that PNA mice do not display proestrus. M = metoestrus, D = dioestrus, P = proestrus, E = 











Figure 7.2: SCN Avp-cre projections in the RP3V are reduced in PCOS-like PNA female mice. 
a, b) Confocal Z-stack images showing the innervation of the RP3V by mCherry-ir fibres in VEH and 
PNA mice; ai) and bi show the transfection in the SCN from the respective VEH or PNA animal. The 
thick white boundaries surrounding the ipsilateral RP3V and SCN represent the regions of interest used 
for pixel density analyses. c, d) RP3V innervation and SCN transfection in VEH and PNA mice. e) 
Correlation analysis of RP3V innervation and SCN transfection in VEH and PNA mice. Symbols 
represent individual mice; dark and light shades represent measurements ipsilateral to the most and least 
transfected side of the SCN, respectively. Data shown as line of best fit ± 95% confidence interval, or 
mean ± SEM. Dotted lines in d and e represent the average value for untreated animals presented in 
Chapter 4. Scale bars = 100 µm. * p < 0.05, **** p < 0.0001. 3V = third ventricle. OX = optic chiasm. 
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7.3.2 SCN Avp-cre appositions to RP3V kisspeptin neurons are 
reduced in the PNA mouse model 
 Given that the Avp-cre fibre projection is reduced in PNA mice compared to VEH, the 
potential innervation of the RP3V kisspeptin neurons was then assessed by looking at close 
Avp-cre appositions to kisspeptin neurons. Using dual fluorescence immunohistochemistry for 
mCherry and kisspeptin in animals with successful SCN transfection, it was found that there 
was a significant reduction in the proportion of kisspeptin neuron somata apposed by mCherry-
ir fibres in PNA animals compared to VEH (Figure 7.3a-c; VEH: 44.3 ± 3.6%, n = 8 mice, 
range = 31.1 – 64.5%; PNA: 28.3 ± 4.3%, n = 6 mice, range = 18.2 – 44.9%; p = 0.020, Mann- 
Whitney test). Further, the average number of appositions per apposed neuron tended to be 
lower in PNA animals compared to VEH, although this did not reach statistical significance 
(Figure 7.3d; VEH: 1.65 ± 0.07/neuron, n = 8 animals, PNA: 1.45 ± 0.07/neuron, n = 6 animals, 
p = 0.059, Mann-Whitney test). 
 Similar to the untreated animals presented in Chapter 4, the VEH animals displayed a 
significant positive correlation between the proportion of RP3V kisspeptin neurons displaying 
close appositions by mCherry-ir fibres and transfection of the ipsilateral SCN (Figure 7.3e; n = 
8 animals, p = 0.001, R2 = 0.55). Interestingly, there was no correlation found for PNA animals 
(Figure 7.3e; n = 6 animals, p = 0.40, R2 = 0.07, linear regression). In addition, the correlations 
were significantly different between the two groups (Figure 7.3e; PNA slope: -0.48 ± 0.55; 
VEH slope: 1.56 ± 0.37; p < 0.004, linear regression slope comparison). These data show that 
there is a lower proportion of RP3V kisspeptin neurons apposed by SCN Avp-cre projections 
in the PNA mouse model. This result cannot be explained by differences in SCN transfection 







Figure 7.3: SCN Avp-cre close appositions to RP3V kisspeptin neurons are reduced in PNA mice. 
a, b) Confocal Z stack images of the RP3V from VEH and PNA animals showing kisspeptin-ir neurons 
(green) with mCherry-ir fibres (red) innervating the region. ai, bi) Single plane images showing mCherry-
ir fibres in close apposition to kisspeptin-ir neurons. Appositions to the somata of kisspeptin-ir neurons 
are marked with empty arrowheads. c) Summary graph of the proportion of kisspeptin-ir neurons apposed 
by mCherry-ir fibres in VEH and PNA mice. d) Summary graph of the number of appositions per 
kisspeptin neuron in VEH and PNA mice. e) Correlation analysis of the proportion of neurons apposed 
and SCN transfection in VEH and PNA mice. Symbols represent individual mice; dark and light shades 
represent measurements ipsilateral to the most and least transfected side of the SCN, respectively. Data 
shown as mean ± SEM, or linear regression ± 95% confidence interval. Dotted lines in c and d represent 
the average value for untreated animals presented in Chapter 4. Scale bars = 100 µm. * p < 0.05, ** p < 




7.3.3 High-frequency light stimulation of Avp-cre projections does 
not alter the activity of kisspeptin neurons in the PNA mouse model 
It was next investigated whether the reduction in RP3V kisspeptin neuron innervation 
in PNA mice had any effect on how SCN Avp-cre neurons regulate RP3V kisspeptin neuron 
firing rate. To test this, optogenetics was used, similar to Chapter 6. As PNA mice have 
disrupted oestrous cycles, tending to stay in dioestrus (Figure 7.1), the effect of optogenetic 
stimulation of SCN Avp-cre neurons on RP3V kisspeptin neuron electrical activity was 
determined in dioestrous VEH and PNA mice. 
 In dioestrous VEH control mice, there was no effect of HFLS on the activity of any 
RP3V kisspeptin neuron in the immediate period. As in Chapter 6, HFLS had varied effects on 
action potential firing rate in the delayed period (Table 7.1). Overall there was no change in the 
group mean firing rate during and following HFLS (Figure 7.4a, c, e; immediate: 108.1 ± 10.6% 
of baseline, p > 0.99; delayed: 111.3 ± 13.2% of baseline, p > 0.99; n = 10 neurons; N = 3 mice; 
Friedman test with post hoc Dunn’s multiple comparisons tests). 
 
HFLS 













VEH 0 10 0 
108.1 ± 
10.6% 
5 4 1 
111.3 ± 
13.2% 
PNA 0 10 0 
93.4 ± 
12.7% 




Table 7.1: Individual and mean responses between VEH and PNA mice to high frequency light 
stimulation. 
The number of neurons showing responses in both the immediate and delayed effect periods, as per the 
criteria outlined in Section 6.2.6.3, are tabulated. The mean response from baseline from all the neurons 
recorded is also provided and presented as mean ± SEM. This table is associated with Figure 7.4. 
 
 Similarly, dioestrous PNA mice did not show any immediate changes to kisspeptin 







Figure 7.4: Kisspeptin neurons do not change action potential firing in response to high-frequency 
light stimulation of ChR2-expressing Avp-cre projections in dioestrous VEH and PNA mice. 
a, b) Representative traces illustrating the effect of HFLS of ChR2-expressing Avp-cre projections on 
action potential firing from a kisspeptin neuron from a vehicle-treated (VEH) and prenatal androgen-
treated (PNA) mouse. c, d) Average time-courses of action potential frequency over the recording periods. 
e) Quantified changes of kisspeptin action potential frequency as a percentage of baseline frequency 
during the effect periods following HFLS of ChR2-expressing Avp-cre projections in VEH and PNA 
mice. f) Proportions of neurons responding to HFLS of ChR2-expressing Avp-cre projections in VEH and 
PNA mice. Scale bars = 60 s/50 pA. Blue bars in a) – d) represent light stimulation. Data presented in c) 
– e) as mean ± SEM, dotted lines represent baseline. VEH: n = 10 neurons, N = 3 mice; PNA: n = 10 
neurons, N = 3 mice. 
183 
 
there was no change in the group mean firing rate during and following HFLS (Figure 7.4b, d, 
e; immediate: 93.4 ± 12.7% of baseline, p = 0.68; delayed: 99.2 ± 11.0% of baseline, p > 0.99; 
n = 10 neurons; N = 3 mice; Friedman test with post hoc Dunn’s multiple comparisons tests). 
 Comparisons between VEH and PNA groups showed no differences in how HFLS of 
SCN Avp-cre projections affected RP3V kisspeptin neuron firing rate (Figure 7.4e; immediate: 
p = 0.12, delayed: p = 0.74, Mann-Whitney tests); nor were there any differences between the 
proportion of kisspeptin neurons responding at either time period (Figure 7.4h, immediate: p > 
0.99, delayed: p = 0.64, chi-squared tests). 
 These data show that there is no difference in the way SCN Avp-cre neurons influence 
the electrical activity of kisspeptin neurons in dioestrous VEH and PNA mice. 
 
7.3.4 AVP application excites kisspeptin neurons similarly in PNA 
and VEH mice 
 For accuracy in comparisons, these experiments can only compare dioestrous PNA and 
VEH mice. As there was no effect of optogenetic stimulation of Avp-cre projections on 
kisspeptin action potential firing in dioestrus, it may be that those experiments were unable to 
detect any impairments in circuit function. As such, it was necessary to determine whether 
RP3V kisspeptin neurons from PNA mice were able to respond to AVP at all. Following 500 
nM AVP application, all RP3V kisspeptin neurons sampled from VEH mice were excited 
(Table 7.2), with a significant increase in mean firing rate (Figure 7.5a, c, e; 216.7 ± 20.8% of 
baseline, n = 12 neurons, N = 3 mice, p < 0.0001, Friedman test with post hoc Dunn’s multiple 
comparisons test). Similarly, AVP excited the majority of kisspeptin neurons from PNA mice 
(Table 7.2), and caused a significant increase in the group mean firing rate (Figure 7.5b, d, e; 
310.8 ± 91.5% of baseline, n = 11 neurons, N = 3 mice, p = 0.005, Friedman test with post hoc 





Figure 7.5: Kisspeptin neurons are excited by AVP application in dioestrous VEH and PNA mice. 
a, b) Representative traces illustrating the effect of 500 nM AVP application on action potential firing 
from a kisspeptin neuron from a vehicle-treated (VEH) and prenatal androgen-treated (PNA) mouse. c, 
d) Average time-courses of action potential frequency over the recording periods. e) Quantified changes 
of kisspeptin action potential frequency as a percentage of baseline frequency following AVP application 
in VEH and PNA mice. f) Proportions of kisspeptin neurons responding to AVP in VEH and PNA mice. 
Scale bars = 60 s/50 pA. Green bars in a) – d) represent AVP wash. Data presented in c) – e) as mean ± 
SEM, dotted lines represent baseline. VEH: n = 12 neurons, N = 3 mice; PNA: n = 11 neurons, N = 3 






Excitation No Change Inhibition Group mean 
VEH 12 0 0 216.7 ± 20.8% 
PNA 8 3 0 310.8 ± 91.5% 
 
Table 7.2: Individual and mean responses between VEH and PNA mice to AVP application. 
The number of neurons showing responses in both the immediate and delayed effect periods, as per the 
criteria outlined in Section 6.2.6.3, are tabulated. The mean response from baseline from all the neurons 
recorded is also provided and presented as mean ± SEM. Yellow boxes indicate mean responses that are 
significantly different from baseline. This table is associated with Figure 7.5. 
 
When firing rates were compared between VEH and PNA mice, there was no difference 
between the extent of their excitation (Figure 7.5e, p > 0.99, Mann-Whitney test). There was, 
however, a trend towards a decrease in the proportion of PNA neurons responding to AVP 
application compared to VEH (Figure 7.5f; p = 0.053 chi-squared tests). These data suggest 
that RP3V kisspeptin neurons respond to AVP in both VEH and PNA mice. 
 
7.4 Discussion 
PCOS is a common endocrine disorder with potential origins in the brain. One of the 
key features of PCOS is ovulatory dysfunction. This chapter investigated the structure and 
function of the projection from the SCN Avp-cre neurons to the RP3V in a mouse model of 
PCOS. RP3V kisspeptin neurons are critical for ovulation and their innervation by SCN AVP 
neurons is suspected to be involved in generating the preovulatory LH surge. Thus, it was 
fascinating to discover that in mice with features of subfertility, including impaired ovulation 
(Moore et al., 2013), there was a substantial reduction in the extent of this circuit. Decreased 
anatomical wiring did not coincide with changes to action potential firing following HFLS of 
Avp-cre projections, however. There was a trend towards RP3V kisspeptin neurons from PNA 
mice displaying a reduced receptivity to AVP, which did not reach significance. Together, these 
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data suggest a potential loss of a mechanism for driving an LH surge in the PNA mouse model, 
that potentially contributes to their ovulatory disfunction. 
 
7.4.1 SCN Avp-cre fibres are reduced in the RP3V of PNA mice 
Viral-tract tracing of the previously identified circuit between SCN Avp-cre neurons to 
RP3V kisspeptin neurons revealed that PNA mice have a significantly reduced Avp-cre fibre 
density in the RP3V compared to VEH control. This may be due to a change in the SCN Avp-
cre projection to the RP3V in PNA mice. Wiring changes in PNA mice have been shown 
previously with ARN GABA neurons increasing their projections to GnRH neurons (Moore et 
al., 2015), however, this is the first report of a PNA-induced change associated with SCN 
neurons.  
Previous studies have shown increased neuronal wiring associated with PCOS (Moore 
et al., 2015; Silva et al., 2018); however, these have been focussed on ARN projections to 
GnRH neurons to address an increase in PNA pulse frequency. As such, the work presented 
here shows a contrasting change in wiring for a decreased response; where an increased pulse 
frequency correlates with increased wiring from the ARN (Moore et al., 2015; Silva et al., 
2018), a loss in wiring to the LH surge-generating kisspeptin neurons correlates with a loss in 
the LH surge. 
 
7.4.1.1 Is this a direct effect of prenatal androgen treatment? 
To model PCOS, the pregnant dam is injected with the non-aromatisable androgen, 
DHT. It is likely that DHT action at the AR in the brain is critical for the development of PCOS-
like features (Caldwell et al., 2017).The distribution of AR expression specifically in the SCN 
throughout development is unknown. If it is similar to adulthood (i.e. distributed through the 
core, but not the shell (Iwahana et al., 2008; Jahan et al., 2015)), it is likely that AR activation 
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would not directly affect the SCN AVP neurons due to their lack of Ars (Karatsoreos et al., 
2007; Iwahana et al., 2008). The SCN production of AVP is low through development and only 
develops to full expression across the first week postnatally (Hyodo et al., 1992). Thus, it could 
be that AR-mediated actions at non-AVP SCN neurons subsequently repress the projections 
from AVP neurons.  
 Aside from action at the AR, there is a chance that the results seen here are due to 
activity at ERβ. Prenatal androgen treatment with DHT might result in the production of the 
DHT metabolite, 3β-androstanediol (Steckelbroeck et al., 2004). 3β-androstanediol is a potent 
activator of ERβ (Handa et al., 2008), which is abundant in the SCN (Shughrue et al., 1996). It 
has been shown that DHT treatment activates ERβ on magnocellular vasopressin neurons in 
culture (Pak et al., 2007). The activation of ERβ on these neurons, however, typically results in 
upregulation of AVP peptide and increased neuronal activity (Shapiro et al., 2000; Pak et al., 
2007), somewhat in contrast to a reduction in the Avp-cre projections seen here. 
Alternatively, prenatal androgen treatment may not affect the SCN, but rather act at the 
RP3V kisspeptin neurons. There in contrasting evidence about how the RP3V Kiss1 mRNA or 
kisspeptin peptide are impacted in PCOS animal models: there is either no change to their 
expression (Cheng et al., 2010; Caldwell et al., 2015; Kauffman et al., 2015; Matsuzaki et al., 
2017; Osuka et al., 2017) or a decrease (Brown et al., 2012; Aliabadi et al., 2017). A decreased 
expression of kisspeptin may result in a decreased branching of Avp-cre fibres, for AVP release, 
that are seen in the RP3V. Critically, however, Cernea et al. (2015) report decreased appositions 
to preoptic kisspeptin neurons in the PNA sheep model, but do not identify from where these 
inputs are coming. Further, they identified these neurons as unlikely to be glutamatergic. As 
such, the decrease may be attributed to the reduced innervation by SCN AVP neurons.  
Questions remain surrounding this circuit and how it is disrupted in the PNA model. 
Primarily, the ontogeny of the reduction in Avp-cre circuitry; is this circuit disrupted from birth, 
or disrupted by hyperandrogenaemia later in adulthood; or as suggested, has it withdrawn due 
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to a lack of kisspeptin neuron activity? Further, the plasticity in this circuit must be explored. 
It will be important to determine whether the reduction in the fibre density is permanent, or if 
restoration of hormone levels are sufficient to re-establish the projection. 
 
7.4.1.2 Is the reduction in Avp-cre projections attributable to altered 
hormonal feedback? 
One remaining possibility is that the loss in the Avp-cre fibre projection seen in the PNA 
mouse is not caused by excess androgen acting directly on the SCN Avp-cre neuron to RP3V 
kisspeptin neuron circuit, but rather due to impaired gonadal steroid hormone feedback. 
Essentially, the lack of positive feedback from the ovary is not priming the RP3V kisspeptin 
neurons for the surge. 
Oestradiol is the key hormone necessary for the development of the LH surge (Karsch 
et al., 1973; Legan et al., 1975). PNA mice are no different to VEH mice in their serum 
oestradiol concentration in dioestrus (Moore et al., 2015). However, the inability to progress 
into proestrus in PNA mice may be caused by failure of their ovaries to increase oestrogen 
production to levels necessary for positive feedback actions that generate the LH surge. Ovaries 
from PNA mice display decreased granulosa cell layer thickness (Moore et al., 2015; Silva et 
al., 2018). The elevated LH pulse frequency could be inhibiting the development of the 
granulosa cell layer, thus inhibiting the conversion of androgens to oestradiol. As kisspeptin 
neurons are highly oestradiol sensitive, this, in turn, would inhibit kisspeptin expression (Smith 
et al., 2006), as well as ion channels necessary for the development of the LH surge (Piet et al., 
2013; Piet et al., 2015a). 
Interestingly, when oestradiol levels are artificially raised by implant, PNA mice are 
able to generate an LH surge at the expected time (Moore et al., 2013), indicating that the 
positive feedback mechanism can be restored. Further, women with PCOS treated with the 
partial ER agonist, clomiphene citrate, display markedly increased ovulation (O’Herlihy et 
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al., 1981; López et al., 2004), indicating that restoration ER activation is sufficient to restore 
positive feedback. How this promotes an LH surge in PNA mice remains unknown, but data 
from Vida et al. (2010) suggest that the increased oestradiol levels may promote more AVP-ir 
fibres in the RP3V.  
Thus, the prolonged dioestrus levels of oestradiol in PNA mice may be causing a 
withdrawal or removal of SCN Avp-cre fibres. This idea would, therefore, be a secondary effect, 
not due to direct androgen action at the SCN or RP3V. 
 
7.4.2 SCN Avp-cre regulation of RP3V kisspeptin neuron electrical 
activity is not impaired in PNA mice 
The data here showed that HFLS of SCN Avp-cre projections did not, overall, excite 
either dioestrous VEH or PNA mice. Based on the results outlined in Chapter 6, a more 
informative experiment would have been to compare the effect of HFLS in proestrous VEH 
and PNA mice. Unfortunately, PNA mice being typically acyclic, often remaining in dioestrus 
without ever displaying proestrus (Figure 7.1), there was little opportunity to test PNA mice in 
proestrus. What can be gleaned from these experiments, however, lies in the proportions of 
RP3V kisspeptin neurons responding to HFLS in VEH and PNA mice (Figure 7.4f). Although 
this was not significantly different, fewer neurons were excited in PNA mice, consistent with 
the decreased innervation by SCN Avp-cre neurons.  
AVP application to the kisspeptin neurons indicated that there was no gross alteration 
in V1R function between VEH and PNA. VEH and PNA kisspeptin neurons were excited to 
similar extents, although a trend towards a lower proportion of RP3V kisspeptin neurons 
responding to AVP application was observed in PNA mice. These data suggest that it is unlikely 
that V1R expression and/or function on RP3V kisspeptin neurons is significantly altered in 
PNA mice. Given the reduction in fibre density, it may be that AVP is still released from the 
190 
 
remaining fibres into the extracellular fluid, but in lower concentrations. If it were possible to 
drive optogenetic stimulation of the SCN Avp-cre neurons in PNA mice, coupled with 
microdialysis of the RP3V, this would provide some evidence as to whether AVP is being 
released at the RP3V.  
Besides subtle, non-significant changes in the response of RP3V kisspeptin neurons to 
HFLS and to exogenous AVP, these results indicate that PNA has little impact on the 
functionality of the SCN Avp-cre neuron to RP3V kisspeptin neuron circuit in dioestrus. This 
likely reflects the inability of these experiments to adequately interrogate the circuit in PNA 
mice due to their profoundly impaired oestrous cycles. 
 
7.5 Summary 
The experiments carried out in this chapter have revealed the surprising result that 
following prenatal androgen treatment, the projection from SCN Avp-cre neurons to RP3V 
kisspeptin neurons is significantly reduced. The disrupted oestrous cycles of the PNA mice 
prevented the undertaking of a meaningful assessment of the functionality of this circuit. The 
subtle changes that were noted did not amount to a significant result, however, these data 
provide the first evidence for a disruption of the circuits between the SCN and RP3V in a mouse 













 This thesis focussed on investigating the circuitry between the SCN AVP neurons and 
the RP3V kisspeptin neurons to better understand how this network contributes to the 
development of the preovulatory LH surge. To address this, viral vector-mediated anterograde 
tract-tracing and optogenetics have been carried out to determine both the anatomy and the 
functionality of the SCN-to-RP3V network. Further, a mouse model of PCOS, which displays 
disrupted oestrous cycles, absence of ovulation and subfertility, has been used to investigate 
changes the anatomy and function of this circuit. 
This chapter summarises the main findings of each chapter and highlights how these 
studies contribute to the wider field; also, the limitations associated with this work are 
discussed. The implications of this work will be put into perspective for both physiological and 
pathology. Lastly, this chapter presents possible avenues for future research that can be 
developed from the present findings.  
 
8.2 Summary of the main findings 
 This work was made possible by a transgenic mouse model that allowed us to target and 
visualise AVP neurons in the SCN. Chapter 3 describes the characterisation of this model by 
crossing the Avp-cre strain to one expressing the fluorescent reporter, tdTomato. 
Immunohistochemistry for AVP revealed that tdTomato expression (i.e. cre-reporter 
expression) was restricted to known AVP-expressing populations within the brain (Rood & de 
Vries, 2011), particularly the PVN, SON, SCN and accessory AVP nuclei. As the focus of this 
thesis was the SCN, tdTomato reporter expression as a marker of where cre was present, even 
transiently throughout life, and virally transduced mCherry, as a marker of temporal cre 
expression, were characterised in colocalisation with AVP-ir neurons. The Avp-cre mouse 
reports approximately 60% of AVP neurons, although nearly half of reporter-expressing 
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neurons are not immunoreactive for AVP. While this may suggest other SCN neuronal 
phenotypes are reported in this model, the findings present indicate this is not likely; reporter-
expressing neurons do not express VIP or GRP, two other major SCN peptides; and AAV-
mediated labelling of Avp-cre neurons revealed a similar pattern of reporter expression, 
indicating that Avp and cre were likely expressed at that time but the peptide was below 
detectable levels. Although the Avp-cre model does not report of all the SCN AVP neurons, 
there was confidence in the specificity of the approach. 
 AAV-mediated tract-tracing in Chapter 4 revealed the extent of the SCN Avp-cre neuron 
projection to the RP3V, and how they interacted on an anatomical level with the RP3V 
kisspeptin neurons. mCherry-expressing Avp-cre projections were in apposition to 
approximately half of the RP3V kisspeptin neurons suggestive of sites for putative synaptic 
input. The correlation analysis of the projection density in the RP3V to reporter expression in 
AVP-expressing brain regions suggested that AVPergic innervation of the RP3V originates in 
the SCN. 
 Based on these findings, and due to the fact that SCN neurons are thought to express 
the amino acid neurotransmitter GABA, the experiments in Chapter 5 investigated the fast 
synaptic transmission between SCN Avp-cre neurons and the RP3V kisspeptin neurons. 
Channelrhodopsin-assisted circuit mapping revealed that there was very limited (~ 5%) 
GABAergic synaptic input from SCN Avp-cre to RP3V kisspeptin neurons. Control 
experiments using Nms-icre mice in Chapter 5 reveal that this result is likely not due to technical 
limitations. 
 Experiments in Chapter 6 investigated whether neuropeptide (i.e. AVP) release from 
Avp-cre projection may impact RP3V kisspeptin neuron activity. These studies revealed that at 
the individual cell level, activation of SCN Avp-cre projections increased action potential firing 
in RP3V kisspeptin neurons through the release of AVP. When considered as a population, the 
RP3V kisspeptin neurons were only excited in proestrus, but not dioestrus or oestrus. 
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Furthermore, during oestrus, it was found that the SCN Avp-cre projections, rather than exciting 
kisspeptin neurons, caused an inhibition. This inhibition was likely mediated by GABA, a fast-
inhibitory neurotransmitter, rather than AVP. As such, these Avp-cre projections likely release 
two different chemicals depending on the stage of the oestrous cycle. 
 To investigate how pathological changes in ovarian hormone feedback may alter the 
SCN-to-RP3V circuit, Chapter 7 outlined how this circuit was changed in a model of subfertility 
caused by prenatal androgen treatment. The subfertile PNA mouse model of PCOS stood in 
stark contrast to the reproductively normal model, with a significantly reduced SCN Avp-cre 
projection to the RP3V and a limited anatomical interaction with the RP3V kisspeptin neurons. 
Stimulation of SCN Avp-cre projections in PNA mice did not alter the activity of the RP3V 
kisspeptin neurons compared to dioestrous VEH control counterparts. As PNA mice have 
severely disrupted oestrous cycles, it was only possible to interrogate the circuit in dioestrus, a 
cycle stage where activation of SCN Avp-cre projections does not have an overall significant 
effect on action potential firing in RP3V kisspeptin neurons. The reduction in SCN-to-RP3V 
circuitry may partially underlie ovulatory dysfunction in this animal model. 
 
8.3 Contributions and limitations of this study 
8.3.1 Anatomy of the SCN-to-RP3V circuitry  
 The studies carried out in this thesis provide conclusive evidence for the projection of 
SCN Avp-cre neurons to the RP3V. Previous studies used immunohistochemical, non-specific 
tracing, and electron microscopy methods (Vida et al., 2010; Williams et al., 2011) to explore 
this circuit. The experiments in this thesis have used a more selective, genetically-specific, 
method to confirm them. Thus, this work supports previous conclusions by providing direct 
anatomical evidence for an SCN-to-RP3V projection. 
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 The specific genetically-targeted viral vector transduction of the mCherry reporter 
allows for visualisation of this circuit, however, it is limited by the Avp-cre mouse itself. While 
there is no better model available to explore this circuit it is important to remember that of the 
cre-expressing neurons that are phenotypically unaccounted for, they are unlikely to produce 
VIP or GRP. This study is limited by its inability to say that this projection is completely AVP-
producing. Unpublished evidence from the Piet laboratory, along with others suggests that there 
is little to no VIP innervation of RP3V kisspeptin neurons (Vida et al., 2010; Williams et al., 
2011), strengthening the idea that the projection seen is not confounded by other SCN peptides. 
 One remaining possibility is that although this circuit is present, it is not, in fact, solely 
an SCN-to-RP3V circuit; that is to say, it does not terminate at the RP3V. While axonal SCN 
projections (these projections have not been shown to be truly axonal, however) are necessary 
for maintaining the LH surge, (Wiegand et al., 1980; Wiegand & Terasawa, 1982; Silver et al., 
1996); they may not terminate in synaptic contacts at kisspeptin neurons. Electron microscopy 
has revealed the presence of some AVP-ir synapses in the RP3V (Vida et al., 2010), although 
this does not necessarily indicate the end of a projection. It could be that these projections 
(which can release AVP in a ‘non-synaptic’ manner) are continuing to elsewhere in the brain 
(Figure 8.1). Retrograde tracing studies reveal the SCN as the origin for RP3V projecting fibres, 
though this may be due to axonal uptake of tracing reagents rather than synaptic ones (Watts & 
Swanson, 1987).  As such, the brain slices through the RP3V reveal the projection to the RP3V, 
but do not indicate where the fibres terminate. Whether the Avp-cre projection to the RP3V is 
solely and specifically to the RP3V, where they may continue from the RP3V, remains to be 
elucidated. 
 While it has been inferred throughout this thesis that the Avp-cre projection acts at 






Figure 8.1: The SCN-to-RP3V circuit: Knowns and unknowns.  
Schematic of the SCN-to-RP3V projection in the horizontal plane. This thesis demonstrates that SCN Avp-
cre neurons project to the RP3V and influence the activity of RP3V kisspeptin neurons (1a). It remains 
unknown how this impacts other RP3V neurons (1b). It also remains unknown whether SCN AVP neurons 
terminate in the RP3V, or go elsewhere, such as previously identified projection regions like the organum 
vasculosum of the lamina terminalis (OVLT), or dorsomedial hypothalamus (DMH) (1c). As they can 
influence the activity of kisspeptin neurons, it remains unknown whether these are the kisspeptin neurons 
that project to the GnRH neurons influencing the LH surge, or other groups of kisspeptin neurons 
projecting to the ventromedial hypothalamus (VMH) that influence sexual behaviour, for example (2). 
While SCN NMS neurons are synaptically linked with RP3V kisspeptin neurons (3a), it unlikely that these 
also coexpress AVP (3b). It remains unknown what other SCN neurons may influence the activity of the 
RP3V neurons (4), although it is unlikely that SCN VIP neurons are involved as they typically project 
elsewhere, such as the rostral preoptic area (rPOA) (5). Table 1.1 lists potential other projection patterns 




influenced are those that do not impinge onto GnRH neurons. RP3V kisspeptin neurons have 
been shown to project to other regions in the hypothalamus such as the PVN, SON and VMH, 
among others (Clarkson & Herbison, 2006; Clarkson et al., 2009; Lehman et al., 2010b; Yeo 
et al., 2016; Marraudino et al., 2017; Seymour et al., 2017; Hellier et al., 2018). A cell-type 
specific tracing of the relationship between input and output (cTRIO) (Schwarz et al., 2015) 
could be used to determine whether the Avp-cre input to RP3V kisspeptin neurons is specific 
to those that project to GnRH neurons or other regions. Broadly cTRIO involves labelling for 
the upstream projections to a population while only labelling those neurons that also project to 
a certain region (Schwarz et al., 2015). As such, the kisspeptin neurons projecting to a known 
region could be traced while also revealing their inputs. Overlap with in the projection pattern 
with Avp-cre neurons would show that the SCN influences kisspeptin neurons that target certain 
regions. While many of the kisspeptin projections have not been fully characterised (and, as 
such, may also influence GnRH neurons as well as other targets), it could be that Avp-cre 
neurons act to impart circadian signals from the SCN to other regions of the brain, via RP3V 
kisspeptin neurons (Figure 8.1).  
 
8.3.2 The functional impact of SCN Avp-cre projections onto RP3V 
kisspeptin neurons 
 Using electrophysiology and optogenetics, this work revealed that SCN Avp-cre 
neurons communicate with RP3V kisspeptin neurons through the release of AVP. This work is 
the first to address how endogenously released AVP from the SCN can impact the activity of 
RP3V kisspeptin neurons. Based on the anatomical tracing, it is likely that the only source of 
AVP that acts at the RP3V is from the SCN. Interestingly, these studies have revealed that AVP 
signalling is likely a plastic phenomenon occurring prior to ovulation, but not post-ovulation. 
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Post-ovulation, the SCN Avp-cre neurons appear to switch from releasing AVP to releasing 
GABA.  
Although this work identified close appositions between SCN Avp-cre projections, 
some of which are likely to be synapses (Vida et al., 2010), there was surprisingly limited fast 
synaptic innervation of the RP3V kisspeptin neurons by SCN Avp-cre neurons. As mentioned, 
it has been suggested that the proportion of AVP-ir appositions to RP3V kisspeptin neurons is 
correlated to oestradiol levels (Vida et al., 2010). This suggests that there is a greater proportion 
of kisspeptin neurons receiving fast-synaptic input, however, as the data presented in Chapter 
5 showed, there was no change across the oestrous cycle. As there is a GABAergic effect on 
the RP3V kisspeptin neurons at oestrus, the lack of fast-synaptic innervation suggests that either 
GABA is released extrasynaptically, or that there is a polysynaptic circuit influencing the 
activity of the kisspeptin neurons. 
 In terms of the LH surge, these results demonstrate a mechanism by which the SCN 
may shape surge onset and duration. SCN neurons are most active towards the end of the light 
phase (Green & Gillette, 1982; Schaap et al., 2003), which coincides with the onset of the LH 
surge. If the increase in electrical activity results in AVP-mediated effects only in proestrus, 
this acts as a gate to the initiation of the LH surge. The coincident fall in oestradiol and rise in 
progesterone may act at the SCN to drive changes in the production of GABA, while 
downregulating V1Rs on the RP3V kisspeptin neurons (Figure 8.2). Studies looking at the time 
course of serum oestradiol and progesterone concentration across ovulation suggest that they 
decrease and increase, respectively, with ample time to exert effects at the brain (Kerdelhué et 
al., 2002; McQuillan et al., 2019). There is no data regarding a change in SCN AVP synthesis 
across the oestrous cycle, thus, the effect of this hormonal change on AVP signalling is still to 
be revealed. Either it is still be released, but due to the downregulation of V1Rs it is unable to 







Figure 8.2: Changes in the SCN-to-RP3V circuit activity across the oestrous cycle direct the 
generation of the LH surge. 
The SCN-to-RP3V circuit imparts different effects on LH surge generation across the oestrous cycle. The 
dial on the left-hand side indicates how the circuit impacts surge generation at each stage, with roughly 
24 hours per stage. Clock genes in the SCN Avp-cre neurons influence their activity, and time excitation 
to mid-late afternoon. In dioestrus, the excited SCN Avp-cre neurons may release variable amounts of 
AVP or GABA which do not cause a change in the activity of RP3V kisspeptin neurons. No kisspeptin is 
released, and, as such, there is no excitation of GnRH neurons to generate the LH surge. In proestrus, the 
excited SCN Avp-cre neurons may release AVP that, in turn, excites RP3V kisspeptin neurons. The 
resulting release of kisspeptin excites GnRH neurons to generate the LH surge. In oestrus, the excited 
SCN Avp-cre neurons may release GABA that inhibits RP3V kisspeptin neurons. No kisspeptin is 
released, and, as such, there is no excitation of GnRH neurons to generate the LH surge. ✓ = hypothesised 
peptide release, ⨯ = no peptide release, ? = unknown peptide release. 
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in oestrus; or AVP production is simultaneously downregulated in the SCN. Oestradiol-induced 
effects at the kisspeptin neurons, such as changes in ion channels (Piet et al., 2015a) may persist 
due to the long-lasting genetic actions of ERs,. Thus, the oestrus change in Avp-cre neurons, to 
begin releasing GABA, would drive inhibition to the kisspeptin neurons and stop a repeated 
LH surge. It could be that this change in production (at the SCN) and responsiveness (at the 
kisspeptin neurons) is effectively timing the LH surge and is a mechanism to stop its recurrence, 
despite the daily circadian signal form the SCN. 
A key limitation of this work is that experiments were carried out at a single time point. 
Even though RP3V kisspeptin neurons do not differ in their responsiveness to AVP over the 
day (Piet et al., 2015b), this does not rule out a difference in AVP production or V1R function. 
The SCN produces AVP across the course of the day peaking during the morning (Jin et al., 
1999; Dardente et al., 2004; van der Veen et al., 2005; Maruyama et al., 2010) As such, 
packaging and export of the peptide to the terminals may be delayed, and brain slices with 
severed projections would not contain AVP. There may be greater AVP available for release 
from projections later in the day, compared to in the morning. Thus, ChR2-mediated stimulation 
of Avp-cre projection fibres, from brain slices taken later in the day may result in a greater 
proportion of kisspeptin neurons excited by increased endogenous AVP release; while 
GABAergic inhibition of kisspeptin neurons might be less prominent towards the time when 
the surge may occur.  
 
8.3.3 The relationship between subfertility and the SCN-to-RP3V 
circuit 
Modelling subfertility by using the PNA mouse model of PCOS, these data have shown 
that the critical SCN-to-RP3V circuit is downregulated. This adds another abnormality to the 
GnRH neuronal network seen in the PNA mouse model, which may explain disrupted fertility 
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in PCOS patients, particularly in terms of ovulatory dysfunction. As PNA mice do not tend to 
display proestrus, it is not altogether surprising that the circuit is decreased. The ontogeny of 
this decrease in circuitry remains unknown, however. Two possibilities for this include an 
organisational effect whereby the SCN-to-RP3V circuit does not develop correctly (due to 
prenatal androgen excess); or an activational effect whereby impaired steroid hormone 
feedback disrupts the circuit in adulthood.  
Androgen treatment during the prenatal period may be disrupting the development of 
the SCN Avp-cre projections, but the mechanism for how is less clear Androgen treatment can 
increase AR expression in the female SCN to a more male-like pattern (Iwahana et al., 2008). 
Thus, the same thing may be occurring in the PNA mouse model, which in turn could inhibit 
the development of SCN projections (Figure 8.3). Androgenisation does not affect SCN AVP 
production (de Vries et al., 1994). As there was no difference in SCN transfection levels, this 
suggests that prenatal androgen treatment does not affect cre expression, and therefore Avp 
expression levels. Thus, the reduction in mCherry-ir fibres, when looked at from an 
organisational perspective, would solely be a problem with the development of the Avp-cre 
projections from the SCN. 
If the cause was activational (i.e. caused by impaired steroid feedback or 
hyperandrogenism later in life), rather than not developing in the first place, the projections 
may retract. The lack of oestradiol positive feedback to the RP3V kisspeptin neurons would fail 
to prime the RP3V kisspeptin neurons and, thus cause a reduction in their activity. This, in turn, 
may result in a reduction in their afferent wiring (Figure 8.3). As alluded to, the question 
remains as to whether this is truly an effect of androgen treatment, or whether it is a secondary 
effect of the loss of oestradiol feedback in PCOS. While Vida et al. (2010) suggest that 
oestradiol treatment increases AVP-ir fibres in the RP3V, the opposite may also be true; that 






Figure 8.3: How might changes in androgen levels affect SCN-to-RP3V wiring? 
Females exposed to prenatal androgens early in life display higher androgen levels throughout puberty 
and in adulthood, associated with the development of PCOS features. Both periods of high androgens 
may contribute to the reduction seen in Avp-cre mCherry fibre projections to the RP3V. If the prenatal 
androgen insult disrupts the development (1) then it may not be present from birth and be limited 
throughout life entirely. If the higher pubertal/adulthood androgens affect an already present projection, 
or the lack of gonadal steroid feedback supporting this network, (2) then it would degrade throughout 




to mount an LH surge when primed with oestradiol (Moore et al., 2013) suggesting that 
oestradiol replacement may be able to restore the circuit. In saying this, it is important not to 
discount the effects of hyperandrogenism in these mice. Increased testosterone may be acting 
at SCN ARs to drive these reductions in fibre density, particularly if SCN AR expression is 
heightened in the PNA model. It will be necessary for future studies to correlate the projection 
density to the circulating oestradiol concentration; as well as comparing how dense the 
projection is in the PNA model to an ovariectomised model where endogenous oestrogens are 
removed. This will provide some evidence as to whether this is an effect of prenatal androgen 
treatment or an effect of decreased oestradiol feedback. 
 
8.4 Relevance to human biology 
The role of the GnRH neuronal network in the human LH surge has been debated with 
conflicting results about both its function and relevance, particularly as to whether human 
oestradiol positive feedback is mediated at the hypothalamus or solely at the pituitary gland 
(Hall et al., 1994; Ottowitz et al., 2008). Early work in the human hypothalamus did not identify 
significant kisspeptin populations outside of the infundibulum, the human analogue to the ARN 
(Rometo et al., 2007). Optimisation of staining techniques, however, has revealed a kisspeptin 
population in the human equivalent to the RP3V (Hrabovszky et al., 2010; Rumpler et al., 2020) 
and, thus, the kisspeptin to GnRH circuit may be present in the human. Further, this population 
appears to be positively regulate by oestrogen feedback (Rumpler et al., 2020). It remains 
unknown the extent at which this kisspeptin population influences the human LH surge. In 
saying this, it is important to note that kisspeptin treatment can induce surge-like LH levels and 
ovulatory responses (Dhillo et al., 2007; Jayasena et al., 2014; Romero-Ruiz et al., 2019). 
While the literature surrounding the human LH surge suggests some aspect of timing 
particularly towards the early morning prior to waking (Edwards, 1981; Cahill et al., 1998; 
204 
 
Kerdelhué et al., 2002), although the mechanism behind this remains unknown. It could be that 
a homologous circuit of SCN-to-RP3V is present in the human, similar to the rodent, which 
relays a timing signal for the LH surge. The increase in LH appears to consistent with daily 
increases in cortisol (Kerdelhué et al., 2002); suggesting some aspect of timing, potentially 
from the SCN. 
The likelihood of a homologous SCN-to-RP3V circuit in humans is suggested by 
endocrine dysfunction in women with disrupted circadian rhythms (Gamble et al., 2013). It 
may be that SCN stimulation of the human GnRH neuronal network is not occurring, or is 
occurring at inappropriate times. The activity of the SCN likely needs to be timed with 
individual clocks in downstream neurons (such as kisspeptin and GnRH), as well as peripheral 
tissues like the gonadotropes and ovary. Thus, asynchrony between these clocks caused by 
circadian disruption may impair gonadal hormone release and/or function (Gamble et al., 2013; 
Stocker et al., 2014; Goldstein & Smith, 2016). Interestingly, fertility in these women appears 
to be restored once normal circadian rhythms are reinstated (Gamble et al., 2013; Stocker et al., 
2014). As such, this temporary subfertility may be due to inappropriate coordination of timing 
in multiple neuronal populations.  
 In women with PCOS, it is possible that hyperandrogenism is affecting the SCN 
circuitry which could contribute to their disrupted ovulation. PCOS patients treated with 
oestrogen receptor agonists and undergoing in vitro fertilisation, are highly amenable to 
ovulation induction, however. This suggests that exogenous steroid and gonadotropin 
administration may be able to override the GnRH neuronal network, and its potential timing 
mechanisms. 
 
8.5 Future studies 
8.5.1 Circuit mapping  
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 The work presented here employs anterograde viral tract-tracing of the SCN Avp-cre 
neurons to define their relationship with RP3V kisspeptin neurons. While this method reveals 
projection fibres, it is limited by its anterograde nature. As mentioned, it remains unknown 
whether the Avp-cre projections seen in the RP3V are terminating fibres or simply en passant 
towards other regions of the brain. Coupling this anterograde tract-tracing with a tissue clearing 
method such as CLARITY or iDISCO (Chung et al., 2013; Renier et al., 2014), would allow 
for reconstruction of this circuit to visualise the extent of the projection. The reconstruction 
would then reveal the true extent of the fibre projection and give insight into where these 
projections are terminating.  
 If these fibres are terminating within the RP3V, it remains unclear as to why they rarely 
form functional synaptic innervation with the kisspeptin neurons. Thus, a marker of synaptic 
contacts could be used in conjunction with the immunohistochemistry presented here. 
Synaptophysin (Syp) is a marker of presynaptic vesicles in synaptic terminals (Calhoun et al., 
1996). An immunohistochemical stain of Syp in conjunction with mCherry (following AAV-
mCherry injection) and kisspeptin could be carried out to identify synaptic contacts. Close 
apposition of Syp/mCherry/kisspeptin-ir would provide evidence as to whether the Avp-cre 
close appositions to kisspeptin neurons are in fact synaptic contacts. Knowing whether synapses 
are present or not would allow for further electrophysiological experiments to identify whether 
these are silent synapses as was discussed in Chapter 5 (Losonczy et al., 2004; Bekkers, 2005; 
Vincent-Lamarre et al., 2018). 
 Finally, an opposite approach could be taken whereby RP3V kisspeptin neurons are 
transfected with a viral-vector for monosynaptic retrograde tracing. This involves transfection 
in a mouse model expressing cre in kisspeptin neurons (Mayer et al., 2010). The viral vector 
would then pass through synaptic contacts on the kisspeptin neurons and transfect the afferent 
neurons with a reporter. Immunohistochemistry for the reporter, as well as AVP, would provide 
irrefutable evidence as to whether SCN AVP neurons form synaptic contacts onto RP3V 
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kisspeptin neurons. Again, however, if SCN AVP neurons were forming synaptic contacts onto 
RP3V kisspeptin neurons, this does not indicate their functionality as shown by the 
electrophysiological data.  
 
8.5.2 The role of hormonal feedback in AVP- and GABA-mediated 
communication from the SCN 
 The switch between AVP- and GABA-mediated communication from SCN Avp-cre 
neurons across proestrus to oestrus is an interesting and previously unknown finding. The key 
change across ovulation is the altered hormonal milieu of the animal, thus, it is likely that 
hormonal changes (i.e. the fall in oestradiol and increased progesterone) are driving a change 
from AVP to GABA release.  
 To investigate this, several relatively simple experiments can be carried out. The first, 
would involve determining whether there are changes across the oestrous cycle in either the 
presynaptic release of AVP or GABA, or looking at how the receptors for these chemicals might 
differ. Sniffer cell techniques can reveal whether AVP is released from projections (Son et al., 
2013; Zaelzer et al., 2018), and would be important to test whether AVP is released at oestrous, 
when kisspeptin neurons do not respond. While GABA release specifically from these neurons 
is harder to examine, anatomical studies of GABA immunoreactivity could be carried out to 
determine whether there is colocalisation of GABA-ir with mCherry-ir in Avp-cre projections. 
Alternatively, a sniffer patch expressing GABAARs could be used to determine whether GABA 
was released in brain slice experiments (Christensen et al., 2014). RP3V kisspeptin neurons 
clearly respond to GABA across the oestrous cycle (as seen with background inhibitory 
postsynaptic currents recorded in Chapter 5); although, it may be that increases in progesterone 
at oestrus are sensitising GABAARs. Bath application of GABAAR agonists such as muscimol 
onto RP3V kisspeptin neurons would determine whether there was a difference in GABAAR 
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activity across the oestrous cycle, that may begin to respond to extrasynaptic GABA released 
by Avp-cre projections.  
Following this, it will be important to determine whether individual hormones may alter 
the Avp-cre projections. Repeating the ChR2-mediated stimulation of Avp-cre projections 
whilst recording kisspeptin neuron activity (as per Chapter 6) could be carried out in an OVX 
mouse. OVX abolishes the vast majority of oestradiol synthesis and therefore all oestradiol-
mediated feedback. OVX will provide an indication as to what the circuit function might be 
without any hormonal feedback. The loss of oestradiol entirely would be problematic as 
oestradiol may be linked to AVP production (Shapiro et al., 2000; Pak et al., 2007), V1R 
expression and function (Kalamatianos et al., 2004a; Piet et al., 2015b), and RP3V kisspeptin 
neuron activity (Frazão et al., 2013; Piet et al., 2013). Thus, OVX alone would likely disrupt 
multiple points of the SCN-to-RP3V circuit. To maintain a stable baseline, low level oestradiol 
replacement to the OVX mouse (OVX + E) could be used, mimicking a dioestrus mouse. 
Comparing this to a mouse with low oestradiol, given a high oestradiol bolus (OVX+E+E) to 
mimic proestrus, would allow for potential oestrogen-mediated differences in the system to be 
interrogated. This may reveal an oestrogen-dependent switch to greater excitation of kisspeptin 
neurons by SCN Avp-cre neurons, as seen here in proestrus mice.  
The transition to oestrus and the GABA-mediated inhibition is harder to investigate. It 
can be hypothesised that increased progesterone levels may be acting to drive changes in 
chemical release from the SCN Avp-cre neurons. Progesterone has been implicated in the 
suppression of AVP production (Auger & Vanzo, 2006), as well as the potentiation of 
GABAARs (Callachan et al., 1987; Brussard & Koksma, 2003; Wang, 2011). The role of 
progesterone on GABA synthesis is unclear, with reports showing increases and decreases in 
GABA synthetic enzymes in different brain regions (Weiland, 1992; Souza et al., 2009; 
Noriega et al., 2010). As progesterone receptor expression is driven by oestrogen levels 
(Moffatt et al., 1998; Wagner et al., 2001), however, OVX with progesterone replacement 
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would not be sufficient to interrogate the role of progesterone action in the SCN-to-RP3V 
circuit. Thus, an OVX mouse with low oestradiol and high progesterone replacement 
(OVX+E+P) could be used to model oestrus. As such, it could be expected that the increased 
progesterone levels may drive a predominantly GABAergic effect from the SCN Avp-cre 
neurons onto RP3V kisspeptin neurons. 
 
8.5.3 An in vivo investigation of the AVP-mediated effects on the 
LH surge  
The role of SCN AVP neurons in vivo on the generation of the LH surge remains 
somewhat unclear. While this thesis has shown that Avp-cre neurons exert a biphasic drive on 
kisspeptin activity (i.e. excitation by AVP prior to, and inhibition by GABA post-ovulation), 
there has been no specific in vivo experiments looking at this circuit. Early lesion studies have 
revealed that the SCN, and by extension the SCN AVP neurons, are necessary for the generation 
of the LH surge (Wiegand et al., 1980; Wiegand & Terasawa, 1982). These were followed by 
showing that AVP injections can generate a surge (Palm et al., 1999, 2001), although these 
have been hampered by studies showing conflicting results on whether V1R inhibition can 
inhibit the surge (Funabashi et al., 2000a; Palm et al., 2001; Miller et al., 2006).  
Modern neuroscientific techniques provide a better method to investigate the role of the 
SCN AVP neurons in vivo. In vivo optogenetic stimulation of Avp-cre neurons coupled with 
repeated blood sampling for LH levels would provide key evidence as to whether their 
stimulation is sufficient to induce a surge. Appendix 9.9 of this thesis presents preliminary 
results and a discussion from a pilot study designed to address this experiment. A similar 
approach utilising designer receptors exclusively activated by designer drugs (DREADDs) 
could be carried out. Injection of a viral vector carrying a modified human M3 muscarinic 
receptor activated by exogenous clozapine-N-oxide (Roth, 2016), could be used to stimulate 
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the Avp-cre neurons, whilst taking blood samples for LH detection, potentially showing that 
increases in SCN Avp-cre neuron activity drive downstream LH release. The reverse 
experiments may also be considered. During proestrus at the expected time of the surge, either 
inhibitory opsins could be stimulated resulting in suppression of Avp-cre neuron activity; or 
activation of an inhibitory DREADD could be used to see whether the expected LH surge is 
inhibited. These experiments would provide evidence as to whether the SCN AVP neurons 
were sufficient and necessary for the development of the LH surge. 
 
8.5.4 Understanding the aetiology of the reduction in SCN-to-RP3V 
circuitry in the PNA mouse model 
There was a clear reduction in the SCN-to-RP3V circuit in the PNA mouse model. 
While it remains unknown what causes this decrease, several experiments can be designed to 
address its aetiology.  
Using an Avp-cre:tdTomato mouse, that reports cre expression from whenever the Avp 
gene has been active, the SCN-to-RP3V circuit from PNA and VEH mice could be examined 
at different time points prior to puberty to determine whether the projection is present, and how 
different levels of androgens over time may cause it to change. The development of this circuit 
in untreated animals remains unknown, thus, experiments could be designed to test how 
heightened androgen levels at different time points may be affecting it through prenatal 
exposure, or through puberty. 
It would be important to determine the time point at which the SCN-to-RP3V circuit 
develops, to determine when it may be impacted by heightened androgens. It is unlikely that 
the RP3V kisspeptin neurons are present before puberty (Clarkson & Herbison, 2006; Mohr et 
al., 2016), thus, the circuit may not be set up in utero and could be unaffected by the prenatal 
androgen treatment. Silva et al. (2018) suggest that androgen levels in the offspring are not 
210 
 
significantly elevated until puberty, thus, it would next be important to see whether the increase 
in androgen levels at puberty either delay the circuits development or drive its regression. 
Investigation of the circuit anatomy at these two time points could provide some indication as 
to whether the reduction in fibre density seen here is either an organisational, or activational 
effect of the prenatal androgen treatment.  
As mentioned, the reduction in the circuitry may not be directly from androgen action, 
but rather from a loss in oestradiol-mediated feedback. An experiments could be developed to 
test the hypothesis that removing androgen effects to restore oestradiol feedback would restore 
the Avp-cre projection to the RP3V. The first would involve OVX of PNA mice, whereby the 
androgen overproducing ovary was removed, and oestradiol was implanted to restore 
oestradiol-mediated feedback. The circuit could then be investigated in these PNA mice to 
determine whether oestradiol replacement is sufficient to re-establish the circuit.  
 
8.6 Concluding remarks 
 The work presented in this thesis confirms previous anatomical studies suggesting the 
presence of a circuit from SCN AVP neurons to RP3V kisspeptin neurons. Using genetically-
mediated viral anterograde tract tracing, the density of this circuit and its anatomical interaction 
with kisspeptin neurons has been characterised, with the findings suggesting it is more 
extensive than previously thought. Selective optogenetic stimulation of this projection has been 
shown to alter the activity of identified kisspeptin neurons in a manner consistent with the 
generation of the LH surge: prior to ovulation, during proestrus, the circuit acts to excite 
kisspeptin neurons, while post ovulation, during oestrus, this circuit inhibits kisspeptin neuron 
activity. Thus, this circuitry appears to be critical in the development of the preovulatory LH 
surge. Finally, the SCN-to-RP3V circuit was interrogated in a clinically-relevant mouse model 
of PCOS, a pathology where ovulation is disrupted. It was found that there was a reduction in 
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the SCN AVP neuron to RP3V kisspeptin neuron circuit, underlying a potential cause for 
ovulatory dysfunction in PCOS.  
Specifics about this circuit remain to be defined, particularly 1) how the activity of 
steroid hormones can influence its anatomy and 2) how they may drive changes in its function, 
and 3) whether changes to the circuit driven by diminished fertility are plastic and can be 
restored. The studies presented in this thesis have given novel insight into the regulation of the 
GnRH neuronal network by focussing on the afferent biological clock. Ultimately, this has 
provided us with a unique insight into how the brain is able to regulate and integrate both 











9.1 Appendix I: List of chemical reagents 
 
No. Solution Reagents pH 
1.1 0.1 M Phosphate buffer (PBS) H2O 
0.1 M Na2HPO4 
0.1 M NaH2PO4•2H2O 7.6 
1.2 4% Paraformaldehyde 0.1 M Phosphate buffer 
4% (w/v) Paraformaldehyde 7.6 
1.3 Tris-buffered saline (TBS) H2O 
0.5 M Tris-HCl 
0.5 M Tris-base 
0.15 M NaCl 7.6 
1.4 30% Sucrose TBS 
30% (w/v) sucrose 7.6 
1.5 Cryoprotectant 
(stored at -20ºC) 
1.0 M phosphate buffer 
0.9% (w/v) NaCl 
30% (w/v) sucrose 
1% (w/v) polyvinylpyrrolidone (PVP-40) 
30% (w/v) ethylene glycol 7.6 
1.6 Immunohistochemistry blocking 
solution 
TBS 
0.25% (w/v) Triton-X-100 
0.3% (w/v) bovine serum albumin (BSA) 




0.25% (w/v) Triton-X-100 
0.3% (w/v) bovine serum albumin (BSA) 7.6 
1.8 Slicing solution for ex vivo brain 
slicing 
H2O 
87 mM NaCl 
2.5 mM KCl 
25 mM NaHCO3 
1.25 mM NaH2PO4 
0.5 mM CaCl2 
6 mM MgCl2 
25 mM D-glucose 
75 mM sucrose  
1.9 Artificial cerebrospinal fluid H2O 
125 mM NaCl 
2.5 mM KCl 
26 mM NaHCO3 
1.25 mM NaH2PO4 
2.5 mM CaCl2 
1.2 mM MgCl2 




No. Solution Reagents pH 
1.9 Potassium chloride pipette 
internal solution 
H2O 
130 mM KCl 
10 mM HEPES 
0.2 mM Na2-GTP 
2 mM Mg-ATP 
1 mM QX314-Cl 
KOH for pH 
Sucrose for osmolarity to ~290 mOsM 7.3 
1.10 PBS-tween 0.1 M phosphate buffer 
0.05% tween-20 7.4 
1.11 Citrate buffer H2O 
1.03% (w/v) citric acid monohydrate 
1.816% (w/v) sodium phosphate 5.0 
1.12 ELISA blocking solution 0.1 M phosphate buffer 
0.05% tween-20 
5% skim milk powder 7.4 
 




9.2 Appendix II: Antibodies 
 
Product No. Antibody Source 
Primary Antibodies 
T-5048.0050 Guinea pig anti-vasopressin 
Peninsula Laboratories 
International, Inc. (CA, USA) 
20077 Rabbit anti-vasoactive intestinal peptide Immunostar (WI, USA) 
20073 Rabbit anti-gastrin releasing peptide Immunostar (WI, USA) 
ab167453 Rabbit anti-mCherry AbCam (Cambridge, UK) 
AC053 Sheep anti-kisspeptin 
Prof. A. Caraty (French National Institute 
for Agricultural Research, Paris, France) 
GA04 Guinea pig anti-GnRH 
Prof. G. Anderson (University of Otago, 
Dunedin, New Zealand) 
Secondary Antibodies 
706-545-148 Donkey anti-guinea pig Alexa Fluor 488 
Jackson ImmunoResearch 
Laboratories, Inc. (PY, USA) 
A21206 Donkey anti-rabbit Alexa Fluor 488 ThermoFisher Scientific (MA, USA) 
A10042 Donkey anti-rabbit Alexa Fluor 568 ThermoFisher Scientific (MA, USA) 
A16045 Biotinylated donkey anti-sheep ThermoFisher Scientific (MA, USA) 
Tertiary Antibodies 
S11223 Streptavidin, Alexa Fluor 488 conjugate ThermoFisher Scientific (MA, USA) 
Antibodies used for ELISA 
518B7 Bovine LHβ monoclonal Dr. L. Sibley (UC Davis, CA, USA) 
AFP240580Rb Rabbit polyclonal LH 
Dr. A. Parlow (National Hormone and 
Pituitary Program, Torrence, CA, USA) 
P0448 Goat anti-rabbit IgG/HRP DAKO (CA, USA) 
 




9.3 Appendix III: Viral vectors 
 
In text as: Full Virus Name Titre Source 
AAV-mCherry AAV-DJ-EF1-DIO-mCherry 5.05×1013 GC/mL Stanford Vector Core 
AAV-ChR2 
AAV-DJ-EF1 DIO hChR2 
(E123T/T159C)-p2a-mCherry-
WPRE 
1.60×1013 GC/mL Stanford Vector Core 
 








Blue light power (466 ± 
40 nm; mW) 
Green light power (562 ± 
40 nm; mW) 
4× Objective (0.1 NA) 
100 100.3 43.3 
90 95.0 40.1 
80 88.5 36.5 
75 85.1 34.8 
70 81.5 33.0 
60 73.6 29.2 
50 64.9 25.3 
40 54.8 21.0 
30 43.1 16.5 
25 36.9 14.1 
20 29.7 11.5 
10 14.8 6.0 
5 6.6 3.0 
2 1.7 1.1 
1 0.1 0.4 
40× Objective (0.8 NA) 
100 53.9 19.6 
90 50.1 18.2 
80 46.0 16.9 
75 44.0 16.1 
70 41.8 15.3 
60 37.0 13.6 
50 32.0 11.8 
40 26.4 9.8 
30 20.4 7.7 
25 17.4 6.6 
20 14.1 5.4 
10 7.0 2.9 
5 3.1 1.4 
2 0.8 0.5 
1 0.1 0.2 
 





9.5 Appendix V: Drugs used in electrophysiology 
 
Product No. Drug Source 
1262 Gabazine Tocris Bioscience (Bristol, UK) 
T-550 Tetrodotoxin Alomone Labs (Jerusalem, Israel) 
275875 4-Aminopyridine Sigma-Aldrich (MO, USA) 
3377 
Manning Compound; catalogued as: 
(d(CH2)5
1,Tyr(Me)2,Arg8)-Vasopressin  
Tocris Bioscience (Bristol, UK) 
2935 
Vasopressin; catalogued as: [Arg8]-
Vasopressin 
Tocris Bioscience (Bristol, UK) 
 











Figure 9.1: Oestrous cycles of mice undergoing stereotaxic surgery. 
Upper: Four representative examples of typical mouse oestrous cycles. Lower: Four representative examples 
of mouse oestrous cycles before and after stereotaxic surgery. Surgery took place on experimental day 0 outlined 






9.7 Appendix VII: GFP characterisation in the female 




Figure 9.2: Characterisation of GFP expression in the Kiss-hrGFP mouse model. 
a) Maximum projection image of a confocal Z-stack showing immunofluorescence staining for kisspeptin (red) 
and endogenous hrGFP fluorescence (green) in the RP3V. Overlap of the two labels indicates colocalisation 
(orange). Filled arrowheads indicate hrGFP expressing cells. Empty arrowheads indicate kisspeptin-ir cells. 
Arrows indicate colocalised cells. b) The efficacy is the proportion of the kisspeptin-ir population expressing 
hrGFP; while the specificity is the proportion of hrGFP cells with kisspeptin-ir. Data shown as mean ± SEM. 





9.8 Appendix VIII: High power light intensity inhibits 
kisspeptin neuron activity 
 
 
Figure 9.3: Inhibition of kisspeptin activity by 60 s of high LED power HFLS. 
Two representative recordings of kisspeptin neurons with high-frequency light stimulation of Avp-cre 
projections at 53.9 mW power. This results in complete and prolonged inhibition of the neurons. Because this 
is not seen with lower power stimulations it is likely due to light-induced unwanted effects. The red lines 
indicate ~ 10 and ~ 12 minutes of inactivity, respectively. Scale bars = 60 s/50 pA.  
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9.9 A pilot study testing the effect of in vivo optogenetic 
stimulation of SCN Avp-cre neurons on the LH surge 
9.9.1 Introduction 
 The surge of LH, necessary for ovulation, is closely timed in mammals to occur 
towards the end of the afternoon in proestrus (Everett & Sawyer, 1950; Murr et al., 1973; Legan 
et al., 1975; Bronson & vom Saal, 1979). The timing is thought to rely on a daily signal from 
the SCN coincident with rises in oestradiol which both impinge on the GnRH neuronal network 
(Everett & Sawyer, 1950; Legan et al., 1975; Legan & Karsch, 1975; Wiegand et al., 1980; 
Wiegand & Terasawa, 1982; Christian et al., 2005; Miller et al., 2006). As mentioned in 
Chapter 8, the sufficiency of the circuit between SCN and RP3V in the generation of the LH 
surge can only be conclusively confirmed by in vivo stimulation. In vivo optogenetic studies of 
the SCN are limited, with most looking at how stimulation of the SCN changes entrainment 
(Jones et al., 2015; Mazuski et al., 2018); only one study has optogenetically stimulated AVP 
projections originating from the SCN (Gizowski et al., 2016). The results in this thesis have 
identified a functional output from SCN Avp-cre neurons that can excite RP3V kisspeptin 
neurons. Further, it is consistent with the idea of the SCN gating the surge to only occur on 
proestrus. Thus, it is important to determine whether the circuit is sufficient alone to trigger the 
LH surge in vivo. 
 
9.9.1.1 Hypothesis and aim 
 As stimulation of SCN Avp-cre neurons in vitro can excite RP3V kisspeptin neurons at 
proestrus, it was hypothesised that stimulation of this circuit is sufficient to trigger the LH 
surge given the appropriate hormonal environment. As oestrogenic feedback is necessary 
for the development of the LH surge (Legan et al., 1975), this was carried out in a model of 
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positive feedback used by others, previously (Bronson, 1981; Wintermantel et al., 2006; 
Czieselsky et al., 2016). To more accurately determine whether stimulation of the SCN Avp-
cre neurons was sufficient to trigger an LH surge, these experiments were carried out mid-
morning, to see whether SCN Avp-cre neuron stimulation could phase-advance the LH surge. 
As such, this pilot study aimed to optogenetically stimulate the SCN Avp-cre neurons, while 
taking blood samples to determine the output of LH.  
 
9.9.2 Methods 
 Most methods are described elsewhere. Supplementary methods are listed below.  
 
9.9.2.1 Stereotaxic fibre-optic implantation 
Following stereotaxic injection of AAV-ChR2 into female Avp-cre mice, bilateral 
optical fibres were inserted above the SCN. Following surgery set up (as per Section 2.2), fur 
covering the scalp was trimmed using small scissors, and 4% hibitane was applied to the 
exposed skin. A midline incision was made in the skin using scissors, and the connective tissue 
covering the skull was cut. Using a small drill bit, the skull was etched to roughen up the 
periosteal surface. Etching gel (Scotchbond, ESPE, 3M) was then applied to the skull and left 
for 60 seconds, before removal with cotton buds and water. One small hole was drilled through 
the skull at the anterior end of the scalp incision, and two at the posterior end; and small screws 
were then inserted halfway into each hole.  
The virus was then injected into the brain at the level of the SCN, as outlined in Section 
2.2.1. Once the virus was injected and the needle removed, a thin layer of primer (Unitek, 3M) 
was applied to the exposed skull surface. The bilateral fibre-optic cannula was then lowered 5.7 
mm into the brain (to sit above the SCN) through the hole made for virus injection. The cannulae 
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used were dual 6 mm flat-tip fibre-optics. The fibre-optics were 200 µm wide each, with a 0.5 
mm inter-fibre distance (Doric Lenses, QC, Canada).  
With the fibre-optic in situ, Transbond XT adhesive (Unitek, 3M) was applied to 
surround the cannula and the screws. The 0.3 mm gap between the cannula ferrule and skull 
was also filled with adhesive. Once in place, blue LED light was used to set the adhesive. 
Following adhesion to the skull, two surgical sutures (Mersilk, Ethicon) were placed anterior 
and posterior to the glued region (Figure 9.4a). The mice were individually housed following 
surgery and left to recover. Postoperative management procedures, outlined by the University 
of Otago Animal Ethics Committee, were carried out following surgery. 
 
9.9.2.2 Ovariectomy, capsule implantation and hormonal positive feedback 
Mice used in in vivo optogenetic experiments underwent ovariectomy and capsule 
implantation six days prior to blood sampling. Following surgery set up (as per Section 2.2), 
mice were placed prone on a heating pad, and the lower back fur was shaved. Four percent 
hibitane was applied to the exposed skin. A small midline cut was made through the skin. The 
cut was moved laterally to expose the dorsal musculature, and a second cut was made through 
the muscle. The ovary and uterine horn were exteriorised, and the distal uterine horn was 
clamped with a haemostat, just below the ovary. The ovary was then excised. The uterine horn 
was placed back into the abdominal cavity, and the procedure was repeated on the contralateral 
side.  
Following bilateral removal of the ovaries, a SILASTIC capsule of 17β-oestradiol 
mixed with medical-grade adhesive (0.1 mg/mL adhesive) into SILASTIC tubing (0.1 mm 
internal diameter, 2.13 mm external diameter) was implanted subcutaneously. Implants were 
cut to 1 cm/20 g body weight to provide 1 µg oestradiol/20 g body weight. Finally, the skin was 







Figure 9.4: Experimental protocol for in vivo optogenetic pilot experiments. 
a) Experimental setup. Bilateral optical fibres (F/O) are implanted above the SCN to shine blue light onto ChR2-
expressing Avp-cre neurons (red). Mice in this experiment are ovariectomised (OVX) and implanted with a 
capsule of 17β-oestradiol (17βE2 Cap). One day prior to blood sampling, mice receive oestradiol benzoate 
subcutaneously (EB). This primes mice for an LH surge (OVX+E+E) on the day of blood sampling. b) Time 
course of experimentation showing surgeries and injection times. Blue bars represent experiment times. bi) 
Time course of blood sampling. Red drops indicate when blood samples are taken (20 min intervals). Blue or 
grey box indicates an hour of optogenetic stimulation, or sham stimulation with the laser turned off. 
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Postoperative management procedures, outlined by the University of Otago Animal 
Ethics Committee, were carried out following surgery. 
Five days post-implantation, mice received a subcutaneous injection of oestradiol 
benzoate (1 µg/ 20 g body weight) to raise serum oestradiol to positive feedback levels 
(Bronson, 1981) (Figure 9.4b). 
 
9.9.2.3 In vivo optogenetic protocol 
Mice were randomly assigned to either stimulation or sham protocol. Sham protocols 
were carried out in exactly the same manner as stimulation, but the laser was not turned on. At 
ZT3 on the day of the experimentation, mice were connected via the fibre-optic cannulae to a 
laser (IkeCool Corporation). At ZT5, the laser was turned on to deliver 5 ms pulses of 473 nm 
wavelength light at 20 Hz for 6 seconds every 12 seconds (based on Piet et al. (2018)), for 60 
mins (Figure 9.4bi). Between ZT4-ZT7 serial blood samples were collected from the tail tip as 
outlined below.  
Following experimentation, mice were then reassigned to the opposite group (i.e. 
stimulation became sham). A second implant and injection (as outlined above) were given, and 
the experiment was repeated at a later date based on the mouse’s new grouping. Thus, each 
animal underwent both stimulation and sham stimulation. At the end of the second experiment, 
the mice were transcardially perfused (Section 2.3.1) so ChR2 expression and optical fibre 
placement could be determined.  
 
9.9.2.4 Serial blood sample collection 
Mice used for in vivo optogenetic experiments were habituated to daily handling for 2-
5 weeks prior to blood sampling, to avoid stress when taking blood. Mice were kept in a quiet 
room in open-top cages during this handling procedure. Blood samples were taken from a small 
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cut at the tip of the mouse’s tail. Three µL of blood was taken every 20 minutes during the 
experimental period (Figure 9.4bi). Whole blood samples were then diluted in 57 µL of 
phosphate-buffered saline (PBS)-tween (Appendix I, 1.10) and immediately frozen on dry ice. 
Blood samples were stored at -20ºC for post hoc hormone assays.  
 
9.9.2.5 LH sandwich enzyme-linked immunosorbent assay (ELISA) 
 An established sandwich ELISA for LH (Steyn et al., 2013; Czieselsky et al., 2016) was 
used to determine the concentration of LH in the small blood samples taken as per Section 2.7. 
A 96-well high-affinity binding plate (Corning) was coated with bovine LHβ518B7 monoclonal 
antibody (50 µL/well; 1:1000 in PBS; Dr. L. Sibley, UC Davis, CA, USA). All incubations 
following, were carried out in a humidified chamber on an orbital shaker. Following overnight 
incubation at 4ºC, wells were filled with 200 µL of blocking buffer (Appendix I, 1.12) and were 
incubated for 120 minutes at room temperature. The plate was then washed with 0.05% PBS-
Tween (Appendix I, 1.10), 3 times for 3 minutes each. Samples, along with standards and 
positive controls, were added to the plate and incubated at room temperature for 120 minutes. 
The standard curve for LH detection was produced by serial dilution of mouse LH-RP reference 
peptide (Dr. A. Parlow, National Hormone and Pituitary Program, Torrence, CA, USA). 
Following this, plates were washed as described previously. Fifty µL/well of rabbit LH 
detection primary antibody (1:10000 in PBS; Dr. A. Parlow, National Hormone and Pituitary 
Program, Torrence, CA, USA) were added to the well for 90 mins and incubated at room 
temperature. This was followed by washing, and incubation with 50 µL/well of horseradish 
peroxidase-conjugated polyclonal goat anti-rabbit IgG secondary antibody (1:1000 in PBS; 
DAKO, Santa Clara, CA, USA) for 90 mins at room temperature. After another wash, 100 
µL/well of H2O2 in citrate buffer (Appendix I, 1.11) with o-phenylenediamine (1 tablet, 
Invitrogen) was added, and incubated while protected from light for 30 mins. The reaction was 
ceased by addition of 50 µL/well of 3M hydrochloric acid. LH levels were then determined 
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using an absorbance plate reader (Molecular Devices) at 490 nm and 650 nm wavelengths. The 
sensitivity of the LH ELISA was 0.002 ng/mL. 
 
9.9.2.6 Statistical analysis 
 General analysis methods are outlined in Section 2.7. LH concentrations were grouped 
into either baseline (1020 – 1100 hr), stimulation/sham (1120 – 1200 hr), or recovery (1220 – 
1300 hr) periods. These were compared across experiments using a Friedman test with post hoc 
Dunn’s multiple comparisons test. To compare between experiments, the stimulation or sham 
period was normalised to the baseline concentrations. The stimulation and sham periods were 
then compared using a Mann-Whitney test. 
 
9.9.3 Preliminary results 
 Eight mice were sampled with either light stimulation of ChR2-expressing SCN Avp-
cre neurons (stimulation), and then at another time with sham stimulation (laser not turned on; 
sham), or in the opposite order. Individual LH secretion profiles over the sampling periods are 
presented in Figure 9.5a. Throughout the experiment, some mice did not display any notable 
differences in LH secretion from baseline, in either stimulation (Figure 9.5a; examples: mice 4 
and 5) or sham experiments (Figure 9.5a; examples: mice 6, 7 and 8). Others showed small 
peaks in LH concentration during stimulation (Figure 9.5a; examples - mice 1, 3 and 5). Similar 
peaks in LH concentration, however, were also seen in control experiments with sham 
stimulation (Figure 9.5a; examples - mice 1 and 2). The highest concentration of LH recorded 
during stimulation was 4.12 ng/mL (Figure 9.5a; mouse 7). The highest concentration of LH 







Figure 9.5: In vivo optogenetic stimulation of SCN Avp-cre neurons does not change plasma LH 
concentration. 
a) Plasma LH profiles in eight individual mice. Each was subjected to optogenetic stimulation, or to sham 
stimulation (laser off), in a randomised order. Blue bars represent the stimulation period. b, c) Averaged LH 
profiles from mice with optogenetic stimulation (b) or sham stimulation (c). d, e) Quantified data from the 
baseline, during the stimulation or during the sham stimulation, and the recovery period post-stimulation. f) 
There was no difference in LH concentration whether stimulation was on or off. Dotted lines represent baseline. 
Symbols represent individual mice and are shown on individual traces. Raw data shown in a). Data in b) – f) 
shown as mean ± SEM. 
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the highest peak in LH concentration at 13.53 ng/mL (Figure 9.5a), however, this peak was 
initiated before the onset of stimulation, and, therefore, could not have been caused by the 
excitation of ChR2-expressing neurons. 
When the data are grouped (Figure 9.5b) there was no synchronised increase in LH 
secretion, suggesting that overall stimulation of ChR2-expressing SCN Avp-cre neurons did not 
trigger an LH surge (Figure 9.5b, d; baseline [LH]: 1.53 ± 0.50 ng/mL; stimulation [LH]: 1.48 
± 0.37 ng/mL, p = 0.91 compared to baseline; stimulation recovery [LH]: 1.37 ± 0.50 ng/mL, 
p = 0.91 compared to baseline; n = 8 mice; Friedman tests with post hoc Dunn’s multiple 
comparisons tests). In sham experiments, there was also no change to LH concentration during 
or following light stimulation (Figure 9.5c, e; sham baseline [LH]: 1.87 ± 0.89 ng/mL; sham 
stimulation [LH]: 1.07 ± 0.35 ng/mL, p > 0.99 compared to baseline; sham recovery [LH]: 1.01 
± 0.41 ng/mL, p > 0.99 compared to baseline; n = 8 mice; Friedman tests with post hoc Dunn’s 
multiple comparisons tests). Due to the difference in raw baseline LH concentrations, the 
stimulation concentrations were normalised to baseline levels before comparison. There was no 
difference between the normalised LH concentrations between stimulation and sham groups 
(Figure 9.5f; normalised stimulation [LH]: 122.0 ± 26.3% of baseline; normalised sham [LH]: 
120.4 ± 33.0% of baseline; p = 0.80, Mann-Whitney test). 
 The data presented here suggest that in vivo optogenetic stimulation of ChR2-expressing 
SCN Avp-cre neurons may not be sufficient to trigger an LH surge out of phase. 
 
9.9.4 Discussion 
9.9.4.1 Limitations of this pilot study 
 There are multiple limitations to this experiment, which will now be considered. This 
experiment relies on multiple coincident successes to ensure that each step is carried out 
accurately. Firstly, the SCN Avp-cre neurons must be accurately targeted by the AAV injection 
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to ensure ChR2-expression is sufficient. The data presented here comes from animals with 
visible mCherry expression in the SCN, with optical fibres placed in the parenchyma above. 
There is little reason to suspect the function of the ChR2 differs in vivo compared to what has 
been shown in in vitro experiments carried out in Chapter 5. Following AAV injection, it was 
necessary to ensure that the fibreoptic placement accurately targeted the SCN. Practise 
experiments carried out show that the fibreoptic can be stereotaxically fitted above the SCN, 
however, the placement in these experiments remains unknown. Secondly, it remains unknown 
as to how the light from the fibreoptic illuminates the SCN. While it was placed above the SCN, 
it may be that the light does not reach all the ChR2-expressing neurons, and thus, fewer neurons 
are stimulated than would be effective in vivo. Thirdly, while the OVX+E+E protocol has been 
shown to induce positive feedback in mice necessary for an LH surge (Bronson & vom Saal, 
1979; Czieselsky et al., 2016), it has not been tested whether this protocol is able to reliably 
induce a normally-timed LH surge in these mice. Finally, serial blood sampling from freely 
behaving animals is anecdotally difficult when mice may be experiencing even the slightest 
amount of stress. Stress hormones can inhibit the LH surge from occurring (Roozendaal et al., 
1995; Wagenmaker & Moenter, 2017). While the mice in this study had been habituated to 
daily handling and manipulation of the tail similar to being bled for at least 4 weeks before the 
end prior to any experimentation, there is a possibility that the stress of the experiments may 
have inhibited the development of an LH surge. As such, all of these factors may have 
contributed to the outcome presented here. 
 While the in vivo experiments have been designed to replicate the in vitro work carried 
out in Chapter 6, there are differences between them that may contribute to the findings 
presented here. Due to brain slices being taken for experiments in Chapter 6, stimulation of 
ChR2-expressing Avp-cre projections was carried out, whilst here, stimulation is targeted at the 
cell bodies. The stimulation paradigm used here is based off that by Piet et al. (2018) to 
stimulate kisspeptin neurons, adapted to 20 Hz, similar to the in vitro experiments in Chapter 
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6. As no studies have addressed the stimulation frequency at the SCN needed to trigger hormone 
release from neurons efferent to SCN projections, this frequency was chosen based on what 
could accurately be used to induce AVP release as per Chapter 6. Green and Gillette (1982) 
suggest that the late-afternoon firing frequency (when the LH surge is expected) of the SCN is 
approximately 10-12 Hz, thus, it could be that a stimulation frequency closer to that range may 
be necessary.  
In saying this, the frequencies reported are for the entire SCN, rather than SCN AVP 
neurons. Whether the frequency accurately represents SCN AVP neuron activity, however, 
would make little difference if AVP was not being produced. One possibility is that as these 
experiments were carried out in the mid-late morning, AVP would not have been synthesised 
or exported to the RP3V. Thus, the SCN itself may not be geared to trigger an LH surge. 
  
9.9.4.2 Downstream mechanisms of timekeeping 
 The above limitations are related to the SCN and Avp-cre neurons to explain our 
observations. It may be that downstream of SCN neurons, timekeeping mechanisms, which 
have not been considered in this experiment, may also play a role. These include mechanisms 
in the kisspeptin and GnRH neurons, as well as gonadotrophs in the anterior pituitary gland.  
 Both kisspeptin neurons and GnRH neurons express clock genes (Hickok & Tischkau, 
2010; Chassard et al., 2015) potentially gating their receptivity to upstream signals. Kisspeptin 
neurons display daily oscillations in clock genes (Chassard et al., 2015); but how this correlates 
to their activity or output is unknown. There may be a circadian pattern of kisspeptin expression 
(Xu et al., 2011) although this could be due oestrogenic feedback and signals from the SCN 
(Robertson et al., 2009; Smarr et al., 2012). Circadian V1R expression in kisspeptin neurons 
specifically has not been addressed. There may be, however, circadian expression of V1R in 
the RP3V (Smarr et al., 2013), although this has not been a consistent finding (Kalamatianos et 
al., 2004a). Despite this, RP3V kisspeptin neurons can respond to AVP similar extents 
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throughout the day (Piet et al., 2015b) suggesting that V1R expression is not regulated in a 
circadian manner. While AVP may be able to stimulate kisspeptin neurons throughout the day, 
the amount of kisspeptin peptide synthesised at the stimulation time here, may not be high 
enough to trigger GnRH activity (Robertson et al., 2009). Immortalised GnRH neurons show 
circadian rhythmic patterns of Kiss1R expression further gating their responsiveness to 
kisspeptin (Tonsfeldt et al., 2011). Finally, studies of anterior pituitary gonadotropes show that 
there may also be gating the activity of GnRH peptide, with circadian regulation of GnRHRs 
(Schirman-Hildesheim et al., 2006; Resuehr et al., 2007). In saying this, however, gonadotrope-
specific knock-out of BMAL1 does not affect the LH surge (Chu et al., 2013). Interestingly, 
kisspeptin, Kiss1R and GnRHR are all likely to be most highly expressed in the mid-afternoon 
when the onset of the LH surge is expected (Schirman-Hildesheim et al., 2006; Robertson et 
al., 2009; Hickok & Tischkau, 2010; Tonsfeldt et al., 2011; Xu et al., 2011). 
 Thus, the stimulation of SCN Avp-cre neurons in vivo, may be able to drive their 
excitation, the multiple downstream gating mechanisms discussed above could prevent this 
signal propagating through the GnRH neuronal network to the GnRH neurons and 
gonadotropes, precluding the generation of the LH surge. 
 
9.9.5 Summary 
 In this pilot study, an LH surge was not triggered by in vivo stimulation of SCN Avp-
cre neurons. There are a number of technical factors, and downstream biological mechanism 
which remain to be validated, that hinder interpreting the results seen here. This study paves 
the way for significant follow-up work. Future experiments could test stimulation of the entire 
SCN to trigger a surge, rather than the cre-expressing subpopulation; whether stimulation of 
the Avp-cre neurons at a different time of could drive the initiation of the LH surge, or whether 
the downstream kisspeptin and GnRH neurons may have gating mechanisms for time-locking 
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